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Abstract 




Selenocysteine (Sec), the 21st genetically encoded amino acid, is the major metabolite of 
the micronutrient selenium. Sec is inserted into nascent proteins in response to a UGA 
codon. The substrate for ribosomal protein synthesis is selenocysteinyl-tRNASec. While 
the formation of Sec-tRNASec from seryl-tRNA5^ by a single bacterial enzyme 
selenocysteine synthase (SelA) has been well described, the mechanism of Sec-tRNASec 
formation in archaea and eukaryotes remained poorly understood. Herein, biochemical 
and genetic data provide evidence that, in contrast to bacteria, eukaryotes and archaea 
utilize a different route to Sec-tRNASec that requires the tRNASec-dependent conversion 
of O-phosphoserine (Sep) to Sec. In this two-step pathway, O-phosphoseryl-tRNA 
kinase (PSTK) first converts Ser-tRNASec to Sep-tRNASec. This misacylated tRNA is the 
obligatory precursor for a Sep-tRNA: Sec-tRNA synthase (SepSecS); this protein was 
previously annotated as Soluble Liver Antigen/Liver Pancreas (SLA/LP). SepSecS genes 
from Homo sapiens, the lower eukaryote Trypanosoma brucei and the archaea 
Methanocaldococcus jannaschii and Methanococcus maripaludis complement an Escherichia 
coli AselA deletion strain in vivo. Furthermore, genetic analysis of selenoprotein 
biosynthesis in T. brucei in vivo demonstrated that eukaryotes have a single pathway to 
Sec-tRNASec that requires Sep-tRNASec as an intermediate. Finally, purified recombinant 
SepSecS converts Sep-tRNASec into Sec-tRNASec in vitro in the presence of sodium selenite 
and purified E. coli selenophosphate synthetase. 
The final step in Sec biosynthesis was further investigated by a structure-based 
mutational analysis of the M. maripaludis SepSecS and by determining the crystal 
structure of human SepSecS complexed with tRNAScc, phosphoserine and thiophosphate 
at 2.8 A resolution. In vivo and in vitro enzyme assays support a mechanism of Sec-
tRNASec formation based on pyridoxal phosphate, while the lack of active site cysteines 
demonstrates that a perselenide intermediate is not involved in SepSecS-catalyzed Sec 
formation. Two tRNA5" molecules, with a fold distinct from other canonical tRNAs, 
bind to each human SepSecS tetramer through their unique 13 base-pair acceptor-T^C 
arm. The tRNA binding induces a conformational change in the enzyme's active site that 
allows a Sep covalently attached to tRNA5", but not free Sep, to be oriented properly for 
the reaction to occur. 
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INTRODUCTION 
A. Selenocysteine, a versatile amino acid 
Selenium is a dietary trace element required for animal and human health. The 
antioxidant properties of selenium are thought to offer protection from diverse human 
ailments including adverse mood states, cardiovascular disease, viral infections and 
cancer (Rayman, 2000). Selenium carries out its functions in proteins in the form of 
selenocysteine (Sec), in which the sulfur-containing thiol group of cysteine has been 
replaced by the selenium-containing selenol moiety (Figure 1) (Cone et al., 1976). 
Although selenium and sulfur belong to the same group of elements in the periodic 
table and hence share some chemical properties (for example, electronegativity and 
major oxidation state), it is the different electronic structure of these two elements that 
makes the selenolate anion more stable than the thiolate one and gives selenoproteins 
their unique selenium-derived catalytic efficiencies. Indeed, the low pKa of selenol 
relative to a thiol (5.2 versus 8.0, respectively) and selenol's lower redox potential (- 488 
mV, versus - 233 mV for the thiol) render it fully ionized at the physiological pH range 
and causes selenocysteine to be substantially more reactive than cysteine (Figure 1) 
(Ambrogelly et al., 2007). Thus, it is not surprising that most known selenoproteins are 
oxidoreductases with an essential (for efficient catalysis) selenocysteine active site 
residue. A selenocysteine-to-cysteine (Cys) mutation in such cases results in a >100-fold 
reduction in catalytic turnover (Axley et al., 1991; Johansson et al., 2005). 
Biochemical studies and genomic analyses have established that selenocysteine 










pKa = 5.2 
Figure 1: The chemical structures and ionization states of cysteine and selenocysteine at 
physiological pH. 
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archaea and eukaryotes — though not in all species. In fact, most organisms do not use 
this amino acid. Except for its occurrence in Chlamydomonas spp. (Fu et al., 2002) and 
green algae of the Ostreococcus and the Volvox spp. (Lobanov et alv 2009), selenocysteine 
is notably absent from fungi and higher plants. Although the mammalian 
selenoproteome (Kryukov et al., 2003) consists of more than 20 selenoproteins, only a 
limited number of prokaryotes contain selenocysteine (Kryukov and Gladyshev, 2004). 
For instance, within the archaea with known genomes (currently representing 43 
genera), selenoproteins are restricted to two genera, Methanococcus and Methanopyrus 
(Stock and Rother, 2009). 
Selenocysteine is the principal metabolite of selenium in the human body and the 
means for exerting its various health benefits (Rayman, 2000). Like the rest of the 20 
canonical amino acids selenocysteine is delivered to the ribosome for protein synthesis 
by its cognate transfer RNA (tRNA) molecule, tRNASec. Knockout of tRNASec in the 
mouse is embryonic lethal, which underscores the importance of Sec-containing proteins 
(or selenoproteins) in mammalian development (Bosl et al., 1997). Mutations and 
polymorphisms in several of the currently known 25 human selenoproteins have been 
implicated in cancer and diseases of the muscular, nervous, immune and endocrine 
systems (Bellinger et al., 2009). Most human selenoenzymes (i.e. thioredoxin reductase, 
glutathione peroxidase, thioredoxin/glutathione reductase and methionine sulfoxide 
reductase) safeguard the cell from the detrimental effects of reactive oxygen species and 
regenerate important antioxidants such as vitamin C, vitamin E and coenzyme Q (Lu 
and Holmgren, 2009). Selenocysteine is also the catalytic residue in iodothyronine 
3 
deiodinase, the enzyme that enables circulating thyroid hormone to exert its pro-
metabolic actions in peripheral tissues. The erroneous replacement of the active site Sec 
with the chemically similar serine (Ser) or Cys diminishes the activity of several 
selenoenzymes (Zhong and Holmgren, 2000; Kuiper et al., 2003). 
B. Selenocysteine, the 21st genetically encoded amino acid 
Ribosomal protein synthesis is the pathway to most natural proteins. The genetic code 
serves as the 'alphabet' used by the translation machinery to ensure faithful decoding of 
the genetic message into the specified amino acid sequence each cellular protein is 
comprised of. The code is usually represented as the assortment of mRNA codons that 
specify each amino acid (Figure 2). With the exception of tryptophan and methionine, 
the code is redundant such that more that one mRNA triplet specifies each canonical 
amino acid. At the same time it is not ambiguous; each codon has only one meaning 
since it specifies only one particular amino acid or a translational stop (codons UGA, 
UAA and UAG). Since the discovery of the code in the mid 1960s (Nirenberg et al., 1965; 
Soil et al., 1965) the canonical amino acids that participate in protein synthesis across all 
species were known to be twenty in number. Given the unambiguous nature of the code, 
the prospect for additional genetically encoded amino acids being discovered seemed 
very faint. 
Nevertheless, in the late 1980s and early 1990s selenocysteine was established as 
the 21st genetically encoded amino acid and UGA as the only codon with an ambiguous 
meaning (Zinoni et al., 1986 ; Leinfelder et al., 1988; Soil, 1988). Although the occurrence 
4 
Figure 2: Circular representation of the genetic code (Adapted from Ambrogelly et al., 
2007). The genetic code maps each trinucleotide sequence (or codon) found in mRNA to 
a specific amino acid. The first nucleotide of each codon lies in the inner circle and 
moving outward are the second and the third ones. The code is composed of 64 codons; 
61 specify one of the 20 canonical amino acids and three are stop codons (UGA, UAG, 
UAA) that indicate translational termination. In selenoprotein-containing organisms 
UGA also codes for Sec (red). Similarly, in the Methanosarcinacea and in 
Desulfitobacterium hafniense UAG also codes for pyrrolysine (Pyl). 
5 
of Sec as the selenium moiety in naturally occurring proteins was discovered in 1976 
(Cone et al., 1976), Sec was thought to be the result of a post-translational modification 
event (Forstrom et al., 1978). Apart from its most common function to signal 
translational termination, an in-frame UGA codon within the coding region of certain 
proteins also codes for selenocysteine in organisms from all three domains of life (Figure 
2). An elegant recoding mechanism allows the translation machinery to accurately 
discriminate between a Sec UGA and a Stop UGA codon (Bock et al., 2005). The presence 
of a stem-loop structure in the mRNA of selenoproteins signals the insertion of 
selenocysteine to the translation apparatus (reviewed in Introduction, section D). 
Currently, the repertoire of genetically encoded amino acids has expanded to 
include 22 members. UAG is also ambiguous in the Methanosarcinaceae and in the 
bacterium Desulfitobacterium hafniense, where in addition to serving as a translational 
stop it also encodes pyrrolysine (Pyl) (Figure 2), the 22nd cotranslationally inserted 
amino acid (Hao et al., 2002; Srinivasan et al., 2002). 
C. Selenocysteine is the universal exception to Crick's adapter hypothesis 
Faithful protein synthesis relies on the presence of an aminoacyl-tRNA (aa-tRNA) with 
an anticodon that matches the mRNA codon by the rules of the wobble hypothesis at the 
ribosome (Crick, 1966; Soil et al., 1966), and the cognate amino acid esterified to the 
tRNA's 3'-terminal adenosine (Ibba and Soil, 2000). Thus, synthesis of the correct 
aminoacyl-tRNA is critical in enabling the genetic code. Aminoacyl-tRNA synthesis is 
the task of a family of enymes called aminoacyl-tRNA synthetases (aaRSs); each enzyme 
6 
esterifies its cognate amino acid to the corresponding tRNA species (Ibba and Soil, 2000). 
AARSs ultimately "read" the genetic code since they are responsible for selecting the 
right amino acid out of the cellular pool of amino acids and pairing it with its cognate 
tRNA (Figure 3). 
According to Crick's adapter hypothesis postulated 40 years ago, there should be 
one aaRS for each amino acid (Crick, 1958). Indeed, this is the case for the twenty 
canonical amino acids and for the most recent addition to the set of genetically encoded 
amino acids, pyrrolysine. Pyrrolysyl-tRNA synthetase is a newly discovered aaRS, 
responsible for the synthesis of pyrrolysyl-tRNA (Blight et al., 2004; Polycarpo et al., 
2004). A prerequisite for the acylation of a tRNA with its cognate amino acid by the 
corresponding aaRS is the presence of a cellular pool of free amino acids synthesized 
prior to this step. Indeed, biochemical experimental efforts of the last century have 
identified biosynthetic pathways for all 20 canonical amino acids and recently for 
pyrrolysine as well (Longstaff et al., 2007). 
Selenocysteine is the only exception; there is no biosynthetic pathway for free Sec 
formation within the cell and a selenocysteinyl-tRNA synthetase (SecRS) does not exist 
(Figure 3). Instead, selenocysteine synthesis occurs on its cognate tRNA in a route that is 
based on misacylation and subsequent tRNA-dependent amino acid transformation. The 
selenocysteine-specific tRNA has a UCA anticodon (thus, it pairs with UGA at the 
ribosome according to the wobble rules) and is denoted as tRNASec (Leinfelder et al., 






































































































































































































































































































































































































































































































































case Sec) denotes the anticodon that is specific for the cognate amino acid (in this case 
Sec). The prefix before the tRNA denotes the amino acid attached to the 3' end of the 
tRNA; for example, Sec-tRNASec denotes that selenocysteine is acylated to the 3' end of 
tRNASec, while Ser-tRNASec denotes that serine is attached (or misacylated) to the 3' end 
of tRNASec. 
D. Biosynthesis of selenocysteine and UGA recoding in bacteria 
Pretranslational amino acid modification is the path to Sec-tRNASec in bacteria (Figure 4). 
Selenocysteine biosynthesis begins with SerRS acylating tRNASec with serine, but 
because of its unusual structure SerRS does so with only 1% efficiency as compared with 
the other five tRNASer isoacceptors (Baron et al., 1990). Based on the requirement of 
Escherichia coli formate dehydrogenase for the presence of selenocysteine for activity, a 
genetic system was developed that led to the identification of four E. coli genes (selA, 
selB, selC and selD), all of which are essential for selenocysteine insertion (reviewed in 
Yoshizawa and Bock, 2009). In addition to tRNASec (SelC), selenocysteine synthase 
(SelA) and selenophosphate synthase (SelD) are needed for conversion of Ser-tRNASec to 
Sec-tRNASec. SelA is a pyridoxal phosphate (PLP)-dependent enzyme with a conserved 
lysine (Lys) residue that catalyzes the formation of an enzyme-bound dehydroalanyl 
intermediate with elimination of a water molecule (Forchhammer et al., 1991). SelD 
synthesizes (from selenide and ATP) the selenium donor selenophosphate (Tormay et 
al., 1998). This compound reacts with the SelA-bound dehydroalanyl-tRNASec to form 
9 
Sec-tRNASec. Thus, selenocysteine is made by a tRNA-dependent amino acid 
modification process (Figure 4). 
Recoding of UGA as selenocysteine requires the presence of an mRNA stem-loop 
structure known as the selenocysteine insertion sequence (SECIS) element (reviewed in 
Yoshizawa and Bock, 2009). In bacteria, the SECIS element is located immediately 
downstream of the UGA codon within the selenoprotein coding region. The general 
translation elongation factor Tu (EF-Tu) does not recognize Sec-tRNASec effectively 
neither in vivo (Leinfelder et al., 1989) nor in vitro (Forster et al., 1990). Instead, the 
specialized elongation factor SelB performs two functions that are crucial for proper 
UGA recoding as selenocysteine: (i) its N-terminal domain, which is homologous to EF-
Tu, binds to Sec-tRNASec with high specificity but not to any other aa-tRNAs including 
Ser-tRNASec (Forchhammer et al., 1989); and (ii) the binding of SelB to the SECIS element 
through its C-terminal domain is required for delivery of Sec-tRNASec to the ribosomal A 
site, by outcompeting release-factor binding to the UGA codon. Thus, the dual 
properties of SelB guard the fidelity of protein translation by ensuring that only UGA 
codons in selenoprotein mRNAs are recoded (Allmang et al., 2009). 
E. Selenocysteine biosynthesis in eukaryotes and archaea: the last riddle in 
aminoacyl-tRNA synthesis 
Because a selenocysteinyl-tRNA synthetase (an enzyme that would directly 
esterify selenocysteine to its cognate tRNASec) has never evolved, tRNA-dependent 


























































































































































































































































































































































































































and archaea. Indeed, serylation of tRNASec by SerRS has been shown in vitro in both 
eukaryotes (Wu and Gross, 1993; Ohama et al., 1994; Stiirchler-Pierrat et al., 1995; 
Geslain et al., 2006) and archaea (Rother et al., 2000; Bilokapic et al., 2004; Kaiser et al., 
2005) and is likely to occur in vivo as well (Allmang and Krol, 2006; Geslain et al., 2006). 
However, the search for a selenocysteine synthase activity that would convert Ser-
tRNASec to Sec-tRNASec proved futile (Kaiser et a l , 2005), suggesting an alternative 
synthetic pathway in eukaryotes and archaea. 
An elegant bioinformatic analysis revealed the enzyme 0-phosphoseryl-tRNASec 
(Sep-tRNASec) kinase (PSTK) to be present only in genomes of organisms that have a 
selenoproteome. The activity was characterized in vitro both for the mouse (Carlson et 
al., 2004) and the Methanocaldococcus jannaschii (Kaiser et al., 2005) enzymes; this kinase 
phosphorylates Ser-tRNASec to form Sep-tRNASec in the presence of ATP and 
magnesium. PSTK exhibits a remarkable specificity for Ser-tRNASec. It does not 
phosphorylate free Ser or Ser attached to its cognate tRNASer (Carlson et al., 2004). Thus, 
only tRNASec binding can appropriately position Ser in the active site of PSTK for 
phosphorylation to occur. Moreover, in contrast to most aaRSs that bind their cognate 
tRNAs with micromolar affinities, PSTK binds both unacylated and serylated tRNASec 
with nanomolar affinity (Sherrer et al., 2008b). Such tight binding of tRNASec to PSTK 
may compensate for the significantly lower abundance of tRNASec than tRNASer even in 
selenocysteine-rich tissues such as liver, kidney and testis (Diamond et al., 1993). 
12 
While the discovery of PSTK lent credence to the old finding of Sep-tRNASec in 
mammalian cell extracts (Maenpaa and Bernfield, 1970), the concomitant discovery of 
Sep-tRNA:Cys-tRNA synthase (SepCysS) in some methanogenic archaea (Sauerwald et 
alv 2005) paved the way for the elucidation of the route to selenocysteine synthesis in 
archaea and eukarya (Figure 5). SepCysS uses PLP as a cofactor and a sulfur donor to 
convert Sep attached to tRNAcys to Cys. Given the similar chemistries of Cys and Sec, the 
presence of Sep-tRNAcys as an intermediate of Cys biosynthesis in certain methanogenic 
archaea suggested Sep-tRNASec as an intermediate in the anabolic cycle of Sec (Su et al., 
2009) and further supported the quest for an archaeal and eukaryal enzyme that would 
perform the Sep to Sec conversion (Figure 5). From a chemical standpoint, O-
phosphoserine would provide a better leaving group (phosphate) than serine (water) for 
replacement with selenium. 
Regarding UGA recoding on the ribosome, several distinguishing features 
account for a more complex picture and a still-hazy understanding of the process in 
archaea and eukaryotes. In particular, the established presence of the eukaryotic and 
archaeal SECIS elements in the 3' untranslated region of the mRNA, the inability of the 
eukaryotic and archaeal homolog of SelB to bind to the SECIS element, and the 
identification of other SECIS-binding proteins have led to the proposition of at least two 
unconfirmed models (Allmang et al., 2009) that may explain how the ribosome 
distinguishes a selenocysteine UGA from a termination codon and how the eukaryotic 




























































































































































































































































































































































































































































































































































F. Scope of Dissertation 
1. Solving the riddle of selenocysteine formation in eukaryotes and archaea 
Sec-encoding organisms have 21 genetically encoded amino acids, but have acquired 
only 20 aminoacyl-tRNA synthetases during their evolution. The biosynthetic route of 
aa-tRNA formation is understood for all genetically encoded amino acids except for 
selenocysteine in archaea and eukarya (Allmang and Krol, 2006; Hatfield et al., 2006). 
Given that a PLP-dependent selenocysteine synthase activity (as manifested by E. coli 
SeLA (Tormay et al., 1998) for the conversion of Ser-tRNASec to Sec-tRNASec) has been 
elusive, we considered other proteins. The most promising enzyme candidate to exhibit 
such an activity is the human protein soluble liver antigen/liver pancreas (SLA/LP). This 
protein was first identified in the early 1990s as it co-precipitated with tRNASec when 
mammalian cell extracts were treated with serum from patients with autoimmune 
hepatitis (Gelpi et al., 1992). Through a computational approach SLA/LP was classified 
as a PLP-dependent serine hydroxymethyltransferase (Kernebeck et al., 2001) and its 
archaeal orthologs are merely found in known Sec-containing archaea. Interestingly, the 
closest homologue of SLA/LP is SepCysS, the only known tRNA-dependent enzyme that 
converts Sep to Cys (Yuan et al., 2006; Su et al., 2009). 
We used biochemical and molecular genetic studies to establish that human 
SLA/LP, as well as its Methanococcus maripaludis orthologue, convert Sep-tRNASec to Sec-
tRNASec in vivo and in vitro. Thus, this enzyme is a Sep-tRNA: Sec-tRNA synthase 
(SepSecS), filling in the question mark in Figure 5 (Yuan et al., 2006). 
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2. The PSTK/SepSecS pathway is the only route to Sec in Trypanosomas, and likely in 
all eukaryotes 
The identification of the human SLA/LP and the M. maripaludis MMP0595 proteins as 
SepSecS enzymes that convert Sep-tRNASec —> Sec-tRNASec was done by in vivo 
complementation assays in a heterologous bacterial system and by in vitro activity 
assays using purified components. However, earlier RNA interference results in 
mammalian cells could not exclude the existence of an alternative SepSecS-independent 
pathway of Sec-tRNASec formation (Xu et alv 2005). In that study, RNAi-mediated 
ablation of SepSecS had only a marginal effect on mammalian selenoprotein synthesis. 
We investigated the potential presence of an alternative pathway to Sec-tRNASec 
in eukaryotes in the insect form of the parasitic protozoon Trypanosoma brucei, which is a 
highly tractable genetic system. Double allelic knockout cell lines can easily be produced 
in T. brucei by homologous recombination-directed gene replacements (Beverley and 
Clayton, 1993), while RNAi-based methods for highly efficient inducible ablation of 
proteins are also available (UUu et al., 2004). Moreover, in silico screens by several 
groups identified tRNASec, SerRS, PSTK, SepSecS, SPS2 (the eukaryotic orthologue of the 
T.coli selenophosphate synthase SelD) and EFSec (the eukaryotic orthologue of the E.coli 
elongation factor SelB) in the T. brucei genome (Cassago et al., 2006; Lobanov et al., 
2006). Genetic knockouts and in vivo selenoprotein analysis in T. brucei revealed the 
presence of a single pathway for Sec-tRNASec synthesis involving the SerRS, PSTK and 
SepSecS sequence and strengthened the notion that all eukaryotes have a single 
route to Sec. 
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3. Insights into archaeal Sec synthesis from the structure of M. maripaludis SepSecS 
The initial characterization of SepSecS revealed that this protein is a PLP-dependent 
enzyme (Yuan et al., 2006; Xu et al., 2007). In nature such enzymes are abundant; in 
some microbial genomes, they represent as much as 1.5% of all genes (Percudani and 
Peracchi, 2003). They have many diverse functions and are often involved in amino acid 
biosynthesis (Eliot and Kirsch, 2004). The structures of three other PLP-dependent 
enzymes that use substrates (selenocysteine, cysteine) chemically similar to those of 
SepSecS have been solved. One is the Archaeoglobus fulgidus SepCysS (Fukunaga and 
Yokoyama, 2007), while another one is the E. coli selenocysteine lyase (CsdB) (Lima, 
2002), an enzyme that converts selenocysteine to alanine and elemental selenium 
(Mihara et al., 1999). The last enzyme is the E. coli cysteine desulfurase (IscS) that 
catalyzes the desulfuration of cysteine (Cupp-Vickery et al., 2003). The reactions 
catalyzed by these enzymes are illustrated in Figure 6; SepSecS and SepCysS carry out |3-
replacements on tRNA-bound Sep, while selenocysteine lyase removes the |3-substituent 
of Sec to form elemental selenium, and cysteine desulfurase catalyzes the fragmentation 
of cysteine to alanine and elemental sulfur. The lack of structural and biochemical data 
on SepSecS prompted us to further characterize this enzyme. The crystal structure of M. 
maripaludis SepSecS (MMPSepSecS) at 2.5 A resolution was solved and a structural 
comparison with E. coli CsdB (ECCsdB) and A. fulgidus SepCysS (AFSepCysS) was 
performed. I identified active site residues important for the enzymatic function of 




























































































































































































































































































































4. The mechanism of tRNASec recognition and Sec formation by the human SepSecS 
Despite the crystal structures of the archaeal and murine SepSecS apo-enzymes several 
questions remained unanswered. SepSecS acts on phosphoserine that is linked to 
tRNASec and not on free phosphoserine or Ser-tRNASec (Yuan et al., 2006; Xu et alv 2007; 
Ganichkin et alv 2008). However, the molecular basis for substrate discrimination and 
the roles of PLP and tRNASec in the mechanism of Sep to Sec conversion were still poorly 
understood. Moreover, in contrast to its closest homologue SepCysS, which functions as 
a dimer to perform a similar reaction on Sep-tRNAcys (Sauerwald et al., 2005; Fukunaga 
and Yokoyama, 2007), SepSecS forms a stable tetramer (Araiso et al., 2008; Ganichkin et 
al., 2008). The tertiary structure of tRNASec itself and the mode of binding to the 
tetrameric SepSecS had yet to be discovered as well. In fact, the unique structure of 
tRNASec is thought to be critical for binding to all the enzymes of the Sec biosynthesis 
and translational incorporation machinery, i.e. SerRS, PSTK, SepSecS, and EFSec 
(Leinfelder et a l , 1988; Baron and Bock, 1991; Wu and Gross, 1993; Wu and Gross, 1994; 
Ohama et al., 1994; Sriirchler-Pierrat et al., 1995; Rudinger et al., 1996; Rother et al., 2000; 
Bilokapic et a l , 2004; Geslain et al., 2006; Sherrer et al., 2008a). 
To provide answers to these questions, we determined the crystal structure of the 
quaternary complex between human SepSecS, unacylated tRNASec, thiophosphate and 
free Sep to 2.8 A resolution. Unlike the physiologic selenium donor of SepSecS, 
selenophosphate, which is stable only under anaerobic conditions, thiophosphate is not 
oxygen-sensitive. Thiophosphate is a surrogate substrate for SepSecS in vitro (Araiso et 
al., 2008) and was, thus, used in the co-crystallization experiment. The structure 
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demonstrated the basis of SepSecS substrate specificity for Sep-tRNASec versus Ser-
tRNASec and free Sep, while additional structure-guided genetic and biochemical 
experiments suggested a detailed PLP-dependent mechanism for the Sep-tRNASec to Sec-
tRNASec conversion. 
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MATERIALS AND METHODS 
A. General 
Oligonucleotide synthesis and DNA sequencing were performed by the Keck 
Foundation Biotechnology Resource Laboratory at Yale University. The pET15b, pET20b 
and pACYCDuet-1 vectors were from Novagen (San Diego, CA, USA). The QuikChange 
site-directed mutagenesis kit was from Stratagene (Lajolla, CA, USA). [75Se]selenite was 
purchased from the University of Missouri Research Reactor Facility (Columbia, MO). 
[14C]Serine (163 mCi/mmol) and [a-32P]ATP (10 mmol/uCi) were obtained from 
Amersham Pharmacia Biosciences (Piscataway, NJ, USA). The polyethyleneimine (PEI) 
cellulose 20 cm * 20 cm thin layer chromatography (TLC) plates were from Merck 
(Darmstadt, Germany). Nickel-nitriloacetic acid (Ni-NTA) agarose and the MaxiPrep 
plasmid purification kit were from Qiagen (Valencia, CA, USA). The Ni- iminodiacetic 
acid (Ni-IDA) pre-packed column, the Resource-Q pre-packed column and the Sephadex 
G25 Microspin columns were from GE-Healthcare (Piscataway, NJ, USA). The protease 
inhibitor cocktail (Complete EDTA-free) was from Roche (Indianapolis, IN). 
B. Bacterial strains and plasmids 
The selA deletion strain was constructed by replacing the gene with the kanamycin 
cassette in BW25113 E. coli strain as described (Datsenko and Wanner, 2000). The T7 
polymerase gene was inserted in the genome by PI transduction. The E. coli BL21-
CodonPlus (DE3)-RIL strain and the pUC18 vector were from Stratagene (Lajolla, CA, 
USA). SepSecS genes from Methanococcus maripaludis (MMP0595) and 
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Methanocaldococcus jannaschii (MJ0610) were amplified from genomic DNA, and the 
human SepSecS gene (GenBank accession no. BX648976) was amplified from an EST 
clone [clone ID: DKFZp686J1361, obtained from the RZPD German Resource Center for 
Genome Research, Berlin, Germany (Wiemann et al., 2001)] followed by cloning into the 
pET15b vector. E. coli selD was cloned into pET15b vector. The M. jannaschii PSTK gene 
was cloned into the pACYCDuet-1 vector. The T. brucei PSTK and SepSecS genes were 
cloned into the pACYCDuet-1 and the pET15b vectors, respectively. 
The M. maripaludis SepSecS mutants R72A, R72Q, R72K, R94A, R94Q, H166A, 
H166F, H166Q, R307A, R307Q, R307K, Q102A, K278A, N247A, D277A, and K278A were 
generated using the QuikChange site-directed mutagenesis kit (Stratagene) and cloned 
into the pET15b vector with an N-terminal His-tag. An N-terminal A1-34 M. maripaludis 
SepSecS deletion mutant was constructed by PCR using the primers 5'-CCGCTCGAGC 
ATCGGAAAATTCCTGAAAACGGAATTGATGACG-3' and 5'- GCTAGTTATTGCTCA 
GCGGTGGCAGC-3' and the pET15b-sepsecS plasmid DNA as the template. The 
resulting DNA fragment was digested with BamHI and Xhol and re-inserted into the 
pET15b vector. 
The human SepSecS mutants (R26A, R26E, K38A, K38E, R75A, R97A, S98A, 
Q105A, K173A, K173M, K284T, N252A, N252D, R271A, R271E, R313A, T397A, T397E, 
T397V, R398A and R398E) were generated using the QuikChange site-directed 
mutagenesis kit and cloned into the pET15b vector with an N-terminal His-tag. An N-
terminal A1-37 human SepSecS deletion mutant was constructed by PCR with the pET15b-
sepsecS plasmid as template and the following primers: 5'-GGAATTCCATATGAAGG 
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GCAAGTGTCCAGAGAATGGCTGGGATGAAAGTACAC-3', and 5'-CGCGGATCCTC 
ATGAAGAAGCATCCTGGTATGTGTCAAGAAGTACATTATC-3'. The resulting 
DNA fragment was subcloned into the pET20b vector (Novagen) with a C-terminal His6-
tag. 
C. In vivo SepSecS assay 
The M. jannaschii SepSecS gene, the M. maripaludis wild-type and mutant SepSecS genes, 
the T. brucei SepSecS gene and the human wild type and mutant SepSecS genes were 
transformed into the E. coli AselA strain with or without the M. jannaschii PSTK gene. 
The T. brucei PSTK gene was transformed into the E. coli AselA strain in the presence of 
T. brucei SepSecS, M. jannaschii SepSecS or human SepSecS. In strains expressing only one 
gene, the corresponding empty plasmid was cotransformed as a control. 
Aerobic overnight cultures were streaked in aerobic conditions on LB-agar plates 
and/or M9 minimal medium-agar plates supplemented with 0.01 mM IPTG, 1 uM 
Na2Mo04,1 uM Na2SeG*3 and 50 mM sodium formate. The plates were placed in an 
anaerobic incubation jar that was flushed with an Nr. CO2: H2 (90 : 5 : 5) gas mix three 
times to give an anaerobic atmosphere and then grown for 5 h at 37 °C and 20 h at 30 °C. 
The plates were then overlaid with agar containing 1 mg/ml benzyl viologen (BV), 0.25 
M sodium formate and 25 mM KH2PO4 adjusted to pH 7.0. The appearance of a 
blue/purple color is the indication of active formate dehydrogenase H. 
23 
D. Metabolic labeling with [75Se]selenite 
A total of 5 x 107 T. brucei cells from each transgenic strain were resuspended in 0.5 mL 
of FCS-supplemented SDM-79 medium (Bran and Schonenberger, 1979). The cultures 
were labeled with 9.6 uCi of Hepes-neutralized [75Se]selenite in the presence of 100 
ug/mL cysteine at 27 °C for 3 h (for the Tb-SepSecS and Tb-PSTK knock-out strains) or 1 
h (for the RNAi cell lines). Cells were harvested, washed with phosphate buffered saline 
p.H 7.4, and lysed by heating to 100 °C for 10 min in buffer containing 100 mM Tris-Cl 
pH 6.8, 8% (w/v) SDS, 24% glycerol, and 0.02% Coomassie blue G-250. The cell lysates 
were subjected to Tris-tricine SDS/PAGE gels and analyzed by autoradiography. 
E. Protein expression and purification 
The M. maripaludis wild-type and mutant SepSecS proteins and the E. coli SelD were 
purified using Ni-NTA column chromatography. The respective constructs were 
transformed into the E. coli BL21-CodonPlus (DE3)-RIL strain. Cells were grown at 37 °C 
to A600 nm = -0.6 at which point the culture was induced with 0.5 mM IPTG for an 
overnight expression at 15 °C. The cells were harvested by centrifugation at 5,000 rpm 
for 15 minutes and resuspended in 50 mM Hepes (pH 8.0), 300 mM NaCl, 10 mM 
imidazole, 3 mM DTT, 10 uM PLP in the presence of a protease inhibitor cocktail 
(Complete EDTA-free, Roche). Following sonication and centrifugation at 14 OOOg 
for 1 h, the supernatant was applied to Ni-NTA resin (Qiagen). Any non-specifically 
bound protein was washed away with 50 mM imidazole, while the His6-tagged proteins 
were eluted with 300 mM imidazole. Proteins were then thoroughly dialyzed against 50 
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mM Hepes (pH 8.0), 300 mM NaCl, 10 mM DTT,10 uM PLP, and 50% glycerol. PLP was 
omitted from the lysis, wash, elution and dialysis buffers during the purification of E.coli 
SelD. 
Purification of the human SepSecS used for crystallization involved two 
chromatographic steps. Briefly, pET15b-sepsecS was transformed into the E. coli BL21-
CodonPlus (DE3)-RIL strain, cells were grown to A600 nm = 0.6 and gene expression 
was induced with 0.5 mM IPTG. After growth for 17 h at 15 °C, cells were harvested 
and resuspended in 20 mM Tris, pH 8.0, 50 mM NaCl, 10% (v/v) glycerol, 1 mM 2-
mercaptoethanol, 10 uM PLP in the presence of the protease inhibitor cocktail (Complete 
EDTA-free, Roche).The cell paste was lysed using a microfluidizer, the insoluble 
material was separated by centrifugation at 32,000 rpm for 40 minutes, and the cleared 
supernatant was loaded onto a Ni-IDA (GE-Healthcare) column pre-equilibrated with 20 
mM Tris-HCl, pH 8.0, 300 mM NaCl, 10 mM imidazole, 1 mM 2-mercaptoethanol and 10 
\JLM PLP. The column was then washed with 50 mM imidazole and the His6-SepSecS was 
eluted with 500 mM imidazole. The protein sample was diluted three-fold with 20 mM 
Tris-HCl, pH 8.0,100 mM NaCl, 1 mM DTT, 10 uM PLP, concentrated to 3 mL and 
loaded onto a S-200pg size-exclusion column. The protein eluted as a tetramer, it was 
concentrated to ~2 mg/mL, flash frozen in liquid nitrogen and stored at -80 °C. 
F. Preparation and purification of tRNA gene transcripts 
The M. maripaludis tRNASec and the human tRNASec used as substrates in the in vitro 
assays were synthesized by in vitro T7 RNA polymerase run-off transcription as 
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described (Milligan et al., 1987). In particular, the M. maripaludis tRNASec and the human 
tRNASec genes together with the T7 promoter were constructed from overlapping 
chemically synthesized oligonucleotides, cloned into the pUC18 and pUC19 plasmids, 
respectively, and purified from E. coli DH5a transformants using a MaxiPrep plasmid 
purification kit (Qiagen). The purified plasmids were digested with BstNl at 55 °C for 
16 h. The in vitro transcription reactions were performed at 37 °C for 5 h in buffer 
containing 40 mM Tris-HCl (pH 8.0), 22 mM MgCL, 25 mM DTT, 2 mM spermidine, 50 
ug/ml BSA, 0.1 mg/ml pyrophosphatase, 4 mM of each nucleoside triphosphate, BstNI-
digested vector containing the tRNASec gene (60 ug/ml) and 1 mM T7 RNA polymerase. 
The tRNASec transcripts were purified by electrophoresis on a 12% denaturing 
polyacrylamide gel. Full-length tRNASec was eluted and desalted on Sephadex G25 
Microspin columns (Amersham). The tRNASec transcripts were refolded by heating for 5 
min at 70 °C in buffer containing 10 mM Tris-HCl (pH 7.0), followed by addition of 
5 mM MgCL and immediate cooling on ice. 
The human tRNASec used for crystallization was cloned into pUC19, expressed in 
E. coli DH5a and synthesized by in vitro T7 RNA polymerase run-off transcription as 
described above. The transcription reaction was performed at 37 °C for 2 h in buffer 
containing 40 mM Tris-HCL pH 8.1, 22 mM MgCh, 10 mM DTT, 1 mM spermidine, 
0.01% Triton X-100, 50 ug/ml BSA, 4 mM of nucleoside triphosphates, 16 mM GMP, 
BstNI-digested vector containing the tRNASec gene (70 ug/ml) and 3 mM T7 RNA 
polymerase. The reaction was briefly centrifuged to pellet the formed pyrophosphate, 
the supernatant reaction mixture was loaded onto a Resource-Q column (GE-Healthcare) 
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and tRNASec was purified using a linear gradient of NaCl (0.2-1 M) in 20 mM Tris-HCl 
pH 8.0. Human tRNASec eluted at -0.6 M NaCl. The purity of the tRNASec-containing 
fractions was checked by electrophoresis on a 12% denaturing polyacrylamide gel. Pure 
tRNASec fractions were ethanol precipitated and kept at -80 °C until use. 
G. Purification and crystallization of the SepSecS-tRNASec complex 
The complex was prepared by mixing human SepSecS with a 1.5-fold molar excess of 
tRNASec. Thus, for each SepSecS tetramer there were 6 molecules of tRNASec available. 
The mixture was concentrated to ~1 mL, loaded onto a S-200pg column (XK 16/60) and 
eluted with 20 mM Tris-HCl, pH 8.0,100 mM NaCl, 1 mM DTT, 10 uM PLP. The first 
peak contained the SepSecS-tRNASec complex, whereas the second peak contained the 
unbound tRNASec. The complex was concentrated to -7.5 mg/mL. The complex was 
crystallized by the sitting-drop vapor-diffusion method at 12 °C by mixing equal 
volumes of the complex sample with the well buffer containing 0.3 M tri-lithium citrate 
and 18% (w/v) PEG 3,350. Addition of various additives to the mother liquor such as 
sorbitol, D-galactose, NDSB-201, Cymal-7, MPD and phenol improved both the crystal 
size and the quality of diffraction. 
H. Ligand soaks and data collection 
A mixture of thiophosphate and O-phosphoserine was added to the binary complex 
crystals to the final concentration of 1 mM and incubated for 1 h prior to freezing. 
Crystals were cryoprotected for 5 minutes in the presence of 20% (v/v) ethylene-glycol 
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and then frozen in liquid propane. Data were collected at the NE-CAT 24IDE beamline 
(APS, Argonne National Laboratory, Chicago) and processed using HKL2000. 
I. Preparation of 32P-labeled Sep-tRNASec 
Refolded tRNASec transcript was 32P-labeled on the 3' terminus by using the E. coli CCA-
adding enzyme and [a-32P]ATP (Amersham) as previously described with some 
modifications (Oshikane et al., 2006). Briefly, 6 pg of tRNASec transcript was incubated 
with the CCA-adding enzyme and [a-32P]ATP (50 uCi) for 1 h at room temperature in 
buffer containing 50 mM Tris-HCl pH 8.0, 20 mM MgCh, 5 mM DTT and 50 uM sodium 
pyrophosphate. After phenol/chloroform extraction the sample was passed over a 
Sephadex G25 Microspin column (GE Healthcare) to remove excess ATP (Bullock et al., 
2003). 
The recovered [32P]-labeled tRNASec was serylated and phosphorylated by 
M. maripaludis SerRS (5 uM) and M. jannaschii PSTK (1 uM) for 75 min at 37 °C in buffer 
containing 50 mM HEPES (pH 7.5), 10 mM MgCb, 20 mM KC1,1 mM DTT, 1 mM serine 
and 10 mM ATP. After phenol/chloroform extraction aminoacylated Sep-tRNASec was 
ethanol precipitated at -20 °C for 45 min and collected as a pellet by centrifugation at 
10,000 g at 4 °C for 30 min. After washing the pellet with 70% ethanol, it was allowed to 
dry on ice in order to avoid deacylation. 
To check levels of serylation and Ser—»Sep conversion, 1 pi aliquots at the start 
and end of the reaction were quenched on ice with 3 pi of 100 mM sodium citrate (pH 
4.75) and 0.66 mg/ml of nuclease PI (Sigma). Following nuclease PI digestion at room 
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temperature for 1 h, 1.5 \A of the sample was spotted onto PEI cellulose 20 cm x 20 cm 
TLC plates (Merck). To separate the Sep-[32P]AMP spot from [32P]AMP and any 
remaining Ser-[32P]AMP the plates were developed for 75 min in buffer containing 
100 mM ammonium acetate, 5% acetic acid. The plates were exposed on an imaging 
plate (FujiFilms) for 14 h, scanned using a Molecular Dynamics Storm 860 scanner and 
quantified using the ImageQuant densitometry software. The amount of Sep-tRNASec 
formed can be calculated by dividing the intensity of the Sep-[32P]AMP spot by the sum 
of the intensities of all spots (Sep-[32P]AMP, [32P]AMP and Ser-[32P]AMP). 
J. In vitro conversion of Sep-tRNASec to Cys-tRNASec 
Purified wild-type or mutant M. maripaludis SepSecS (1 uM) was incubated with 1 uM 
32P-labeled Sep-tRNASec in buffer containing 50 mM HEPES (pH 7.0), 20 mM KC1,10 mM 
MgCL, 5 mM DTT, 2 uM PLP and 500 \JLM sodium thiophosphate. Reactions were 
carried out anaerobically at 37 °C over 40 min. At each time point taken, 1 ul reaction 
aliquots were quenched on ice with 3 \A of 100 mM sodium citrate (pH 4.75) and 0.66 
mg/ml of nuclease PI (Sigma). Following nuclease PI digestion, 1.5 ul of the sample was 
spotted onto PEI cellulose TLC plates that were developed, scanned and quantified as 
described above. To separate the Cys-[32P]AMP spot from the Sep-[32P]AMP, the 
[32P]AMP and any remaining Ser-[32P]AMP spots the plates were developed for 75 min 
in buffer 100 mM ammonium acetate, 5% acetic acid. The plates were exposed on an 
imaging plate (FujiFilms) for 14 h, scanned using a Molecular Dynamics Storm 860 
scanner and quantified using the ImageQuant densitometry software. The amount of 
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Cys-[32P]AMP formed was calculated by dividing the intensity of the Cys-[32P]AMP spot 
by the sum of the intensities of all spots (Cys-[32P]AMP, Sep-[32P]AMP, [32P]AMP and 
Ser-[32P]AMP). The added elevated concentration of PLP was used to assure that the 
mutant enzymes were saturated with the cofactor. 
For the human in vitro SepSecS assay, refolded tRNASec (10 |aM) was serylated 
and phosphorylated by M. maripaludis SerRS (5 uM) and M. jannaschii PSTK (3 uM) for 
75 min at 37 °C in buffer containing 50 mM HEPES pH 7.2,10 mM MgCk, 20 mM KC1,1 
mM DTT, 10 mM ATP and 300 uM [14C]Ser. After phenol/chloroform extraction Sep-
tRNASec was purified by application on a Sephadex G25 Microspin column and ethanol 
precipitation. The conversion of Sep to Cys was done under anaerobic conditions using 
wild-type human SepSecS and human SepSecS treated with either hydroxylamine or 
NaBH4. For the hydroxylamine treatment, the SepSecS sample was dialyzed for 5 hours 
against buffer containing 50 mM HEPES pH 7.2, 250 mM NaCl, 1 mM DTT, 7.5 mM 
hydroxylamine, whereas for the borohydride treatment the SepSecS sample was 
incubated in the dark for 1 hour in the presence of 100 mM NaBHi. The excess of 
hydroxylamine and borohydride was removed from the samples by dialysis against 50 
mM HEPES pH 7.2, 250 mM NaCl, 1 mM DTT. SepSecS (20 ug) was incubated with 10 
uM Sep-tRNASec in buffer containing 50 mM HEPES pH 7.2, 20 mM KC1,10 mM MgCh, 
1 mM DTT and 250 |aM sodium thiophosphate. All buffers were prepared anaerobically 
and the reaction was carried out at 37°C inside an anaerobic chamber over 40 min. The 
reaction was stopped by phenol/chloroform extraction, the aqueous phase was applied 
to a Sephadex G25 Microspin column and the eluted aminoacylated-tRNAs were 
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ethanol precipitated. The purified aa-tRNAs were deacylated in 20 mM NaOH for 10 
min at 22 °C. The released amino acids were oxidized with per formic acid as described 
previously (Sauerwald et al., 2005). The final samples were spotted onto silica gel 60 
TLC aluminium sheets (Merck) that were developed in 85% ethanol. To detect the 
labelled amino acids, the TLC plate was dried and then exposed on an imaging plate 
(FujiFilms) for 60 hours. The imaging plate was scanned using a Molecular Dynamics 
Storm 860 scanner. 
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RESULTS 
A. The missing step of selenocysteine biosynthesis in archaea and eukaryotes 
This part of my research was done in collaboration with Jing Yuan, Juan Salazar and Dan Su. 
1. SepSecS rescues selenoprotein biosynthesis in an E. coli AselA deletion strain 
When grown anaerobically, E. coli produces the selenium-dependent formate 
dehydrogenase H (FDHH) . Its activity enables the cells to reduce benzyl viologen (BV) in 
the presence of formate; this is usually observed by a blue/purple color in agar overlay 
plates under anaerobic conditions (Lacourciere et al., 2002). An E. coli AselA deletion 
strain was constructed in which selenoprotein production is abolished. 
Complementation of this strain with archaeal SepSecS genes from M. maripaludis 
(MMP0595) and M. jannaschii (MJ0610) and with the human homologue allowed testing 
of the ability of these genes to restore selenoprotein biosynthesis as detected by F D H H 
activity (Yuan et al., 2006). The E. coli cells were grown under anaerobic conditions for 
24 h and overlaid with top agar containing BV and formate. Blue-colored cells indicated 
that BV was reduced and, therefore, F D H H activity was present, whereas cells without 
F D H H activity remained colorless. 
Complementation was achieved when the SepSecS genes were cotransformed 
with the gene encoding M. jannaschii PSTK (Figure 7). Neither PSTK alone nor the 
archaeal and human SepSecS genes alone were able to restore Sec synthesis in the E. coli 
AselA deletion strain (Yuan et al., 2006). These data imply that Sec formation was 
achieved by a two-step process: PSTK phosphorylates the endogenous Ser-tRNASec to 















































































































































































































































































































































































SepSecS. Moreover, Ser-tRNASec, present in the E. coli AselA deletion strain, cannot be 
converted to Sec-tRNASec in the absence of PSTK and, therefore, is not a substrate for 
SepSecS (Yuan et al., 2006). Finally, PSTK from the parasitic protozoon T. brucei in 
combination with either T. brucei SepSecS (Tb-SepSecS) or the corresponding archaeal or 
human enzymes reconstituted selenoprotein synthesis in the E. coli AselA deletion strain 
(Figure 8) (Aeby et al., 2009). Likewise, archaeal PSTK and Tb-SepSecS also restored 
F D H H activity in the E. coli AselA deletion strain (Figure 8) (Aeby et al., 2009). Taken 
together, these results underscore the conserved nature of the PSTK/SepSecS pathway of 
Sec-tRNASec formation in archaea and eukaryotes. 
The bacterial SelA is a PLP-dependent enzyme with a critical Lys residue 
engaged in PLP binding (Tormay et al., 1998). As the archaeal and eukaryal SepSecS 
proteins also have PLP binding domains (Kernebeck et al., 2001), I constructed Lys to 
Ala or Thr mutations that replaced the critical lysine position in these enzymes (M. 
maripaludis SepSecS K278A, and human SepSecS K284T). Even in the presence of PSTK, 
the mutant SepSecS genes were no longer able to complement the bacterial selA deletion 
strain (Figure 7) (Yuan et al., 2006). This finding strengthens the notion that the SepSecS 
proteins need PLP to carry out the Sep —> Sec conversion. 
2. SepSecS converts Sep-tRNASec to Sec-tRNASec in vitro 
To prove that SepSecS is a SelA that catalyzes a tRNA-dependent Sep —> Sec synthesis 
we analyzed the conversion of [,4C]Sep-tRNA to [14C]Sec-tRNA in vitro. To this end, 
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Figure 8: Expression of SepSecS together with PSTK restores F D H H activity in an 
anaerobically-grown E. coli AselA deletion strain (Taken from Aeby et al., 2009). The 
indicated genes of the following organisms were tested: T. brucei (Tb-PSTK, Tb-SepSecS), 
M. jannaschii (Mj-PSTK, Mj-SepSecS), and human (Hs-SepSecS). 
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M. maripaludis tRNASec was acylated with [14C]Ser by using pure M. maripaludis SerRS 
(Kim et alv 1998). Phosphorylation was performed with pure M. jannaschii PSTK. We 
then incubated the isolated [14C]Sep-tRNA under anaerobic conditions with purified 
recombinant SepSecS and E. coli SelD in the presence of selenite. After the reaction, 
aminoacyl-tRNA was deacylated, and the amino acid products were identified by thin 
layer chromatography (TLC) (Figure 9) (Yuan et alv 2006). The data show that SepSecS 
from both M. maripaludis (Figure 9, lane 3) and human (Figure 9, lane 4) were able to 
form Sec-tRNASec from Sep-tRNASec, but not from Ser-tRNASec (Figure 9, lane 5) (Yuan et 
al., 2006). Thus, Sep-tRNASec is the crucial precursor for Sec-tRNASec formation in 
archaea and eukarya. 
B. In vivo evidence for a single pathway of Sec-tRNASec formation in T. brucei 
This part of my thesis research was done in collaboration with EricAeby, who constructed the 
T. brucei RNAi and knock-out strains. 
A bioinformatic analysis of the T. brucei genome predicted 3 selenoproteins. They 
include distant homologs of mammalian selenoprotein K (SelK) and selenoprotein T 
(SelT) and a selenoprotein, termed SelTryp, that is specific for the kinetoplastid line 
(Lobanov et al., 2006). Moreover, all major components of the eukaryotic Sec-inserting 
system have trypanosomal orthologues. Thus, Tb-tRNASec, Tb-SerRS, Tb-PSTK, Tb-
SepSecS, Tb-SPS2, and Tb-EFSec have been identified in silico (Cassago et a l , 2006). 
However, of these only Tb-SerRS, Tb-tRNASec (Cassago et al., 2006; Bouzaidi-Tiali et al., 
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Figure 9: Conversion of in yz'fro-synthesized Sep-tRNASec to Sec-tRNASec (Taken from 
Yuan et al., 2006). Phosphorimages of TLC separation of [14C]Sep and [14C]Sec recovered 
from the aa-tRNAs of the SepSecS activity assay. Sec was analyzed in its oxidized form 
as selenocysteic acid (Secya). Lane 1, Ser marker; lane 2, Sep marker; lane 3, Sep-tRNASec 
with M. maripaludis SepSecS; lane 4, Sep-tRNASec with human SepSecS; lane 5, Ser-
tRNASec with M. maripaludis SepSecS; lane 6, reaction of lane 3 without selenite. 
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2007; Geslain et al., 2006), and Tb-SPS2 (Sculaccio et al., 2008) have been subject to 
preliminary experimental analyses. To analyze the SeotRNASec formation pathway in 
vivo and establish its physiological importance for T. brucei, RNAi cell lines that allow 
inducible ablation of Tb-SerRS, Tb-SPS2, and Tb-EFSec were constructed. Moreover, we 
prepared knock-out cell lines that lack either Tb-PSTK or Tb-SepSecS, the two core 
components of the eukaryotic Sec-tRNASec formation pathway. I analyzed all cell lines 
for selenoprotein synthesis by labeling with radioactive 75Se (Figure 10) (Aeby et al., 
2009). 
Labeling of uninduced Tb-SerRS-RNAi cells with 75Se and subsequent analysis by 
Tris-Tricine polyacrylamide gels revealed three bands whose molecular masses are 
consistent with the three predicted trypanosomal selenoproteins SelK, SelT, and SelTryp 
(Figure 10A) (Lobanov et al., 2006). Induction of Tb-SerRS RNAi causes, in line with the 
role of SerRS in serylation of tRNASec, a significant reduction in selenoprotein labeling 
(Figure 10A) (Aeby et al., 2009). Similarly, RNAi-mediated ablation of Tb-SPS2 (Figure 
10C) and of Tb-EFSec (Figure 10D) severely impairs selenoprotein synthesis (Aeby et al., 
2009). Most importantly, though, labeling of the three selenoproteins was abolished in 
the Tb-PSTK and the Tb-SepSecS knock-out cell lines (Figure 10B). Moreover, 
tetracycline-inducible ectopic expression of Tb-SepSecS in the Tb-SepSecS knock-out cell 
line restored 75Se labeling of all three proteins (Figure 10B) (Aeby et al., 2009). Taken 
together, these results show that both Tb-PSTK and Tb-SepSecS are indispensable for 
selenoprotein synthesis and imply that eukaryotes have a single pathway of Sec-tRNASec 


























































































































































































































































































































































































































































































































































































































C. Structural insights into archaeal RNA-dependent selenocysteine biosynthesis 
This part of my thesis research was done in collaboration with Yuhei Araiso, who crystallized and 
solved the structure of SepSecS from Methanococcus maripaludis. 
1. Experimental Approach 
In order to investigate the mechanism of selenocysteine formation in archaea, I 
performed a structure-based biochemical characterization of SepSecS from M. 
maripaludis. The crystal structure of MMPSepSecS with covalently-bound PLP was 
determined at 2.5 A resolution (Araiso et al., 2008). To assess the activity of wild-type 
and mutant MMPSepSecS proteins, I used genetic complementation of the E. coli AselA 
deletion strain as an in vivo test (described in Results, section A.l) as well as two in vitro 
tests. The first detects the enzyme's final reaction product, Sec-tRNASec, as determined by 
TLC of Sec released from tRNASec (Yuan et al., 2006). Given the difficulty in working 
with selenophosphate (availability and oxygen sensitivity), I used thiophosphate as a 
surrogate substrate to measure the time course of Cys-tRNASec formation by SepSecS. In 
this assay, I incubated 32P-labeled Sep-tRNASec anaerobically with wild-type or mutant 
SepSecS proteins and thiophosphate. After nuclease PI digestion of the tRNA in the 
reaction mixture, the product Cys-[32P]AMP was separated from Sep-[32P]AMP by TLC 
and quantified. 
2. Overall structure of SepSecS from Methanococcus maripaludis 
The MMPSepSecS protein adopts an L-shaped structure consisting of the N-terminal 
extension domain (1-130), a catalytic domain (131-309) and a C-terminal domain (353-
40 
436) (Figure 11A). Long, kinked helices (310-352) connect the catalytic and C-terminal 
domains. The PLP molecule is covalently bound to the conserved Lys residue K278 
(Figure 12) at the active site. As can be seen in Figure 11 (Araiso et alv 2008), the overall 
architecture of MMPSepSecS is similar to the Fold Type I (Eliot and Kirsch, 2004) PLP 
enzymes, A.fulgidus SepCysS (Fukunaga and Yokoyama, 2007) and E. coli selenocysteine 
lyase (Lima, 2002). These enzymes consist of a catalytic domain similar to that of 
MMPSepSecS, and a 'small domain', formed by the N-terminal and C-terminal 
polypeptides, which also resembles the MMPSepSecS C-terminal domain (Figure 11B 
and C) (Fukunaga and Yokoyama, 2007; Lima, 2002). We used a structure-based 
sequence alignment (Figure 12) to compare MMPSepSecS to three PLP enzymes, 
AFSepCysS, ECCsdB and ECIscS, that act upon chemically similar substrates (Araiso et 
al., 2008). SepCysS, CsdB and IscS share 24 identical residues while these proteins have 
only 8 residues in common with SepSecS (Figure 12). The alignment also shows that the 
archaeal SepSecS proteins lack the C-terminal extension that has been identified as the 
major antigenic region for the human SLA/LP autoantibodies (Herkel et al., 2002). 
3. Archaeal SepSecS is active only as a tetramer 
The crystal of the apo-MMPSepSecS contains four SepSecS molecules in the asymmetric 
unit that are related by non-crystallographic symmetry (Figure 13A). This is in 
agreement with our gel-filtration results that have shown that SepSecS forms a 
homotetramer (dimer of homodimers) in solution (Figure 13E). The N-terminal 
extension domain of each subunit plays a pivotal role in the tetrameric organization of 
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Figure 11: The overall architectures of SepSecS and related enzymes (Taken from Araiso 
et alv 2008). (A) Stereo view of the M. maripaludis SepSecS (MMPSepSecS) structure. The 
N-terminal domain (residues 1-130), the catalytic domain (residues 131-309), the linker 
helix (310-352) and the C-terminal domain (residues 353-434) are colored yellow, green, 
blue and pink, respectively. The carboxy-terminal two residues are disordered. The PLP 
molecule bound to the active site is shown as a ball and stick model. (B) Stereo view of 
the Archaeoglobus fulgidus SepCysS (AFSepCysS) structure in the same orientation as (A) 
(Fukunaga and Yokoyama, 2007). The small domain, the linker helices and the catalytic 
domain are colored pink, blue and green, respectively. (C) Stereo view of the E. coli 
selenocysteine lyase (ECCsdB) structure in the same orientation as (A) (Lima, 2002). 
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Figure 12: Structure-based sequence alignment (Taken from Araiso et alv 2008). The 
alignment includes SepSecS sequences from two archaea (Methanococcus maripaludis and 
Methanopyrus kandleri) and two eukaryotes (Homo sapiens and Tetrahymena thermophila) as 
well as Archaeoglobus fulgidus SepCysS, E. coli cysteine desulfurase (IscS) and E. coli 
selenocysteine lyase (CsdB). Amino acids are colored according to residue types, and 
strictly conserved residues are marked (*). The secondary structure of MMPSepSecS is 
shown above the alignment, and the active site arginines are highlighted in blue. The 
autoimmune antigenic region of human SepSecS (Herkel et al, 2002) and a eukaryotic 
specific insertion are shown in gray boxes and green, respectively. 
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Figure 13: The oligomeric states of SepSecS and related enzymes (Taken from Araiso et 
al., 2008). (A) The overall architecture of the MMPSepSecS tetramer. Chains A and B, 
and chains C and D form dimers, respectively. Chain A, chain B, chain C and chain D 
are colored pink, blue, green and yellow, respectively. (B) The N-terminal extension 
domains of chains B and C form a hydrophobic core that stabilizes the tetrameric state of 
MMPSepSecS. Three a-helices (1, 2, 4) are labeled. Chains B and C are colored blue and 
green, respectively. (C) Stereo view of the AFSepCysS dimer in the same orientation as 
(A) (Fukunaga and Yokoyama, 2007). Chains A and B are colored pink and blue, 
respectively. The PLP molecules are shown as ball and stick models. (D) Stereo view of 
the ECCsdB dimer in the same orientation as (A) (Lima et al, 2002). The coloring scheme 
and the PLP representation are the same as in (C). (E) Gel filtration of MMPSepSecS on 
Sephacryl S-300. Absorbance at 280 nm is shown as a blue line. The elution volumes of 
other oligomeric proteins are indicated in the chromatogram. The molecular weight of 
the MMPSepSecS monomer is 50 kDa. MMPSepSecS eluted at the size expected for a 
tetrameric species. 
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SepSecS (Araiso et al., 2008). These domains interact with each other to form a 
hydrophobic core (chain A with chain D, and chain B with chain C), which involves 
inward-facing hydrophobic residues protruding from the helices, a l , al and a4 (Figure 
13B). Thus, the N-terminal extension facilitates tetramer formation and its deletion is 
predicted to produce a dimeric SepSecS. Interestingly, AFSepCysS (Fukunaga and 
Yokoyama, 2007) and ECCsdB (Lima, 2002) lack the N-terminal extension domain and 
form dimers (Figure 13C and D). 
In order to investigate whether SepSecS would be active in a homodimeric form I 
assayed the enzymatic activity of an MMPSepSecS protein that lacks the N-terminal 
extension residues 1-34. The A1-34 SepSecS mutant did not form Sec-tRNASec in vivo 
(Figure 14) since it did not rescue selenoprotein biosynthesis in the complementation test 
of the E.coli AselA deletion strain (Araiso et al., 2008). Since the active site of SepSecS, like 
other PLP enzymes, is formed at the dimer interface it is clear that SepSecS would not 
function as a monomer. Why the tetrameric organization of SepSecS is critical for 
function remained unclear until the determination of the human SepSecS-tRNASec co-
crystal structure (reviewed in Results, section D) (Palioura et al., 2009). 
4. Active site mutants define PLP recognition 
As in other Fold Type I PLP enzymes, the active sites of MMPSepSecS lie on the dimer 
interface with each monomer contributing essential residues (Eliot and Kirsch, 2004). 
The active site of chain A is formed by chains A and B that both recognize the PLP 































































































































































































































































































Figure 15: PLP recognition (Taken from Araiso et al., 2008). Stereo views of (A) Ribbon 
representation of the active site of MMPSepSecS in the dimer interface between chains A 
and B that are colored pink and blue, respectively. The PLP molecule is covalently 
bound to Lys278 of chain A. The Fo-Fc omit map of the PLP molecule, contoured at 3.5 
a, is shown. (B) The amino acid residues that recognize the PLP molecule. The residues 
of chains A and B are colored pink and blue, respectively. The Fo-Fc omit map 
(contoured at 3.5 a) of all of the residues and PLP is shown. 
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|3-sheet, with only the sixth (3-strand being antiparallel; this is a common feature of Fold 
Type IPLP enzymes (Eliot and Kirsch, 2004; Jansonius, 1998) including AFSepCysS 
(Fukunaga and Yokoyama, 2007) and ECCsdB (Lima, 2002). In the MMPSepSecS 
structure, PLP is covalently bound via a Schiff base to the strictly conserved Lys278 
(chain A) (Figure 12), which is located between the sixth and seventh (3 strand in the 
active site (Figure 15A) (Araiso et al., 2008). Indeed, a Lys278Ala mutation abolishes 
MMPSepSecS catalytic activity as shown both in vivo by the lack of BV reduction by 
F D H H (Figure 14), and in vitro by the inability of the Lys278Ala mutant to form Cys-
tRNASec (Figure 16) (Araiso et al., 2008). 
All known Fold Type I PLP enzymes possess a critical aspartate that forms a 
hydrogen bond with the N l atom of the pyridine ring (Schneider et al., 2000), which is 
thought to increase the electron sink character of the PLP cofactor. SepSecS is an 
exception to this paradigm; Asn247 is found in the corresponding position, and it forms 
a hydrogen bond with the pyridinium nitrogen (Figure 15). The other 'nonconforming' 
enzyme is SepCysS where the structure also reveals a similar Asn contact with PLP 
(Fukunaga and Yokoyama, 2007). To test whether Asn247 is responsible for the 
discrimination that MMPSepSecS exhibits towards Ser-tRNASec, we mutated it to Asp 
and Ala. Though still fully active towards Sep-tRNASec, the Asn247Asp MMPSepSecS 
mutant is inactive towards Ser-tRNASec (Figure 17) (Araiso et al., 2008). Finally, the 
replacement of Asn247 with the uncharged Ala yields an enzyme that is only partially 

































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Fold Type IPLP enzymes. The protonated PLP is critical for the stabilization of the 
covalently attached carbanion intermediate in the reaction pathway. 
The aromatic pyridine ring of PLP is sandwiched between Hisl66 (chain A) and 
Ala249 (chain A) through hydrophobic interactions at the floor of the catalytic site 
(Figure 15). This recognition mode is commonly observed in the structures of Fold Type 
I PLP enzymes where the His residue increases the electron sink character of PLP's 
pyridine ring through the stacking interactions with it and may also play a role in 
substrate activation and acid base catalysis. In the latter case, the His residue makes a 
direct hydrogen bond with the critical aspartate that contacts the Nl atom of the 
coenzyme pyridine ring in all Fold Type I PLP enzymes and is, thus, thought to assist in 
the dissipation of the negative charge generated around PLP's ring during catalysis 
(Yano et al., 1991). Furthermore, the phosphate moiety hydrogen bonds with the main-
chain amide and carbonyl groups of Glyl40 and Serl68, respectively (Figure 15B). The 
MMPSepSecS mutant Hisl66Ala was partially active in forming Sec-tRNASec in vivo 
(Figure 14). In vitro, the Hisl66Ala MMPSepSecS mutant was partially active in forming 
Cys-tRNASec as can be seen by the increase in intensity of the Cys-[32P]AMP spot and the 
concomitant decrease of the Sep-[32P]AMP spot during the course of the reaction (Figure 
16B) (Araiso et al., 2008). Obviously, the mutant enzyme with Alal66 has PLP still in a 
partially functional position. A mutation of the corresponding His residue (position 143) 
in E. coli aspartate aminotransferase also led to a functional enzyme (Yano et al., 1991). 
In contrast, both the Hisl66Gln and Hisl66Phe mutants were inactive in vivo (Figure 14). 
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Since the catalytic pocket is formed at the dimerization interface, chain B also 
contributes residues that participate in PLP recognition. In particular, the guanidinium 
group of Arg72 and the main-chain amide group of Arg307 (from chain B) hydrogen 
bond to the phosphate moiety of PLP (Figure 15B). Mutations of Arg72 and Arg307 to 
Ala, Gin or Lys resulted in MMPSepSecS mutants that were significantly less active in 
Sec-tRNASec formation in vivo (Figures 14 and 17) and Cys-tRNASec formation in vitro 
(Figure 16C). Such PLP recognition differs from that of AFSepCysS (Fukunaga and 
Yokoyama, 2007) and ECCsdB (Lima, 2002). Unlike in the MMPSepSecS structure, the 
adjacent subunit of ECCsdB does not come close to the active site (Figure 18A, B) (Araiso 
et al., 2008). In ECCsdB, an additional |3a(3 structural motif covers the active site, 
presumably to stabilize the PLP and Sec substrates inside the pocket. This motif also 
precludes interaction between residues from the neighboring subunit and the active site 
(Figure 18B). Although the active site of AFSepCysS is formed by residues from chains A 
and B, the chain B amino acids are located too distant for PLP recognition (Figure 18C). 
The active sites of MMPSepSecS and AFSepCysS are spacious enough to accommodate 
the Sep-CCA end of the tRNASec or tRNAcys species, respectively. 
5. The active site 
The crystallization solution contained 10 mM magnesium sulfate. In the present 
structure, we observed a strong electron density peak (4.5 a), presumably corresponding 
to a sulfate ion, adjacent to the PLP molecule of chains A and B (Figure 18A). The sulfate 
ion may be mimicking the position of the phosphate moiety of Sep attached to tRNASec. 
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Figure 18: The active site in MMPSepSecS, ECCsdB, and AFSepCysS (Adapted from 
Araiso et al., 2008). Chains A and B are colored pink and blue, respectively. PLP is 
covalently bound to chain A. (A) The sulfate ion is shown as a ball-and-stick model in 
the active site of MMPSepSecS. (B) In the active site of ECCsdB PLP is covalently bound 
to Lys226 of chain A and is covered by the |3a(3 structural motif. (C) In the active site of 
AFSepCysS, PLP is covalently bound to Lys209 of chain A. The orientation of PLP is the 
same as that in (A). The chain A residues that recognize PLP and sulfate are shown. 
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Indeed, the quaternary structure of the human SepSecS complexed with tRNASec, Sep 
and thiophosphate revealed that the phosphate moiety of Sep occupies the same 
position in the active site of the human enzyme as the sulfate ion in the MMPSepSecS 
structure (reviewed in Results, section D) (Palioura et al., 2009). Mutations of Arg94, 
Glnl02 and Arg307 of chain B that recognize the sulfate ion (Figure 18A) significantly 
decreased the catalytic activity of MMPSepSecS both in vivo (Figures 14 and 17) and in 
vitro (Figure 16) (Araiso et a l , 2008). 
The MMPSepSecS structure reveals three conserved arginines (Arg72, Arg94 and 
Arg307) that are located in proximity of each other and close to the active site; they 
recognize the phosphate groups of PLP and presumably of Sep acylated to tRNASec 
(Figures 12 and 18A). Mutations of Arg72, Arg94 and Arg307 to Ala, Gin or Lys yielded 
MMPSepSecS enzymes that were unable to form Sec-tRNASec in vivo (Figures 14 and 17) 
(Araiso et al., 2008). Asp277 interacts electrostatically with Arg72, and the Asp277Ala 
enzyme was also inactive in vivo (Figure 14). The Arg72Gln, Arg94Gln and Arg307Gln 
MMPSepSecS mutants were inactive in forming Cys-tRNASec in vitro (Figure 16) (Araiso 
et al., 2008). In addition to the PLP-conjugated Lys278, the side chains of the Sep-binding 
arginines may also facilitate general acid/base catalysis as was shown for the tRNA 
modification enzyme TrmH where an arginine activated by a phosphate group acts as a 
general base (Nureki et al., 2004). 
Finally, to investigate whether the reaction proceeds through an enzyme-bound 
phosphorylated intermediate I mutated the two Ser residues located close to the active 
site, Ser95 and Serl68. Ser95 interacts with the sulfate ion, while Serl68 recognizes the 
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PLP phosphate moiety. Since the Ser95Ala, Ser95Thr and Serl68Ala mutants are active 
in forming Sec-tRNASec in vivo (Figure 17), a phosphorylated state of the enzyme is 
unlikely to be part of the reaction mechanism. 
D. The human SepSecS-tRNASec complex 
This part of my thesis research was done in collaboration with Miljan Simonovic. I crystallized 
the human SepSecS-tRNASec complex and performed in vivo and in vitro activity assays and Dr. 
Simonovic solved the structure. 
1. SepSecS can bind tRNASec only as a tetramer 
In order to investigate the mode of binding of tRNASec to SepSecS and the role of 
PLP in the catalytic mechanism, we determined the crystal structure of the quaternary 
complex between human SepSecS, unacylated tRNASec, Sep and Thiophosphate to 2.8 A 
resolution. In this complex, SepSecS forms a tetramer that is bound to two tRNASec 
molecules (Figure 19) (Palioura et al., 2009). The physiological tetramer in this crystal is 
the same as that found in studies of the archaeal and murine apo-enzyme (Figure 19) 
(Araiso et al., 2008; Ganichkin et al., 2008). Each monomer has a PLP cofactor covalently 
linked to the Ne-amino group of the conserved Lys284 via formation of a Schiff base 
(internal aldimine). Two SepSecS monomers form a homodimer, and two active sites are 
formed at the dimer interface. The two homodimers associate into a tetramer through 
interactions between the N-terminal al-loop-a2 motifs (Figure 19C, D). Given that 
SepCysS, the closest PLP Fold Type I homologue of SepSecS that also acts on tRNA-
bound Sep (Sep-tRNAcys), is a dimer and that the active sites of one homodimer do not 
55 
Figure 19: Structure of human SepSecS in complex with unacylated tRNASec (Adapted 
from Palioura et al., 2009). (A, B) Surface representation of the complex of SepSecS with 
tRNASec. The subunits of the catalytic dimer are dark and light blue, those of the 
noncatalytic dimer are dark and light red; the backbone and bases of tRNASec are green 
and gray, respectively. (C, D) Ribbon diagram of the SepSecS-tRNASec complex. The 
catalytic dimer interacts with the acceptor arm of tRNASec through helices a l 4 and a l 5 
(blue). The a l helix (red) of the noncatalytic dimer interacts with the rest of the acceptor-
TWC arm. The variable arm of tRNASec interacts with helix a9 (red) of the noncatalytic 
dimer. The al-loop-a2 motif is important for the tetramerization of the enzyme and is 
annotated in both dimers. The regions of tRNASec that interact with SepSecS are shown 
in orange; the rest is green. One tRNASec molecule is shown for clarity. The view in B and 
D is rotated -90° clock-wise around the vertical axis relative to that in A and C. 
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communicate with the active sites of the other homodimer in the apo-SepSecS tetramer 
(Araiso et alv 2008; Ganichkin et al., 2008), the reason for the tetrameric organization of 
SepSecS was not known. The mode of tRNASec binding to SepSecS provides an answer to 
this question. 
The CCA-ends of both tRNASec molecules point to the active sites of the same 
homodimer, which will be referred to as the catalytic dimer (Figure 19). The other 
homodimer, which will be referred to as the noncatalytic dimer, serves as a binding 
platform that orients tRNASec for catalysis (Figure 19) (Palioura et al., 2009). The 
structure reveals that SepSecS binds only to the acceptor-, TWO and variable arms of 
tRNASec (Figure 19C, D). The tip of the acceptor arm interacts with the C-terminus of the 
catalytic dimer, whereas the rest of the acceptor-, TWC- and variable arms wrap around 
a monomer from the non-catalytic dimer (Figure 19). The most important binding 
element is an interaction between the discriminator base G73 of tRNASec and the 
conserved Arg398 of the catalytic dimer (Figure 20A) (Palioura et al., 2009). The 
guanidinium group of Arg398 forms hydrogen bonds with the Hoogsteen face of G73. 
The discriminator base G73 of tRNASec is universally conserved in archaea and 
eukaryotes. Neither adenine nor cytidine in position 73 could form hydrogen bonds 
with Arg398 because they have amino-groups instead of the keto-group. Also, if a 
cytidine or uridine was in position 73, the C5 and C6 atoms of the pyrimidine ring 
would clash with the side-chain of Thr397, thus, preventing the interaction of these 



















































































































































































































































































The majority of interactions between the enzyme and tRNASec, however, occur 
between the highly conserved basic residues in the N-terminal al helix of the 
noncatalytic dimer and the phosphate-sugar backbone of the acceptor-TWC arm (Figure 
19C, D). For instance, the side-chain of Arg26 forms hydrogen bonds with the phosphate 
backbone of C2-C3 of the acceptor arm, the Ne-amino group of Lys38 forms a hydrogen 
bond with the 2'-hydroxyl group of C64 (Figure 20B), whereas the side-chain of Lys40 
interacts with the phosphate oxygen of G50 from the TWC arm (Figure 20B). Moreover, 
the 13-base pair (bp) length of the acceptor-T^C arm is important for positioning the 
variable arm to interact with the neighboring noncatalytic dimer. The nucleotides C46A 
and C46L interact with Ser260 and Arg271 from the noncatalytic dimer, respectively 
(Figure 20C) (Palioura et al., 2009). 
The interactions between SepSecS and tRNASec observed in the crystal are 
consistent with in vivo activity assays of SepSecS mutants (Figure 21) (Palioura et al., 
2009). Replacing Arg398 with either alanine or glutamate renders the enzyme 
completely inactive suggesting that the interaction between the discriminator base and 
the highly conserved Arg398 of the catalytic dimer is critical for tRNASec recognition 
(Figure 21). Furthermore, Thr397Ala is completely active, Thr397Val is partially active 
and Thr397Glu is inactive in vivo (Figure 21). Thus, Thr397 strengthens the interaction of 
the acceptor arm with the a l 4 helix. In addition, the Arg271Glu mutant is partially 
active suggesting that the interaction between the variable arm and the noncatalytic 























































































































































































































































































































Glu, the enzyme is partially active in vivo, whereas both the Arg26Ala and Arg26Glu 
mutants are completely active (Figure 21), suggesting that the Arg26-C2 interaction 
alone is not critical for complex formation. Finally, both the human and archaeal 
SepSecS enzymes are completely inactive in vivo when the a l helix is deleted (Figure 21) 
(Araiso et al., 2008; Palioura et al., 2009). 
2. The antigenic region 
In the structure of the SepSecS-tRNASec binary complex, the first twelve residues of the 
proposed antigenic region (residues 452-463) form the C-terminal helix al5. The 
remaining residues of the antigenic region (residues 463-501) form the extreme C-
terminal tail of SepSecS and have been disordered in all crystal structures of the enzyme 
determined to date (Araiso et al., 2008; Ganichkin et al., 2008). Interestingly, helix a l 5 is 
spatially located near the entrance to the active-site cleft and it is proximal to helix a l 4 
(Figures 19B and 22A) (Palioura et al., 2009; Palioura et al., 2010). Both a l 4 and a l 5 
interact with distinct parts of the acceptor arm (Figure 22) (Palioura et al., 2010). The side 
chains of Thr397 and Arg398 from helix a l 4 interact with the discriminator base G73 
and, thus, establish the identity of the bound tRNA molecule (Figure 22B). The 
importance of Thr397 and Arg398 for tRNASec binding has been confirmed in the in vivo 
assays (Figure 21) (Palioura et al., 2009). On the other hand, the residues Arg453, Arg456 
and Lys463 in a l 5 form the 5'-phosphate binding groove and they interact with the 
tRNA backbone atoms (Figure 22B) (Palioura et al., 2010). 



















































































































































































































































































































































































































































































































































































the ribonucleoprotein SepSecS-tRNASec complex, such autoantibodies would bind to an 
interface that lies between the a l 4 and al5 helices of SepSecS and the tip of the acceptor 
arm of tRNASec (Figure 22B). Binding of the antibody near the active site of SepSecS may, 
in fact, inhibit the enzyme's function directly or indirectly by stabilizing the entire 
protein-RNA complex and preventing release of tRNASec. The inhibitory effect of 
antibodies would resemble the mechanism by which LKM-1 autoantibodies inhibit 
cytochrome P450 isoenzyme 2D6 (CYP2D6) in a subgroup of autoimmune hepatitis 
patients (Manns et al., 1989). 
3. The unique 9/4 fold of tRNASec is recognized by the Sec-specific proteins 
Human tRNASec contains 90 nucleotides rather than the conventional 75 nucleotides of 
canonical tRNA molecules. The structure shows that human tRNASec adopts a unique 9/4 
fold with a 13 bp acceptor-TWC arm (where 9 and 4 reflect the number of base pairs in 
the acceptor and TWC arms, respectively) and a long variable arm (Figure 23) (Palioura 
et al., 2009). This resolves a controversy between conflicting models in which the 7/5 
model suggested 12 bp in the acceptor-T^C arm as found in all known tRNA structures 
(Ioudovitch and Steinberg, 1998), whereas the 9/4 model suggested a unique 13 bp 
acceptor-T^C arm (Sturchler et al., 1993). 
In the 9/4 fold of the human tRNASec, the linker between the acceptor- and the D-
stem is two residues long (A8-U9) as was proposed earlier (Sturchler et al., 1993). The 
base of A8 does not participate in any tertiary interactions, while the base of U9 stacks 

























































































































































































































































































































































































































































































































































































































































































































































couple followed by a C11-G24 pair (Figure 23C) (Palioura et al., 2009). Four nucleotides 
U16, G18, G19 and U20 form the D-loop and interact with U55, C56, A57 and A58 from 
the V¥C loop closing the cloverleaf structure as proposed (Sturchler et al., 1993). The 
rest of the tRNASec structure agrees well with the proposed model (Sturchler et al., 1993). 
The 13 bp acceptor-T^C arm and a long variable arm are distinct structural 
features that serve as major recognition motifs for binding to SepSecS (Figure 19). 
The structure of the human SepSecS in complex with tRNASec along with the in vivo 
mutagenesis data reveal that SepSecS can bind tRNASec only as a tetramer. The 
interaction between Arg398 and G73 along with the longer 13 bp acceptor-T^C arm and 
the variable arm of tRNASec secure binding of the tRNA to the enzyme. The only tRNA 
with a G73 discriminator base and a long variable arm yet with a 12 bp acceptor-T^C 
arm is tRNASer. However, neither unacylated tRNASer nor Ser-tRNASer is able to bind to 
SepSecS (Xu et al., 2007). To examine the importance of the length of the acceptor-TWC 
arm for SepSecS binding, we superimposed tRNAAsP (Eiler et a l , 1999) onto tRNASec 
(Figure 24) (Palioura et al., 2009). The tRNAAsP was chosen because it is a canonical 
tRNA molecule with G73 as the discriminator base and because the complete structure 
of tRNASer is not available. Two approaches were used for superimposing the two 
tRNAs. In the first approach, the atoms of the sugar-phosphate backbone of the 
acceptor-, T^C- and anticodon arms were superimposed. Although the secondary 
structure elements of tRNAAsP were oriented as observed in tRNASec, G73 of tRNAAsP 
could not reach Arg398 due to its shorter acceptor-T^C arm (Figure 24B). In the second 
























































































































































































































































































































































































































































































































































































with Arg398 using its Hoogsteen face, and then the tips of the acceptor arms 
(nucleotides 1-3 and 70-73) were superimposed. In this case, the anticodon and variable 
arms of tRNAAsP are positioned away from the enzyme, whereas its TWC arm clashes 
with the al helix of the noncatalytic dimer (Figure 24C), thus preventing the formation 
of the SepSecS-tRNAAsP complex. In addition, the absence of a long and properly 
oriented variable arm in tRNAAsP diminishes further its capacity for interaction with 
SepSecS (Figure 24A, C) (Palioura et al., 2009). Thus, modeling of the SepSecS-tRNAAsP 
complex suggests that tRNASer is not able to bind to SepSecS due to its shorter acceptor-
W C arm. 
Further, it has been proposed that the variable arm of tRNASec serves as the major 
recognition motif for its binding to SerRS, which allows Ser-tRNASec formation to occur 
(Bilokapic et al., 2004; Geslain et al., 2006; Leinfelder et al., 1988; Ohama et al., 1994; 
Rother et al., 2000; Sherrer et al., 2008a; Sturchler-Pierrat et al., 1995; Wu and Gross, 1993, 
1994). Modeling of the SerRS-tRNASec complex based on the crystal structure of the 
bacterial SerRS complexed with tRNASer (Biou et al., 1994) suggests that SerRS can 
recognize the variable arm of tRNASec similarly to tRNASer providing an explanation for 
the inability of SerRS to discriminate between tRNASer and tRNASec (Figure 25). 
4. Sep binds to the active site only in the presence of tRNASec 
To explore the mechanism by which the phosphoryl group is converted to the 
selenocysteinyl moiety, I soaked crystals of the binary SepSecS - tRNASec complex in a 
solution containing a mixture of O-phosphoserine and thiophosphate. I used Sep and 
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Figure 25: Modeling of the SerRS-tRNASec complex (Taken from Palioura et alv 2009). 
tRNASec was superimposed onto the tRNASer that is in complex with SerRS. SerRS is a 
non-discriminating aminoacyl-tRNA synthetase because it recognizes variable arms of 
both tRNASer (red) and tRNAs« (green) 
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and thiophosphate as mimics of the phosphoseryl group attached to tRNASec and 
selenophosphate, respectively. Although both ligands were used in the soaking 
experiments, Sep bound only to the active sites of the catalytic dimer (Figure 26A) 
(Palioura et al., 2009), whereas thiophosphate bound only to the active sites of the non-
catalytic dimer (Figure 26B), i.e. Sep can bind to an active site only in the presence of 
£RNASec. Both thiophosphate and the phosphoryl group of Sep bound to the same 
binding pocket (Figure 26) suggesting that a specific active site can accommodate only 
one ligand at a time (Palioura et al., 2009). 
Sep binds to the catalytic active site in either of two different orientations (Figure 
26A). The phosphoryl group occupies a similar location in the two orientations, whereas 
the seryl moieties are rotated by -90° around the phosphate group. In what appears to 
be a non-productive orientation of Sep (SepN), its seryl group is sandwiched between the 
side-chains of Arg97 and Lysl73 at the catalytic dimer interface, while its amino group 
lies -12 A away from the PLP Schiff base (Figure 27A) (Palioura et al., 2009). Thus, it is 
unlikely that SepSecS would act on SepN, unless a PLP-independent mechanism is 
utilized. In the productive-like orientation of Sep (Sepp), the amino-group of Sep is -3.5 
A away from the Schiff base yet it is not positioned for attack due to a hydrogen bond 
with Glnl72 (Figure 27B). The carboxyl group of Sepp also forms a hydrogen bond with 
the side-chain of Glnl72. Electron density for both the amino and the carboxyl groups of 
Sepp is weak suggesting higher mobility in this part of Sepp. This is presumably due to 























































































































































































































































































































































































































































































































































































































































































































































































































with the side-chains of Ser98, Glnl05 and Arg313 anchor Sep in the active site. That the 
phosphoryl group is required to properly position the ligand for catalysis explains why 
the obligate substrate for SepSecS is Sep-tRNASec and not Ser-tRNASec, which is the 
physiological substrate for the bacterial selenocysteine synthase. 
A comparison of the catalytic and noncatalytic sites reveals that Sep binds to the 
active site only in the presence of tRNASec because the conformation of the P-loop 
(residues Gly96-Lysl07) differs between the two active sites (Figure 27C). In the 
noncatalytic dimer the guanidinium group of Arg97 and the side-chain of Glnl05 are 
rotated towards the phosphate-binding groove where they coordinate thiophosphate 
(Figures 26B and 27C) (Palioura et al., 2009). In the catalytic dimer, the side-chain of 
Arg97 rotates away from the phosphate-binding groove, and forms a hydrogen bond 
with the 2'-OH group of C75. Glnl05 also rotates away from the phosphate and this 
concerted movement of Arg97 and Glnl05 in the P-loop upon tRNASec binding allows 
Sep to bind to the active site (Figure 27C). Free Sep enters the active site through the gate 
formed by the side-chains of Arg97, Glnl05 and Lysl73. The affinity for the SepN is high 
enough to trap the free ligand in this orientation as well. Moreover, the free amino 
group of Sepp cannot be positioned appropriately for attack onto the Schiff base 
probably due to free rotation around the Ca-C(3 bond explaining why the reaction does 
not occur in the crystal. Thus, the covalent attachment of Sep to tRNASec is necessary for 
the proper placement of the Sep moiety into the active site and for orienting the amino-
group of Sep for attack onto the Schiff base of PLP. 
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5. SepSecS utilizes a PLP-dependent mechanism for Sec-tRNASec formation 
I used both in vivo and in vitro activity assays to investigate the mechanism of Sep-
tRNASec to Sec-tRNASec conversion by human SepSecS. Several lines of evidence suggest 
that SepSecS catalyzes the Sep-tRNASec to Sec-tRNASec conversion in a PLP-dependent 
reaction. First, the reduction of the Schiff base by sodium borohydride to form a 
chemically stable secondary amine and, thus, cross-link PLP to Lys284 renders SepSecS 
completely inactive in vitro (Figure 28) (Palioura et al., 2009). The catalytic activity of 
SepSecS is also quenched upon removal of PLP by treatment with hydroxylamine 
(Figure 28) (Palioura et al., 2009). Some residual activity that is observed upon 
hydroxylamine treatment is probably due to an incomplete removal of PLP (Figure 28). 
Second, we show that the Arg75Ala, Glnl05Ala and Arg313Ala mutants are inactive in 
vivo (Figure 21) (Palioura et al., 2009). These residues are involved in coordinating either 
the phosphate group of PLP or that of Sep. Finally, the in vivo activities of the Arg97Ala, 
Arg97Gln, Lysl73Ala and Lysl73Met mutants are indistinguishable from that of the 
wild-type enzyme confirming that Arg97 and Lysl73 are involved only in the non-
productive binding of free Sep (Figure 21). Therefore, a PLP-dependent mechanism for 
the Sep to Sec conversion is proposed (Figure 29) (reviewed in Discussion, section D) 
(Palioura et al., 2009). 
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Figure 28: In vitro conversion of Sep-tRNASec to Cys-tRNASec by wild type and PLP-cross-
linked SepSecS (Taken from Palioura et al., 2009). Phosphorimages of TLC separation of 
[14C]Sep and [14C]Cys recovered from the aminoacylated-tRNAs of the SepSecS activity 
assays. Cysteine was analyzed in its oxidized form as cysteic acid (Cya). Lane 1, Ser 
marker; lane 2, Sep marker; lane 3, Cys marker; lane 4, Sep-tRNASec with human SepSecS 
in the absence of thiophosphate; lane 5, Sep-tRNASec with wild-type human SepSecS; 
lane 6, Sep-tRNASec with human SepSecS treated with 7.5 mM hydroxylamine; lane 7, 
Sep-tRNASec with human SepSecS treated with 100 mM sodium borohydride. 
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Figure 29: The PLP-dependent mechanism of Sep to Sec conversion (Taken from 
Palioura et alv 2009). (A) The phosphoseryl moiety of Sep-tRNA
Sec is bound to the active 
site similarly to Sepp. The amino group is oriented for attack onto the Schiff base 
(internal aldimine), while the phosphoryl group is stabilized by the side-chains of Ser98, 
Glnl05 and Arg313. Hydrogen bonds are shown in dashed lines. (B) After the formation 
of the external aldimine, the side-chain of Lys284 rearranges and abstracts the Ca proton 
from Sep. The protonated pyridine ring of PLP stabilizes the carbanion. (C) Electron 
derealization leads to a rapid |3-elimination of phosphate and to the formation of 
dehydroalanyl-tRNASec. Free phosphate dissociates and selenophosphate binds to the 
active site. (D) An unidentified base (~B) activates water that hydrolyzes 
selenophosphate. Free phosphate dissociates again, and selenium attacks the 
dehydroalanyl-tRNASec. Lys284 returns the proton to the Ca carbon and the 
selenocysteinyl moiety is formed. (E) The reaction of reverse transaldimination is shown. 
Lys284 forms the Schiff base with PLP leading to a release of the oxidized form of Sec-
tRNASec (red box). (F) The free amino-group of Sec-tRNASec is protonated, and the active 
site of SepSecS is regenerated. 
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DISCUSSION 
A. SepSecS: the missing step in Sec biosynthesis in eukaryotes and archaea 
We used in vivo complementation assays and in vitro activity assays to establish the 
human SLA/LP and its archaeal and trypanosomal orthologs as SelA analogs able to 
catalyze Sec-tRNASec formation. However, in contrast to bacterial SelA that converts Ser-
tRNASec directly to Sec-tRNASec, SepSecS acts on the phosphorylated intermediate, Sep-
tRNASec (Figure 30) (Palioura et al., 2009). Therefore, the bacterial SelA is replaced by 
PSTK and SepSecS in archaea and eukaryotes. Thus, archaeal and eukaryal Sec 
biosynthesis requires three enzymes, SerRS, PSTK, and SepSecS, whereas bacteria 
accomplish the same task without PSTK. Interestingly, both SelA and SepSecS are PLP-
dependent enzymes. From a chemical standpoint, a Sep —»• Sec conversion is desirable, 
as Sep would provide a better leaving group (phosphate) than Ser (water) for 
replacement with selenium. Sep-tRNA is reported to be more stable than Ser-tRNA 
(Carlson et al., 2004), which is known to deacylate faster than any other aa-tRNA species 
(Matthaei et al., 1966). This would presumably improve the overall efficiency of the 
selenocysteinylation reaction and the rate of production of Sec-tRNA in all organisms 
that possess an extended selenoproteome. Most selenoprotein-containing bacteria only 
have one to three selenoproteins that are expressed under specific environmental 
conditions and a nonessential tRNASec (Kryukov and Gladyshev, 2004). In contrast, 
humans have an essential tRNASec and an extended selenoproteome whose 25 members 



















































































































































































































































































































































































































































































































































































B. The indirect RNA-dependent PSTK/SepSecS pathway is the only route to Sec 
Despite the in vitro experiments that indicated that PSTK and SepSecS are the core 
components for selenocysteine biosynthesis in eukaryotes (Xu et alv 2007; Yuan et al., 
2006), the in vivo analysis of Sec-tRNASec formation in eukaryotes has been hampered by 
the lack of a suitable system. Using T. brucei to produce knock-out cell lines for the 
trypanosomal orthologues of PSTK and SepSecS and RNAi strains of Tb-SerRS, Tb-PSTK 
and Tb-EFSec, I carried out analysis of the eukaryotic selenoprotein synthesis machinery 
in vivo. Formation of Sec-tRNASec in T. brucei requires the sequential action of Tb-PSTK 
and Tb-SepSecS along with Tb-SerRS, Tb-SPS2 and Tb-EFSec. 
These results also reveal the existence of a single pathway to Sec-tRNASec that 
requires Sep-tRNASec as an intermediate. While RNAi knock-down of SepSecS in 
mammalian cells had only a minor effect on selenoprotein synthesis (Xu et al., 2005), in 
T. brucei there is no alternative route to Sec-tRNASec independent of SepSecS. However, 
the results obtained in T. brucei might not be readily comparable with the study in 
mammalian cells. In T. brucei, selenoprotein synthesis was assayed in a double knock-
out cell line completely devoid of Tb-SepSecS, whereas in mammalian cells the RNAi-
mediated knock-down may have not completely depleted the human SepSecS protein; 
western blot analysis of SepSecS protein levels in the mammalian knock-down strains 
would confirm this hypothesis. Nevertheless, it is likely that even in mammalian cells, 
just as in T. brucei, only a single pathway for Sec-tRNASec formation exists. 
78 
C. M. maripaludis SepSecS structure: insights into the reaction mechanism 
SepSecS is a PLP enzyme catalyzing a (3-replacement (Figure 6), leading to the exchange 
of a phosphate group for a selenol moiety. The active site of MMPSepSecS lacks a Cys 
residue. In contrast, the crystal structures of ECCsdB (Lima, 2002) and of AFSepCysS 
(Fukunaga and Yokoyama, 2007), which are close homologs of SepSecS and catalyze 
similar reactions, reveal Cys364 and Cys247 in the active sites of ECCsdB and 
AFSepCysS, respectively (Figure 18) (Araiso et al., 2008). The Cys364 residue of ECCsdB 
recognizes Sec and withdraws its selenium to form perselenide as an intermediate 
(Lima, 2002). Cys364 of ECCsdB resides in the (3a|3 structural motif which does not exist 
in MMPSepSecS. On the other hand, Cys247 of AFSepCysS is the candidate residue that 
forms a persulfide, which is the sulfur source for the enzyme-catalyzed Cys-tRNAcys 
formation (Fukunaga and Yokoyama, 2007). The absence of such a Cys active site 
residue that could be involved in the formation of a catalytically important perselenide 
intermediate indicates that the reaction mechanisms and chemistries of SepSecS are 
fundamentally different from those of CsdB and SepCysS. Thus, SepSecS and SepCysS, 
two related PLP enzymes that perform chemically analogous tRNA-dependent 
transformations of Sep to Sec or Cys, respectively, proceed with different selenium and 
sulfur transfer mechanisms. 
D. The human SepSecS-tRNASec complex reveals the mechanism of Sec formation 
The structure of the quaternary complex of SepSecS-tRNASec with Sep and 
thiophosphate along with the in vivo and in vitro activity assays suggest the following 
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PLP-based mechanism of Sep-tRNASec to Sec-tRNASec conversion. The reaction begins by 
the covalently attached Sep being brought into the proximity of the Schiff base when 
Sep-tRNASec binds to SepSecS. The amino group of Sep can then attack the Schiff base 
formed between Lys284 and PLP, which yields an external aldimine (Figure 29A, B) 
(Palioura et al., 2009). The reoriented side chain of Lys284 abstracts the Ca proton from 
Sep (Figure 29C), and the electron derealization by the pyridine ring assists in rapid (3-
elimination of the phosphate group, which produces an intermediate dehydroalanyl-
tRNASec (Figure 29C, D). After phosphate dissociation and binding of selenophosphate, 
the concomitant attack of water on the selenophosphate group and of the nucleophilic 
selenium onto the highly reactive dehydroalanyl moiety yield an oxidized form of Sec-
tRNASec (Figure 29D). The protonated Lys284 returns the proton to the Ca carbon and 
then attacks PLP to form an internal aldimine (Figure 29E). Finally, Sec-tRNASec is 
released from the active site (Figure 29F) (Palioura et al., 2009). 
This mechanism is clearly distinct from the persulfide-intermediate mechanism 
in the Sep-tRNAcys to Cys-tRNAcys reaction (Hauenstein and Perona, 2008) and explains 
why SepSecS does not group together with its closest homologue, SepCysS, in the family 
tree of fold-type I PLP enzymes (Araiso et al., 2008). Moreover, the proposed mechanism 
for SepSecS is similar to the one used by the bacterial SelA that also proceeds through a 
dehydroalanyl-tRNASec intermediate (Forchhammer and Bock, 1991). SepSecS, 
therefore, uses a primordial tRNA-dependent catalytic mechanism in which the PLP 
cofactor is directly involved, while using a tetrameric Fold Type I architecture as the 
scaffold for binding the distinct structure of tRNASec. 
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Comprised of 90 nucleotides, tRNASec is the largest eukaryotic tRNA. Its 
acceptor-TWC 'helix' contains an additional base pair resulting in a 9/4 fold, in contrast 
to the 7/5 fold adopted by all known canonical tRNAs (Figure 23) (Palioura et al., 2009; 
Ithoh et al., 2009). Except for tRNASec, all tRNAs are transferred to the ribosome bound 
to either EF-Tu in bacteria or eEFIA in eukaryotes. The atypical 9/4 fold of tRNASec 
accounts for the evolution of the specialized elongation factor SelB in bacteria 
(Forchhammer et al., 1989) and EFSec in eukaryotes (Fagegaltier et al., 2000), which 
binds only Sec-tRNASec and not other aminoacyl-tRNAs. Both the variable and D arms of 
tRNASec are longer than the corresponding elements in canonical tRNAs, while the 
eighth position in tRNASec is occupied by adenine instead of the highly conserved 
uridine that is found in all canonical tRNAs. In a striking contrast to U8, the base of A8 
does not form any tertiary interactions with the D- and TWC arms leaving a hole in the 
core of the tRNA molecule (Palioura et al., 2009; Itoh et al , 2009; Yuan et al , 2010). All 
these features result in a distinct three-dimensional structure of tRNASec, which is likely 
to be recognized by all Sec-specific enzymes. 
In fact, while SerRS recognizes common structural features of tRNASer and 
tRNASec (Figure 25), it is thought that PSTK, SepSecS and EFSec recognize the distinct 
structural elements of tRNASec instead. The structure of the human SepSecS in complex 
with tRNASec and the in vivo mutagenesis data reveal that SepSecS does exactly that. It 
binds the longer acceptor-T^C 'helix', the long variable arm, the 5' phosphate and the 
acceptor-T^C-variable elbow (Figure 19). The tRNASec molecule is anchored to the 
SepSecS tetramer on one end by interactions between the tip of its acceptor arm (G73) 
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and the catalytic dimer (Arg398), and on the other end by interactions between its 
variable arm (C46L) and the non-catalytic dimer (Arg271) (Figure 20). The rest of the 
interactions between the a l helix of the non-catalytic dimer of SepSecS (Arg26, Lys38 
and Lys40) and the acceptor-TWC arm (C2, G50, and C64) further stabilize the complex 
(Palioura et al., 2009). Practically, SepSecS measures the length of the acceptor-TWC 
'helix' as the distance between the variable arm and the acceptor tip of tRNASec. 
Modeling of canonical tRNAs onto the human SepSecS showed that the length of their 
acceptor-T^PC 'helix' is too short to reach the active site of the enzyme (Figure 24A, B). 
Even if a productive interaction between the tip of the acceptor arm and the enzyme 
were forced to form, multiple steric clashes between the PFC arm and the N-terminal a l 
helix would prevent binding of the canonical tRNA to SepSecS (Figure 24C). 
The mode of tRNASec recognition by human SepSecS is reminiscent of the tRNA-
dependent amidotransferases GatDE and GatCAB that also recognize only the acceptor 
stem of the cognate tRNA (tRNAGln) (Nakamura et al., 2006; Oshikane et al., 2006). Given 
that SepSecS only binds to one side of the acceptor-TM/C arm of tRNASec, it is plausible 
that PSTK would bind to a different side of the acceptor-TWC arm or to the D-stem as it 
is proposed for the archaeal and human enzymes, respectively (Araiso et al., 2009; 
Sherrer et al., 2008a). This would then allow PSTK, SepSecS and tRNASec to form a 
ternary complex in vivo similar to that of the transamidosome involved in prokaryotic 
tRNA-dependent asparagine biosynthesis (Bailly et al., 2007). 
Finally, the observations that the archaeal PSTK and SepSecS are able to act on E. 
coli tRNASec in vivo, that human SepSecS can use E. coli tRNASec in vivo as well as the 
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archaeal tRNASec in vitro (Yuan et al., 2006), and that the bacterial selenocysteine 
synthase can use both archaeal and murine tRNASec in vitro (Xu et al., 2007) suggest that 
the length of the acceptor-TWC arm of tRNASec, the position of the variable arm and the 
mode of tRNASec recognition are likely to be conserved in all domains of life. 
Taken together, the structure of the SepSecS-tRNASec complex in the presence of 
Sep and thiophosphate provided key insights into the mechanism of Sec formation in 
humans. (1) SepSecS can interact with tRNASec only as a tetramer. (2) The crystal 
structure of human tRNASec revealed a novel fold distinct from other canonical tRNA 
molecules. (3) The discriminator base G73, a 13 bp long acceptor-TWC arm and a long 
variable arm, are the major recognition motifs for binding to SepSecS and may be critical 
for binding to other Sec-specific proteins such as SerRS and the Sec-specific elongation 
factors SelB or EFsec. (4) The epitope of human SepSecS autoantibodies is part of the 
interface of the enzyme's active site and the acceptor arm of tRNASec. (5) SepSecS can act 
only on Sep linked to tRNASec and not on free Sep or on Ser-tRNASec. (6) Both structural 
and biochemical data support a PLP-dependent mechanism of Sep-tRNASec to Sec-
tRNASec conversion. The mechanism of selenocysteine formation and the general mode 
of tRNASec recognition presented here is likely to be conserved in all other organisms 
that encode selenocysteine. 
83 
REFERENCES 
Aeby, E., Palioura, S., Pusnik, M., Marazzi, J., Lieberman, A., Ullu, E., Soil, D., and 
Schneider, A. (2009). The canonical pathway for selenocysteine insertion is dispensable 
in Trypanosomes. Proc Natl Acad Sci USA. 206, 5088-5092. 
Allmang, C , and Krol, A. (2006). Selenoprotein synthesis: UGA does not end the story. 
Biochimie55, 1561-1571. 
Allmang, C , Wurth, L., and Krol, A. (2009). The selenium to selenoprotein pathway in 
eukaryotes: more molecular partners than anticipated. Biochim Biophys Acta 1790, 1415-
1423. 
Ambrogelly, A., Palioura, S., and Soil, D. (2007) Natural expansion of the genetic code. 
Nat. Chem. Biol. 3, 29-35. 
Araiso, Y., Palioura, S., Ishitani, R., Sherrer, R.L., O'Donoghue, P., Yuan, J., 
Oshikane, H., Domae, N., Defranco, J., Soil, D., and Nureki, O. (2008). Structural 
insights into RNA-dependent eukaryal and archaeal selenocysteine formation. Nucleic 
Acids Res 36, 1187-1199. 
Araiso, Y., Sherrer, R.L., Ishitani, R., Ho, J.M., Soil, D., and Nureki, O. (2009). 
Structure of a tRNA-dependent kinase essential for selenocysteine decoding. Proc Natl 
Acad Sci USA 106, 16215-16220. 
Axley, M.J., Bock, A., Stadtman, T.C. (1991). Catalytic properties of an Escherichia 
coli formate dehydrogenase mutant in which sulfur replaces selenium. Proc Natl Acad 
Sci USA 88, 8450-8454. 
Bailly, M., Blaise, ML, Lorber, B., Becker, H.D., and Kern, D. (2007). The 
transamidosome: a dynamic ribonucleoprotein particle dedicated to prokaryotic tRNA-
dependent asparagine biosynthesis. Mol Cell 28, 228-239. 
Baron, C , and Bock, A. (1991). The length of the aminoacyl-acceptor stem of the 
selenocysteine- specific tRNASec of Escherichia coli is the determinant for binding to 
elongation factors SELB or Tu. J Biol Chem 266, 20375-20379. 
Baron, C , Heider, J., and Bock, A. (1990). Mutagenesis of selC, the gene for the 
selenocysteine-inserting tRNA-species in E. coli: effects on in vivo function. Nucleic 
Acids Res 18, 6761-6766. 
84 
Bellinger, F.P., Raman, A.V., Reeves, M.A., and Berry, M.J. (2009). Regulation and 
function of selenoproteins in human disease. Biochem J 422, 11 -22. 
Beverley, S.M., and Clayton, C.E. (1993). Transfection of Leishmania and 
Trypanosoma brucei by electroporation. Methods Mol Biol 21, 333-348. 
Bilokapic, S., Korencic, D., Soil, D., and Weygand-Durasevic, I. (2004). The unusual 
methanogenic seryl-tRNA synthetase recognizes tRNASer species from all three 
kingdoms of life. Eur J Biochem 271, 694-702. 
Biou, V., Yaremchuk, A., Tukalo, M., and Cusack, S. (1994). The 2.9 A crystal 
structure of T. thermophilus seryl-tRNA synthetase complexed with tRNA(Ser). Science 
263, 1404-1410. 
Blight, S.K., Larue, R.C., Mahapatra, A., Longstaff, D.G., Chang, E., Zhao, G., 
Kang, P.T., Green-Church, K.B., Chan, M.K., and Krzycki, J.A. (2004). Direct 
charging of IRNACUA with pyrrolysine in vitro and in vivo. Nature 431, 333-335. 
Bock , A., Thanbichler, M., Rother, M., and Resch, A. (2005). Selenocysteine. In 
Aminoacyl-tRNA Synthetases, M. Ibba, C.S. Francklyn, and S. Cusack, eds. 
(Georgetown, TX, Landes Bioscience), pp. 320-327. 
Bosl, M.R., Takaku, K., Oshima, M., Nishimura, S., and Taketo, M.M. (1997). Early 
embryonic lethality caused by targeted disruption of the mouse selenocysteine tRNA 
gene (Trsp). Proc Natl Acad Sci USA 94, 5531-5534. 
Bouzaidi-Tiali, N., Aeby, E., Charriere, F., Pusnik, M., and Schneider, A. (2007). 
Elongation factor la mediates the specificity of mitochondrial tRNA import in T. brucei. 
EMBO J 26, 4302-4312. 
Brun, R., and Schonenberger (1979). Cultivation and in vitro cloning or procyclic 
culture forms of Trypanosoma brucei in a semi-defined medium. Acta tropica 36, 289-
292. 
Bullock, T.L., Uter, N., Nissan, T.A., and Perona, J.J. (2003). Amino acid 
discrimination by a class I aminoacyl-tRNA synthetase specified by negative 
determinants. J Mol Biol 328, 395-408. 
Carlson, B.A., Xu, X.M., Kryukov, G.V., Rao, M., Berry, M.J., Gladyshev, V.N., and 
Hatfield, D.L. (2004). Identification and characterization of phosphoseryl-tRNA[Ser]Sec 
kinase. Proc Natl Acad Sci USA 101, 12848-12853. 
85 
Cassago, A., Rodrigues, E.M., Prieto, E.L., Gaston, K.W., Alfonzo, J.D., Iribar, 
M.P., Berry, M.J., Cruz, A.K., and Thiemann, O.H. (2006). Identification of 
Leishmania selenoproteins and SECIS element. Mol Biochem Parasitol 149, 128-134. 
Cone, J.E., Del Rio, R.M., Davis, J.N., and Stadtman, T.C. (1976). Chemical 
characterization of the selenoprotein component of clostridial glycine reductase: 
identification of selenocysteine as the organoselenium moiety. Proc Natl Acad Sci USA 
73, 2659-2663. 
Crick, F.H.C. (1958). On protein synthesis. Symp Soc Exp Biol 12, 138-163. 
Crick, F.H.C. (1966). Codon-anticodon pairing: the wobble hypothesis. J Mol Biol 19, 
548-555. 
Cupp-Vickery, J.R., Urbina, H., and Vickery, L.E. (2003). Crystal structure of IscS, a 
cysteine desulfurase from Escherichia coli. J Mol Biol 330, 1049-1059. 
Datsenko, K.A., and Wanner, B.L. (2000). One-step inactivation of chromosomal genes 
in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci USA 97, 6640-6645. 
Diamond, A.M., Choi, I.S., Crain, P.F., Hashizume, T., Pomerantz, S.C., Cruz, R., 
Steer, C.J., Hill, K.E., Burk, R.F., McCloskey, J.A., and Hatfield, D.L. (1993). 
Dietary selenium affects methylation of the wobble nucleoside in the anticodon of 
selenocysteine tRNA([Ser]Sec). J Biol Chem 268, 14215-14223. 
Eiler, S., Dock-Bregeon, A., Moulinier, L., Thierry, J.C., and Moras, D. (1999). 
Synthesis of aspartyl-tRNA(Asp) in Escherichia coli -a snapshot of the second step. 
EMBO J 18, 6532-6541. 
Eliot, A.C., and Kirsch, J.F. (2004). Pyridoxal phosphate enzymes: mechanistic, 
structural, and evolutionary considerations. Annu Rev Biochem 73, 383-415. 
Fagegaltier, D., Hubert, N., Yamada, K., Mizutani, T., Carbon, P., and Krol, A. 
(2000). Characterization of mSelB, a novel mammalian elongation factor for 
selenoprotein translation. EMBO J 19, 4796-4805. 
Forchhammer, K., and Bock, A. (1991). Selenocysteine synthase from Escherichia 
coli. Analysis of the reaction sequence. J Biol Chem 266, 6324-6328. 
Forchhammer, K., Boesmiller, K., and Bock, A. (1991). The function of 
selenocysteine synthase and SELB in the synthesis and incorporation of selenocysteine. 
Biochimie 73, 1481-1486. 
86 
Forchhammer, K., Leinfelder, W., and Bock, A. (1989). Identification of a novel 
translation factor necessary for the incorporation of selenocysteine into protein. Nature 
342, 453-456. 
Forster, C , Ott, G., Forchhammer, K., and Sprinzl, M. (1990). Interaction of a 
selenocysteine-incorporating tRNA with elongation factor Tu from E.coli. Nucleic Acids 
Res 18, 487-491. 
Forstrom, J.W., Zakowski, J. J., and Tappel, A.L. (1978) Identification of the catalytic 
site of rat liver glutathione peroxidase as selenocysteine. Biochemistry 17, 2639-2644. 
Fu, L.H., Wang, X.F., Eyal, Y., She, Y.M., Donald, L.J., Standing, K.G., and Ben-
Hayyim, G. (2002). A selenoprotein in the plant kingdom. Mass spectrometry confirms 
that an opal codon (UGA) encodes selenocysteine in Chlamydomonas reinhardtii 
glutathione peroxidase. J Biol Chem 277, 25983-25991. 
Fukunaga, R., and Yokoyama, S. (2007). Structural insights into the second step of 
RNA-dependent cysteine biosynthesis in archaea: crystal structure of Sep-tRNA: Cys-
tRNA synthase from Archaeoglobus fulgidus. J Mol Biol 370, 128-141. 
Ganichkin, O.M., Xu, X.M., Carlson, B.A., Mix, H., Hatfield, D.L., Gladyshev, V.N., 
and Wahl, M.C. (2008). Structure and catalytic mechanism of eukaryotic selenocysteine 
synthase. J Biol Chem 283, 5849-5865. 
Gelpi, C , Sontheimer, E.J., and Rodriguez-Sanchez, J.L. (1992). Autoantibodies 
against a serine tRNA-protein complex implicated in cotranslational selenocysteine 
insertion. Proc Natl Acad Sci USA 89, 9739-97'43. 
Geslain, R., Aeby, E., Guitart, T., Jones, T.E., Castro de Moura, M., Charriere, F., 
Schneider, A., and Ribas de Pouplana, L. (2006). Trypanosoma seryl-tRNA synthetase 
is a metazoan-like enzyme with high affinity for tRNASec. J Biol Chem 281, 38217-
38225. 
Hao, B., Gong, W., Ferguson, T.K., James, CM., Krzycki, J.A., and Chan, M.K. 
(2002). A new UAG-encoded residue in the structure of a methanogen methyltransferase. 
Science 296, 1462-1466. 
Hatfield, D.L., Carlson, B.A., Xu, X.M., Mix, H., and Gladyshev, V.N. (2006). 
Selenocysteine incorporation machinery and the role of selenoproteins in development 
and health. Prog Nucleic Acid Res Mol Biol 81, 97-142. 
87 
Hauenstein, S.I., and Perona, J.J. (2008). Redundant synthesis of cysteinyl-tRNACys in 
Methanosarcina mazei. J Biol Chem 283, 22007-22017. 
Herkel, J., Heidrich, B., Nieraad, N., Wies, I., Rother, M., and Lohse, A.W. (2002). 
Fine specificity of autoantibodies to soluble liver antigen and liver/pancreas. Hepatology 
35, 403-408. 
Ibba, M., and Soil, D. (2000). Aminoacyl-tRNA synthesis. Annu Rev Biochem 69, 617-
650. 
Ioudovitch, A., and Steinberg, S.V. (1998). Modeling the tertiary interactions in the 
eukaryotic selenocysteine tRNA. RNA 4, 365-373. 
Itoh, Y., Chiba, S., Sekine, S., and Yokoyama, S. (2009). Crystal structure of human 
selenocysteine tRNA. Nucleic Acids Res 37, 6259-6268. 
Jansonius, J.N. (1998). Structure, evolution and action of vitamin B6-dependent 
enzymes. Curr Opin Struct Biol 8, 759-769. 
Johansson, L., Gafvelin, G., and Arner, E.S. (2005). Selenocysteine in proteins-
properties and biotechnological use. Biochim Biophys Acta 1726, 1-13. 
Kaiser, J.T., Gromadski, K., Rother, M., Engelhardt, H., Rodnina, M.V., and Wahl, 
M.C. (2005). Structural and functional investigation of a putative archaeal selenocysteine 
synthase. Biochemistry 44, 13315-13327. 
Kernebeck, T., Lohse, A.W., and Grotzinger, J. (2001). A bioinformatical approach 
suggests the function of the autoimmune hepatitis target antigen soluble liver 
antigen/liver pancreas. Hepatology 34, 230-233. 
Kim, H.S., Vothknecht, U.C., Hedderich, R., Celic, I., and Soil, D. (1998). Sequence 
divergence of seryl-tRNA synthetases in archaea. J Bacteriol 180, 6446-6449. 
Kryukov, G.V., Castellano, S., Novoselov, S.V., Lobanov, A.V., Zehtab, O., Guigo, 
R., and Gladyshev, V.N. (2003). Characterization of mammalian selenoproteomes. 
Science 300, 1439-1443. 
Kryukov, G.V., and Gladyshev, V.N. (2004). The prokaryotic selenoproteome. EMBO 
Rep 5, 538-543. 
Kuiper, G.G., Klootwijk, W., and Visser, T.J. (2003). Substitution of cysteine for 
selenocysteine in the catalytic center of type III iodothyronine deiodinase reduces 
catalytic efficiency and alters substrate preference. Endocrinology 144, 2505-2513. 
88 
Lacourciere, G.M., Levine, R.L., and Stadtman, T.C. (2002). Direct detection of 
potential selenium delivery proteins by using an Escherichia coli strain unable to 
incorporate selenium from selenite into proteins. Proc Natl Acad Sci USA 99, 9150-9153. 
Leinfelder, W., Stadtman, T.C, and Bock, A. (1989). Occurrence in vivo of 
selenocysteyl-tRNASer UCA in Escherichia coli. Effect of selC mutations. J Biol Chem 
264, 9720-9723. 
Leinfelder, W., Zehelein, E., Mandrand-Berthelot, M.A., and Bock, A. (1988). Gene 
for a novel tRNA species that accepts L-serine and cotranslationally inserts 
selenocysteine. Nature 331, 723-725. 
Lima, CD. (2002). Analysis of the E. coli NifS CsdB protein at 2.0 A reveals the 
structural basis for perselenide and persulfide intermediate formation. J Mol Biol 315, 
1199-1208. 
Lobanov, A.V., Gromer, S., Salinas, G., and Gladyshev, V.N. (2006). Selenium 
metabolism in Trypanosoma: characterization of selenoproteomes and identification of a 
Kinetoplastida-specific selenoprotein. Nucleic Acids Res 34, 4012-4024. 
Lobanov, A.V., Hatfield, D.L., and Gladyshev, V.N. (2009). Eukaryotic selenoproteins 
and selenoproteomes. Biochim Biophysica Acta 1790, 1424-1428. 
Longstaff, D.G., Larue, R.C., Faust, J.E., Mahapatra, A., Zhang, L., Green-Church, 
K.B., and Krzycki, J.A. (2007). A natural genetic code expansion cassette enables 
transmissible biosynthesis and genetic encoding of pyrrolysine. Proc Natl Acad Sci USA 
104, 1021-1026. 
Lu, J., and Holmgren, A. (2009). Selenoproteins. J Biol Chem 284, 723-727. 
Maenpaa, P.H., and Bernfield, M.R. (1970). A specific hepatic transfer RNA for 
phosphoserine. Proc Natl Acad Sci USA 67, 688-695. 
Manns, M.P., Johnson, E.F., Griffin, K.J., Tan, E.M., and Sullivan, K.F. (1989). 
Major antigen of liver kidney microsomal autoantibodies in idiopathic autoimmune 
hepatitis is cytochrome P450dbl. J Clin Invest 83, 1066-1072. 
Matthaei, J.H., Voigt, H.P., Heller, G., Neth, R., Schoch, G., Kiibler, H., Amelunxen, 
F., Sander, G., and Parmeggiani, A. (1966). Specific interactions of ribosomes in 
decoding. Cold Spring Harb Symp Quant Biol 31, 25-38. 
89 
Mihara, H., Maeda, M., Fujii, T., Kurihara, T., Hata, Y., and Esaki, N. (1999). A 
nifS-like gene, csdB, encodes an Escherichia coli counterpart of mammalian 
selenocysteine lyase. Gene cloning, purification, characterization and preliminary x-ray 
crystallographic studies. J Biol Chem 274, 14768-14772. 
Milligan, J.F., Groebe, D.R., Witherell, G.W., and Uhlenbeck, O.C. (1987). 
Oligoribonucleotide synthesis using T7 RNA polymerase and synthetic DNA templates. 
Nucleic Acids Res 15, 8783-8798. 
Nakamura, A., Yao, M., Chimnaronk, S., Sakai, N., and Tanaka, I. (2006). Ammonia 
channel couples glutaminase with transamidase reactions in GatCAB. Science 312, 1954-
1958. 
Nirenberg, M., Leder, P., Bernfield, M., Brimacombe, R., Trupin, J., Rottman, F., 
and O'Neal, C. (1965). RNA codewords and protein synthesis, VII. On the general 
nature of the RNA code. Proc Natl Acad Sci USA 53, 1161-1168. 
Nureki, O., Watanabe, K., Fukai, S., Ishii, R., Endo, Y., Hori, H., and Yokoyama, S. 
(2004). Deep knot structure for construction of active site and cofactor binding site of 
tRNA modification enzyme. Structure 12, 593-602. 
Ohama, T., Yang, D.C., and Hatfield, D.L. (1994). Selenocysteine tRNA and serine 
tRNA are aminoacylated by the same synthetase, but may manifest different identities 
with respect to the long extra arm. Arch Biochem Biophys 575, 293-301. 
Oshikane, H., Sheppard, K., Fukai, S., Nakamura, Y., Ishitani, R., Numata, T., 
Sherrer, R.L., Feng, L., Schmitt, E., Panvert, M., Soil, D., and Nureki, O. (2006). 
Structural basis of RNA-dependent recruitment of glutamine to the genetic code. Science 
312, 1950-1954. 
Palioura, S., Sherrer, R.L., Steitz, T.A., Soil, D., and Simonovic, M. (2009). The 
human SepSecS-tRNASec complex reveals the mechanism of selenocysteine formation. 
Science 325, 321-325. 
Palioura, S., Herkel, J., Simonovic, M., Lohse, A., and Soil, D. (2010). Human 
SepSecS or SLA/LP: selenocysteine formation and autoimmune hepatitis. Biol Chem (in 
press). 
Percudani, R., and Peracchi, A. (2003). A genomic overview of pyridoxal-phosphate-
dependent enzymes. EMBO Rep 4, 850-854. 
90 
Polycarpo, C , Ambrogelly, A., Berube, A., Winbush, S.M., McCloskey, J.A., Crain, 
P.F., Wood, J.L., and Soil, D. (2004). An aminoacyl-tRNA synthetase that specifically 
activates pyrrolysine. Proc Natl Acad Sci USA 101, 12450-12454. 
Rayman, M.P. (2000). The importance of selenium to human health. Lancet 356, 233-
241. 
Rother, M., Wilting, R., Commans, S., and Bock , A. (2000). Identification and 
characterisation of the selenocysteine-specific translation factor SelB from the archaeon 
Methanococcus jannaschii. J Mol Biol 299, 351-358. 
Rudinger, J., Hillenbrandt, R., Sprinzl, M., and Giege, R. (1996). Antideterminants 
present in minihelix(Sec) hinder its recognition by prokaryotic elongation factor Tu. 
EMBO J 75, 650-657. 
Sauerwald, A., Zhu, W., Major, T.A., Roy, H., Palioura, S., Jahn, D., Whitman, 
W.B., Yates, J.R., 3rd, Ibba, M., and Soil, D. (2005). RNA-dependent cysteine 
biosynthesis in archaea. Science 307, 1969-1972. 
Schneider, G., Kack, H., and Lindqvist, Y. (2000). The manifold of vitamin B6 
dependent enzymes. Structure 8, Rl-6. 
Sculaccio, S.A., Rodrigues, E.M., Cordeiro, A.T., Magalhaes, A., Braga, A.L., 
Alberto, E.E., and Thiemann, O.H. (2008). Selenocysteine incorporation in 
Kinetoplastid: selenophosphate synthetase (SELD) from Leishmania major and 
Trypanosoma brucei. Mol Biochem Parasitol 162, 165-171. 
Sherrer, R.L., Ho, J.M., and Soil, D. (2008a). Divergence of selenocysteine tRNA 
recognition by archaeal and eukaryotic 0-phosphoseryl-tRNA ec kinase. Nucleic Acids 
Res 36, 1871-1880. 
Sherrer, R.L., O'Donoghue, P., and Soil, D. (2008b). Characterization and evolutionary 
history of an archaeal kinase involved in selenocysteinyl-tRNA formation. Nucleic Acids 
Res 36, 1247-1259. 
Soil, D. (1988). Genetic code: enter a new amino acid. Nature 331, 662-663. 
Soil, D., Jones, D.S., Ohtsuka, E., Faulkner, R.D., Lohrmann, R., Hayatsu, H., and 
Khorana, H.G. (1966). Specificity of sRNA for recognition of codons as studied by the 
ribosomal binding technique. J Mol Biol 19, 556-573. 
91 
Soil, D., Ohtsuka, E., Jones, D.S., Lohrmann, R., Hayatsu, H., Nishimura, S., and 
Khorana, H.G. (1965). Studies on polynucleotides, XLIX. Stimulation of the binding of 
aminoacyl-sRNA's to ribosomes by ribotrinucleotides and a survey of codon assignments 
for 20 amino acids. Proc Natl Acad Sci USA 54, 1378-1385. 
Srinivasan, G., James, CM., and Krzycki, J.A. (2002). Pyrrolysine encoded by UAG 
in Archaea: charging of a UAG-decoding specialized tRNA. Science 296, 1459-1462. 
Stock, T., and Rother, M. (2009). Selenoproteins in Archaea and Gram-positive 
bacteria. Biochim Biophys Acta 1790, 1520-1532. 
Sturchler-Pierrat, C , Hubert, N., Totsuka, T., Mizutani, T., Carbon, P., and Krol, 
A. (1995). Selenocystenylation in eukaryotes necessitates the uniquely long aminoacyl 
acceptor stem of selenocysteine tRNASec. J Biol Chem 270, 18570-18574. 
Sturchler, C , Westhof, E., Carbon, P., and Krol, A. (1993). Unique secondary and 
tertiary structural features of the eukaryotic selenocysteine tRNA(Sec). Nucleic Acids 
Res 21, 1073-1079. 
Su, D., Hohn, M.J., Palioura, S., Sherrer, R.L., Yuan, J., Soil, D., and O'Donoghue, 
P. (2009). How an obscure archaeal gene inspired the discovery of selenocysteine 
biosynthesis in humans. IUBMB Life 61, 35-39. 
Tormay, P., Wilting, R., Lottspeich, F., Mehta, P.K., Christen, P., and Bock, A. 
(1998). Bacterial selenocysteine synthase-structural and functional properties. Eur J 
Biochem 254, 655-661. 
Ullu, E., Tschudi, C , and Chakraborty, T. (2004). RNA interference in protozoan 
parasites. Cell Microbiol 6, 509-519. 
Wiemann, S., Weil, B., Wellenreuther, R., Gassenhuber, J., Glassl, S., Ansorge, W., 
Bocher, M., Blocker, H., Bauersachs, S., Blum, H., etal. (2001). Toward a catalog of 
human genes and proteins: sequencing and analysis of 500 novel complete protein coding 
human cDNAs. Genome Res 11, 422-435. 
Wu, X.Q., and Gross, H.J. (1993). The long extra arms of human tRNA(Ser)Sec and 
tRNASer function as major identify elements for serylation in an orientation-dependent, 
but not sequence-specific manner. Nucleic Acids Research 21, 5589-5594. 
92 
Wu, X.Q., and Gross, H.J. (1994). The length and the secondary structure of the D-stem 
of human selenocysteine tRNA are the major identity determinants for serine 
phosphorylation. EMBO J 13, 241-248. 
Xu, X.M., Carlson, B.A., Mix, H., Zhang, Y., Saira, K., Glass, R.S., Berry, M.J., 
Gladyshev, V.N., and Hatfield, D.L. (2007). Biosynthesis of selenocysteine on its tRNA 
in eukaryotes. PLoS Biol 5, e4. 
Xu, X.M., Mix, H., Carlson, B.A., Grabowski, P.J., Gladyshev, V.N., Berry, M.J., 
and Hatfield, D.L. (2005). Evidence for direct roles of two additional factors, SECp43 
and soluble liver antigen, in the selenoprotein synthesis machinery. J Biol Chem 280, 
41568-41575. 
Yano, T., Kuramitsu, S., Tanase, S., Morino, Y., Hiromi, K., and Kagamiyama, H. 
(1991). The role of His 143 in the catalytic mechanism of Escherichia coli aspartate 
aminotransferase. J Biol Chem 266, 6079-6085. 
Yoshizawa, S., and Bock , A. (2009). The many levels of control on bacterial 
selenoprotein synthesis. Biochim Biophys Acta 1790, 1404-1414. 
Yuan, J., Palioura, S., Salazar, J.C., Su, D., O'Donoghue, P., Hohn, M.J., Cardoso, 
A.M., Whitman, W.B., and Soil, D. (2006). RNA-dependent conversion of 
phosphoserine forms selenocysteine in eukaryotes and archaea. Proc Natl Acad Sci USA 
103, 18923-18927. 
Yuan, J., O'Donoghue, P., Ambrogelly, A., Gundllapalli, S., Lynn Sherrer, R., 
Palioura, S., Simonovic, M., and Soil, D. (2010). Distinct genetic code expansion 
strategies for selenocysteine and pyrrolysine are reflected in different aminoacyl-tRNA 
formation systems. FEBS Lett 584, 342-349. 
Zhong, L., and Holmgren, A. (2000). Essential role of selenium in the catalytic 
activities of mammalian thioredoxin reductase revealed by characterization of 
recombinant enzymes with selenocysteine mutations. J Biol Chem 275, 18121-18128. 
Zinoni, F., Birkmann, A., Stadtman, T.C., and Bock, A. (1986). Nucleotide sequence 
and expression of the selenocysteine-containing polypeptide of formate dehydrogenase 




Yuan, J.*, Palioura, S.*, Salazar, J.C., Su, D., O'Donoghue, P., Hohn, M.J., Cardoso, 
A.M., Whitman, W.B., and Soil, D. (2006). RNA-dependent conversion of 
phosphoserine forms seleno-cysteine in eukaryotes and archaea. Proc Natl Acad Sci 
USA 203,18923-18927. 
Ambrogelly, A., Palioura, S., and Soil, D. (2007). Natural expansion of the genetic code. 
Nat Chem Biol 3, 29-35. 
Araiso, Y.*, Palioura, S.*, Ishitani, R., Sherrer, R. L., Yuan, J., Oshikane, H., Domae, N., 
DeFranco, J., Soil, D., and Nureki, O. (2008). Structural insights into RNA-dependent 
eukaryal and archaeal selenocysteine formation. Nucleic Acids Res 36,1187-99. 
Su, D., Hohn, M.J., Palioura, S., Sherrer, R.L., Yuan, J., Soil, D., and O'Donoghue, P. 
(2008). How an obscure archaeal gene inspired the discovery of selenocysteine 
biosynthesis in humans. IUBMB Life 61, 35-9. 
Aeby, E., Palioura, S., Pusnik, M., Marazzi, J., Lieberman, A., Ullu, E., Soil, D., and 
Schneider, A. (2009). The canonical pathway for selenocysteine insertion is dispensable 
in Trypanosomes. Proc Natl Acad Sci U S A . 206, 5088-92. 
Palioura, S., Sherrer, R.L., Steitz, T.A., Soil, D., and Simonovic, M. (2009). The human 
SepSecS-tRNASec complex reveals the mechanism of selenocysteine formation. Science 
325, 321-325. 
Yuan, J., O'Donoghue, P., Ambrogelly, A., Gundllapalli, S., Sherrer, R.L., Palioura, S., 
Simonovic, M., and Soil, D. (2010). Distinct genetic code expansion strategies for 
selenocysteine and pyrrolysine are reflected in different aminoacyl-tRNA formation 
systems. FEBS Lett 584, 342-349. 
94 
RNA-dependent conversion of phosphoserine forms 
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The trace element selenium is found in proteins as selenocysteine 
(Sec), the 21st amino acid to participate in ribosome-mediated 
translation. The substrate for ribosomal protein synthesis is sel-
enocysteinyl-tRNASec. Its biosynthesis from seryl-tRNASec has been 
established for bacteria, but the mechanism of conversion from 
Ser-tRNASec remained unresolved for archaea and eukarya. Here, 
we provide evidence for a different route present in these domains 
of life that requires the tRNASec-dependent conversion of 
O-phosphoserine (Sep) to Sec. In this two-step pathway, O-phos-
phoseryl-tRNASec kinase (PSTK) converts Ser-tRNASec to Sep-
tRNASec. This misacylated tRNA is the obligatory precursor for a 
Sep-tRNA:Sec-tRNA synthase (SepSecS); this protein was previ-
ously annotated as SLA/LP. The human and archaeal SepSecS genes 
complement in vivo an Escherichia coli Sec synthase (SelA) deletion 
strain. Furthermore, purified recombinant SepSecS converts Sep-
tRNASec into Sec-tRNASecm vitro in the presence of sodium selenite 
and purified recombinant E. coli selenophosphate synthetase 
(SelD). Phylogenetic arguments suggest that Sec decoding was 
present in the last universal common ancestor. SepSecS and PSTK 
coevolved with the archaeal and eukaryotic lineages, but the 
history of PSTK is marked by several horizontal gene transfer 
events, including transfer to non-Sec-decoding Cyanobacteria and 
fungi. 
aminoacyl-tRNA | evolution | formate dehydrogenase | 
pyridoxal phosphate 
Amino acids enter protein synthesis as aminoacyl-tRNAs (aa-tRNAs). The identity of an amino acid inserted into the 
nascent polypeptide is determined by two factors: the interaction 
of the aa-tRNA anticodon with an appropriate mRNA codon, 
and the correct pairing of amino acid and tRNA anticodon in the 
aa-tRNA. Thus, faithful protein synthesis requires the presence 
in the cell of a full set of correctly aminoacylated tRNAs (1). Two 
routes to aa-tRNA synthesis exist (2): (/) direct acylation of the 
amino acid onto its cognate tRNA catalyzed by an aa-tRNA 
synthetase, and (H) tRNA-dependent modification of a noncog-
nate amino acid attached to tRNA. Although the majority of 
aa-tRNAs are made by direct aminoacylation, the indirect 
pathway is also widely used, e.g., for Gln-tRNAGln and Asn-
tRNAAsn formation (3). 
The biosynthetic route of aa-tRNA formation is understood 
for all of the currently known cotranslationally inserted amino 
acids. The sole exception is the case of selenocysteine (Sec) in 
eukarya and archaea (e.g., refs. 4 and 5). The bacterial case was 
solved in the 1990s when genetic and biochemical studies with 
Escherichia coli revealed that bacterial Sec-tRNASec was synthe-
sized by an indirect tRNA-dependent amino acid transformation 
mechanism (6). Sec is cotranslationally inserted into proteins in 
response to the codon UGA; thus the tRNAScc species has the 
corresponding anticodon UCA (7). This tRNA is misacylated 
with serine by E. coli seryl-tRNA synthetase (SerRS) to form 
Ser-tRNASec (8). Then a pyridoxal phosphate (PLP)-dependent 
Sec synthase (SelA) catalyzes the Ser-tRNASec -> Sec-tRNASec 
conversion using selenophosphate as selenium donor (Fig. 1 
Upper). For archaea and eukarya our understanding is still 
fragmentary. Serylation of tRNAScc by eukaryal (9-12) and 
archaeal (13-15) SerRS enzymes has been well established. 
However, the demonstration of an analogous reaction to the 
bacterial pathway converting Ser-tRNASec —» Sec-tRNASec has 
remained elusive. In particular, the archaeal protein MJ0158, 
annotated as the ortholog to bacterial SelA, did not support in 
vitro Sec formation (15). 
Recently, a pathway for cysteine formation was discovered 
in methanogens based on a tRNA-dependent conversion of 
O-phosphoserine (Sep) to cysteine (16). This route involves 
the attachment of Sep to tRNACys by SepRS and the subse-
quent Sep-tRNA^5 -* Cys-tRNA^5 transformation by Sep-
tRNA:Cys-tRNA synthase, a PLP-dependent enzyme using a 
still unknown sulfur donor (Fig. 1 Lower). The implications of 
this pathway for Sec formation were obvious (16), especially 
because a phosphoseryl-tRNASec kinase (PSTK) had just been 
identified (17). Its activity was characterized in vitro for the 
murine (17) and the Methanocaldococcus jannaschii (15) en-
zyme; this kinase phosphorylates specifically Ser-tRNASec to 
Sep-tRNAScc. This finding would lend credence to early re-
ports of the existence of mammalian Sep-tRNA formed from 
Ser-tRNA (18, 19). Because the initial search for a PLP-
dependent SelA activity as manifested by E. coli SelA was 
unsuccessful (15), we considered other proteins. The most 
promising candidate was the human protein SLA/LP (soluble 
liver antigen/liver pancreas), which forms a ribonucleoprotein 
antigenic complex with tRNASec in patients suffering from an 
autoimmune chronic hepatitis (20). This protein was classified 
computationally as a PLP-dependent serine hydroxymethyl-
transferase that might have SelA function (21). To lend further 
credibility, this protein (22, 23) has very well conserved 
archaeal orthologs but only in Methanocaldococcus jannaschii 
(MJ0610), Methanococcus maripaludis (MMP0595), Meth-
anopyrus kandleri (MK0672), Methanococcus voltae, Methano-
thermococcus thermolithotrophicus, and Methanococcus van-
nielii; these are the known archaea that use Sec. Considering 
all of these data, it appeared probable that this protein was the 
missing Sep-tRNA:Sec-tRNA synthase (SepSecS) (Fig. 1 Up-
per). 
Here, we report the identification of the human SLA/LP and 
Methanococcus maripaludis MMP0595 proteins as SepSecS en-
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Fig. 1. tRNA-dependent amino acid transformations leading to Sec and 
cysteine. (Upper) The SelA route is the bacterial pathway (6). The PSTK/SepSecS 
is the archaeal/eukaryal route. {Lower) The SepRS/Sep-tRNA:Cys-tRNA syn-
thase (SepCysS) pathway operates in methanogens to synthesize cysteine (16). 
zymes (encoded by spcS) that convert Sep-tRNASec —> Sec-
tRNASec. 
Results 
SepSecS Rescues Selenoprotein Biosynthesis in an E. coliselA Deletion 
Strain. When grown anaerobically, E. coli produces the selenium-
dependent formate dehydrogenase H ( F D H H ) . Its activity en-
ables the cells to reduce benzyl viologen (BV) in the presence of 
formate, which is usually observed in agar overlay plates under 
anaerobic conditions (24). We therefore constructed an E. coli 
selA deletion strain (JS1) in which selenoprotein production is 
abolished. Complementation of the JS1 strain with archaeal 
SepSecS genes from Methanococcus maripaludis (MMP0595) 
and Methanocaldococcus jannaschii (MJ0610) and with the 
human homolog (Q9HD40) allowed us to test the ability of these 
genes to restore selenoprotein biosynthesis as detected by F D H H 
activity. The E. coli cells were grown under anaerobic conditions 
for 24 h and overlaid with top agar containing BV and formate. 
Blue-colored cells indicated that BV was reduced and therefore 
F D H H activity was present, whereas cells without F D H H activity 
remained colorless. Neither the archaeal nor the human SepSecS 
genes were able to complement the E. coli JS1 strain (Fig. 2). 
However, complementation was achieved when the SepSecS 
genes were cotransformed with the gene encoding Methanocal-
dococcus jannaschii PSTK; the latter gene alone was not able to 
restore Sec synthesis in the E. coli JS1 strain. Confirmation of 
these results was with MacConkey nitrate agar plates where cells 
with inactive formate dehydrogenase N form dark red colonies 
(data not shown). These data imply that Sec formation was 
achieved by a two-step process: PSTK phosphorylates the en-
dogenous Ser-tRNASec to Sep-tRNASec, and then this misacy-
lated aa-tRNA species is converted to Sec-tRNASec by SepSecS. 
Thus, the human and archaeal SepSecS enzymes are active in E. 
coli. The data also demonstrate that Ser-tRNASec, present in E. 
coli JS1, cannot be converted to Sec-tRNAScc, and therefore is 
not a substrate for SepSecS. 
The bacterial SelA is a PLP-dependent enzyme with a critical 
lysine residue engaged in PLP binding (25). As the archaeal and 
eukaryal SepSecS proteins also have PLP binding domains (21), we 
introduced Lys —» Ala mutations to replace the critical lysine 
position in these enzymes (Methanocaldococcus jannaschii SepSecS 
Fig. 2. SepSecS genes restore FDHH activity in an E. coliselA deletion strain. 
The E. coli JS1 strains complemented with the indicated SepSecS genes were 
grown anaerobically on glucose minimal medium plates supplemented with 
0.01 mM IPTG at 30°C for 2 days. FDHH activity was observed by overlaying top 
agar containing formate and BV. Colonies with active FDHH reduced BV to a 
blue color. The SepSecS genes were from Methanocaldococcus jannaschii 
(MJ), Methanococcus maripaludis (MMP), human (HS), and E. coli selA (EC). 
K284T denotes a mutant human SepSecS where the Lys residue critical to PLP 
binding is changed to Thr. 
K277A, Methanococcus maripaludis SepSecS K278A, and human 
SepSecS K284A). Even in the presence of PSTK, the mutant 
SepSecS genes were no longer able to complement the bacterial 
selA deletion (the result for the human SepSecS mutant is shown in 
Fig. 2). This finding strengthens the notion that the SepSecS 
proteins need PLP to carry out the Sep -* Sec conversion. 
"Selenium Incorporation into E. coli Proteins. To directly follow 
selenoprotein production in E. coli, we labeled with 75Se the E. 
coli JS1 transformants (with SepSecS genes). These JS1 trans-
formant strains were grown anaerobically in the presence of 
[75Se]selenite and formate. Subsequently, the cell extracts were 
separated on a polyacrylamide gel and the radioactively labeled 
FDHn was visualized by autoradiography. In agreement with the 
BV assay results, 75Se-labeled FDHn was detectable in the 
presence of archaeal SepSecS only in the strains also trans-
formed with PSTK, whereas no labeling occurred when PSTK 
was absent (Fig. 3). The relatively lower labeling efficiency 
compared with the positive control, which was the transformant 
with E. coli WT selA, may be caused by the inefficient expression 
of the archaeal enzyme and the heterologous Sec biosynthesis 
FDhL 
Fig. 3. 75Se incorporation into the E. coli selenoprotein FDHH. Cells were 
grown in the presence of [75Se]selenite in TGYEP medium (see Materials and 
Methods) supplemented with 0.05 mM IPTG anaerobically at 37°C for 24 h. Cell 
extracts were separated by 10% SDS/PAGE, and the formation of 75Se-
containing FDHH was followed by autoradiography. The E. coli strain JS1 was 
complemented with E. coli SelA (lane 1), empty plasmids (lane 2), Methano-
caldococcus jannaschii SepSecS (lane 3), Methanocaldococcus jannaschii Sep-
SecS with PSTK (lane 4), and Methanocaldococcus jannaschii SepSecS, PSTK 
with Methanococcus maripaludis tRNASec (lane 5). 
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tion by coexpressing archaeal tRNASec in the E. coli JS1 strain. 
However, no significant increase in F D H H production was 
observed, which suggests that the endogenous E.coli tRNAScc is 
a good substrate for archaeal SepSecS. As the secondary struc-
ture of tRNAScc differs considerably among tRNA species from 
the different domains, SepSecS might display a relaxed recog-
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Fig. 4. Conversion o f in w'fro-synthesized Sep-tRNASec t o Sec-tRNASec. Phos-
phor images o f TLC separat ion of [14C]Sep and [14C]Sec recovered f r o m the 
aa-tRNAs of t h e SepSecS act iv i ty assay (see Materials and Methods). Sec was 
analyzed in its ox id ized f o r m as selenocysteic acid (Secya). Lane 1, Ser marker; 
lane 2, Sep marker ; lane 3, Sep-tRNASec w i t h Methanococcus maripaludis 
SepSecS; lane 4, Sep-tRNASec w i t h human SepSecS; lane 5, Ser-tRNASec w i t h 
Methanococcus maripaludis SepSecS; lane 6, react ion of lane 3 w i t h selenite 
o m i t t e d . 
SepSecS Converts Sep-tRNASec to Sec-tRNASec in Vitro. To prove that 
SepSecS is a SelA that catalyzes a tRNA-dependent Sep —> Sec 
synthesis we analyzed the conversion of [14C]Sep-tRNA to 
[14C]Sec-tRNA. To this aim Methanococcus maripaludis 
tRNASec was acylated with [14C]serine by using pure Methano-
coccus maripaludis SerRS (26). Phosphorylation was performed 
with pure Methanocaldococcus jannaschii PSTK. The isolated 
tRNA was then incubated under anaerobic conditions with 
purified recombinant SepSecS and E. coli selenophosphate 
synthetase (SelD) in the presence of selenite. After the reaction 
aa-tRNA was deacylated, and the amino acids were identified by 
TLC in two systems (one is shown in Fig. 4). The data show that 
SepSecS from both Methanococcus maripaludis (Fig. 4, lane 3) 
and human (Fig. 4, lane 4) were able to form Sec-tRNAScc from 
Sep-tRNASec, but not from Ser-tRNASec (Fig. 4, lane 5). Thus, 
Sep-tRNA is the crucial precursor for Sec-tRNA formation in 
archaea and eukarya. 
system. The second labeled band with lower molecular weight 
was likely caused by the degradation of FDHn considering the 
cells were harvested in stationary phase. 
In a different experiment we investigated the effect of a 
homologous SepSecS:tRNASec system on selenium incorpora-
Evolution of Two Sec Biosynthesis Pathways. Although genetic cod-
ing of Sec is limited in organismal distribution, selenoproteins are 
found in all domains of life. Phylogenetic evidence demonstrates 
that the core Sec-decoding genes (tRNAScc, SelB, and SelD), and 
thus translation of genetically encoded Sec, is an ancient process 
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that was already in existence at the time of the last universal 
common ancestor (27-29). SelA is of bacterial origin and was 
vertically inherited in that domain (30). Phylogenetic analysis of 
SepSecS and PSTK reveals distinct archaeal and eukaryal versions 
of these enzymes. This pathway can be traced back (at least) to the 
evolutionary split between the archaeal and eukaryal sister lineages 
(Fig. 5). SepSecS is confined to Sec decoding archaea and eukarya. 
Its evolutionary history is consistent with vertical inheritance and 
gene loss in non-Sec-decoding lineages (Fig. 5^4). 
More interesting is the complex picture presented in the PSTK 
phylogeny (Fig. 5B). Like SepSecS, PSTK shows an initial deep 
divide between a strictly eukaryal group on the one hand and an 
archaeal group on the other. The archaeal PSTK appears to have 
been horizontally transferred to several of the Sec-decoding 
eukarya. The unexpected association between Oryza sativa and 
Strongylocertrotus purpuratus implies multiple horizontal gene 
transfer events, whereas a single transfer to mammals early in 
their evolution accounts for the clustering of these organisms 
within the archaeal genre. An additional horizontal gene transfer 
of the archaeal version to non-Sec-decoding Cyanobacteria is 
also suggested. The eukaryal PSTK is clearly discernable in a 
distinct group of non-Sec-decoding fungi that lack all other Sec 
biosynthesis components. These fungi form a coherent cluster in 
the eukaryal group, implying vertical inheritance. Retention of 
PSTK in this group suggests that it was recruited to perform a 
different function. Some eukarya (e.g., Caenorhabditis and Xe-
nopus) retained both their native eukaryal PSTK and the 
acquired archaeal version, whereas in other lineages, including 
ancestors of mammals and trypanosomes, the archaeal version 
displaced its eukaryal counterpart. Most surprisingly, Plasmo-
dium falciparum is Sec-decoding (30, 31), yet neither the PSTK 
nor SelA gene can be found, which contributes to the idea that 
a third pathway for Sec formation may exist in some organisms. 
In summary, the last universal common ancestor genetically 
encoded Sec, and whether one or both pathways for converting 
Ser-tRNAScc —> Sec-tRNASec were present in the common 
ancestor remains to be seen. 
Discussion 
SepSecS has been suggested to be involved in Sec synthesis in 
eukarya since the early 1990s (20). In the current work, in vivo and 
in vitro results revealed that SepSecS is indeed a SelA analog able 
to catalyze the Sec-tRNASec formation. However, in contrast to 
bacterial SelA that converts Ser-tRNASec directly to Sec-tRNASec, 
SepSecS acts on the phosphorylated intermediate, Sep-tRNASec 
(Fig. 1). Therefore archaeal and eukaryal Sec biosynthesis requires 
three enzymes, SerRS, PSTK, and SepSecS, whereas bacteria 
accomplish the same task without PSTK. Both SelA and SepSecS 
are PLP-dependent enzymes. From a chemical standpoint a Sep —> 
Sec conversion is desirable, as Sep would provide a better leaving 
group (phosphate) than Ser (water) for replacement with selenium. 
The detailed reaction mechanism of SepSecS should be subject to 
future structural and biochemical investigations. Sep-tRNA is re-
ported to be more stable than Ser-tRNA (17), which is known to 
deacylate faster than any other aa-tRNA species (32). This fact 
would greatly improve the overall efficiency of the selenocysteiny-
lation reaction and the rate of production of Sec-tRNA in all 
organisms that possess an extended selenoproteome. Most seleno-
protein-containing bacteria only have one to three selenoproteins 
that are expressed under specific environmental conditions and a 
nonessential tRNASec (33). In contrast, humans have an essential 
tRNASec and an extended selenoproteome whose 25 members have 
been variously implicated in health and disease (4, 34). 
Phylogenetic analyses showed that SelA is of bacterial origin, 
whereas SepSecS is confined to archaea and eukarya, and PSTK, 
principally an archaeal and eukaryal enzyme, has been horizon-
tally transferred to the Cyanobacteria. tRNASec has distinct 
secondary structure features: the long extra arm for recognition 
by SerRS, the elongated acceptor stem for SelB binding (35), and 
still unknown recognition sites for PSTK and SepSecS. Consid-
ering the number of proteins that tRNASec interacts with, the 
clear division of bacterial and archaeal/eukaryal protein lineages 
and the discernable differences in tRNAScc structures in the 
three domains of life, it is interesting to see that E. coli tRNASec 
can be recognized by archaeal and human SepSecS at least in vivo 
(35). Moreover, although the biological archaeal and mamma-
lian selenium donors have not been characterized (6), our results 
indicate that selenophosphate provided by E. coli SelD can be 
used by SepSecS both in vitro and in vivo. 
Are there other pathways? The absence of both PSTK and 
SelA genes in P. falciparum brings out interesting questions: Is 
there a third pathway or enzyme to make Sec? And why is Sec 
the only amino acid among the 22 naturally cotranslationally 
inserted protein building blocks that has not developed its own 
aa-tRNA synthetase? 
Materials and Methods 
General. Oligonucleotide synthesis and DNA sequencing was 
performed by the Keck Foundation Biotechnology Resource 
Laboratory at Yale University. [14C]serine (163 mCi/mmol) was 
obtained from Amersham Pharmacia Biosciences (Piscataway, 
NJ). [75Se]selenite was purchased from the University of Mis-
souri Research Reactor Facility (Columbia, MO). 
Bacterial Strains and Plasmids. The selA deletion strain JS1 was 
constructed by replacing the gene with kanamycin cassette in 
BW25113 E. coli strain as described (36). The T7 polymerase 
gene was inserted in the genome by PI transduction. The selC 
deletion strain FM460 (37) was obtained from the Yale E. coli 
Stock Center. SepSecS genes from Methanococcus maripaludis 
(MMP0595) and Methanocaldococcus jannaschii (MJ0610) were 
amplified from genomic DNA, and the human SepSecS gene 
(GenBank accession no. BX648976) was amplified from an EST 
clone [clone ID: DKFZp686J1361, obtained from the RZPD 
German Resource Center for Genome Research, Berlin, Ger-
many (38)] followed by cloning into the pET15b vector. E. coli 
selD was cloned into pET15b vector. Methanococcus maripaludis 
tRNASec and Methanocaldococcus jannaschii PSTK gene were 
cloned into the pACYC vector individually or together. Human 
SepSecS K284T was generated by using the QuikChange site-
directed mutagenesis kit (Stratagene, La Jolla, CA) according to 
the manufacturer's directions. 
Protein Expression and Purification. Human SepSecS, Methanococ-
cus maripaludis SepSecS, and E. coli SelD were transformed into 
BL21(DE3) cd+ strain. Cells were grown to A6oo = 1-0, and 
protein production was induced by the addition of 0.5 mM 
isopropyl )3-D-thiogalactoside (IPTG). The cells were grown for 
20 h at 15°C and then spun down and resuspended in 50 mM 
Hepes (pH 8.0), 300 mM NaCl, 10 mM imidazole, 3 mM DTT, 
10 fiM PLP, and protease inhibitor mix (Roche, Indianapolis, 
IN). After sonication, cell lysates were applied to Ni-NTA resin 
(Qiagen, Valencia, CA). The resin was washed, and the Hisr,-
tagged proteins were eluted according to the manufacturer's 
manual. Proteins were then thoroughly dialyzed against 50 mM 
Hepes (pH 8.0), 300 mM NaCl, 10 mM DTT, 10 yM PLP, and 
50% glycerol. 
Complementation of an E. coli AselA Strain. Methanocaldococcus 
jannaschii, Methanococcus maripaludis, or human SepSecS were 
transformed into a AselA E. coli JS1 strain, with or without the 
Methanocaldococcus jannaschii PSTK gene. The deletion strain 
complemented with its own selA gene served as positive control. 
E. coli AselA strain plus PSTK, SepSecS, or both genes was plated 
on glucose-minimum medium agar plates with 0.01 mM IPTG 
and grown anaerobically for 2 days at 30°C. The plates then were 
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overlaid with agar containing 1 mg/ml BV, 0.25 M sodium 
formate, and 25 mM KH2PO4 adjusted to pH 7.0. The appear-
ance of blue/purple color is the indication of active FDHH (24). 
The same experiments were also carried out for SepSecS mu-
tants. Formate dehydrogenase N activity was tested with Mac-
Conkey nitrate medium plates. 
Metabolic Labeling with [7SSe]selenite. E. coli cells were grown 
aerobically overnight and diluted (1:50) under anaerobic con-
ditions in 5 ml of TGYEP medium (0.5% glucose, 1% tryptone, 
0.5% yeast extract, 1.2% K2HP04 ,0.3% KH 2P0 4 ,0 .1% formate, 
1 juM Na2Mo04 , pH adjusted to 6.5) (39) with 1 /uCi [
75Se]se-
lenite and 0.05 mM IPTG added. The cells were further grown 
anaerobically at 37°C for another 24 h and harvested. Cell lysates 
were prepared and subjected to SDS/PAGE, followed by auto-
radiography. 
Preparation of tRNA Substrates. The Methanococcus maripaludis 
tRNASec gene was cloned into pUC18 with T7 promoter and 
terminator. The plasmid was transformed together with a pA-
CYC vector encoding T7 RNA polymerase gene to the E. coli 
selC deletion strain (FM460). tRNASec was overexpressed and 
purified with biotinylated DNA oligonucleotides as described 
(40). Purified tRNASec (10 /j,M) was serylated in the presence of 
[14C]Ser (200 /LIM) and Methanococcus maripaludis SerRS (6 
/xM) in reaction buffer (100 mM Hepes, pH 7.0/10 mM KC1/10 
mM magnesium acetate/1 mM DTT/0.1 mg/ml BSA) at 37°C for 
1 h. To prepare Sep-tRNASec, 3 ixM PSTK was added to the 
reaction. Aminoacylated tRNA products were purified by phe-
nol extraction and ethanol precipitation followed by G-25 de-
salting column application. 
In Vitro Sep -» Sec Conversion. Purified recombinant SepSecS was 
incubated in reaction buffer (100 mM Hepes, pH 7.0/300 mM 
KCl/10 mM MgCl2) with Sep-tRNA
Sec or Ser-tRNASec (10 /u,M), 
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DTT (1 mM), Na2Se03 (250 /J,M), and purified recombinant E. 
coli SelD (100 yM) at 37°C for 30 min. The oxygen in the buffer 
was removed, and the reaction was carried out in the anaerobic 
chamber. After incubation, proteins were removed by phenol 
extraction. The tRNAs were purified with G-25 column and 
ethanol precipitation to remove small molecules and salts. 
Purified tRNA products were deacylated in 20 mM NaOH at 
room temperature for 10 min. The released amino acids were 
oxidized with performic acid (16) and subjected to TLC analysis 
[system 1: 85% ethanol; system 2: butanol/acetic acid/water 
(4:1:1)]. 
Phylogenetic Analysis. Sequences, taken from the National Center 
for Biotechnology Information nonredundant database or the 
ERGO database, were aligned by using Multiseq in VMD 1.8.5 
(41). The most parsimonious trees were generated with 
PAUP4M0 (42). Gaps were counted as missing data and a 
parsimony cost matrix, based on the Blosum45 substitution 
matrix (43), was used. Of the 1,000 most parsimonious trees, the 
topology with the maximum likelihood was chosen and branch 
lengths were optimized with PHYML v.2.4.4 (44). The JTT+T 
model with eight rate categories was used for amino acid 
substitution, and adjustable parameters were derived from max-
imum-likelihood estimates. Bootstrap values were computed by 
using the re-estimation of log likelihoods (RELL) method in 
PROTML from the Molphy 3.2 package (45). 
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Natural expansion of the genetic code 
Alexandre Ambrogelly, Sotiria Palioura & Dieter Soil 
At the time of its discovery four decades ago, the genetic 
code was viewed as the result of a "frozen accident." Our 
current knowledge of the translation process and of the 
detailed structure of its components highlights the roles 
of RNA structure (in mRNA and tRNA), RNA modification 
(in tRNA), and aminoacyl-tRNA synthetase diversity in the 
evolution of the genetic code. The diverse assortment of codon 
reassignments present in subcellular organelles and organisms 
of distinct lineages has ' thawed' the concept of a universal 
immutable code; it may not be accidental that out of more 
than 140 amino acids found in natural proteins, only two 
(selenocysteine and pyrrolysine) are known to have been added 
to the standard 20-member amino acid alphabet. The existence 
of phosphoseryl-tRNA (in the form of tRNA0 ' '8 and tRNASec) 
may presage the discovery of other cotranslationally inserted 
modified amino acids. 
Ribosomal protein synthesis is the pathway to most natural proteins. 
Faithful decoding of the genetic message relies on the presence of an 
aminoacyl-tRNA whose anticodon matches the mRNA codon, with 
the cognate amino acid esterified to the tRNA's 3'-terminal adenosine. 
Thus, synthesis of the correct aminoacyl-tRNA is critical in enabling the 
genetic code. Aminoacyl-tRNA (aa-tRNA) synthesis is the task of the 
aminoacyl-tRNA synthetases (aaRSs); each enzyme esterifies its cognate 
amino acid to the corresponding tRNA species1. In certain cases, how-
ever, aa-tRNA synthesis is carried out by an evolutionarily older route 
based on misacylation and subsequent tRNA-dependent amino acid 
modification2. Although over 140 different amino acids are found in 
natural proteins, most of them arise by post-translational modification 
of the 20 canonical amino acids3. The biosynthesis of proteins contain-
ing modified amino acids, which has long been a subject of great interest, 
relies on the existence of a designated codon and of enzymes that are 
able to acylate a specific tRNA with the desired amino acid. Though 
great strides have been made in introducing man-made amino acids into 
proteins based on the development of such orthogonal pairs4 of aaRSs 
and tRNA species5,6, there is also a natural expansion of the genetic code 
beyond the 20-amino-acid repertoire that leads to the coding of modi-
fied amino acids. Here we review our current knowledge of the makeup 
of the genetic code and the cotranslational insertion of noncanonical 
amino acids into proteins. 
Alexandre Ambrogelly and Sotiria Palioura are in the Department of Molecular 
Biophysics and Biochemistry, and Dieter Soil is in the Department of Molecular 
Biophysics and Biochemistry and the Department of Chemistry, Yale University, 
New Haven, Connecticut 06520-8114, USA. e-mail: dieter.soll@yale.edu 
Published online 15 December 2006; doi:10.1038/nchembio847 
Diversity of genetic code includes modified amino acids 
The apparent universality of the genetic code at the time of its elucida-
tion was thought to attest to the principle of common descent of all life 
from a single organism and provided support for Crick's "frozen acci-
dent" hypothesis regarding the evolution of the code itself7. According to 
this theory, ambiguous decoding that inevitably leads to the generation 
of a pool of "statistical proteins"8 (that is, by translation of any given 
gene into a group of related proteins) must have been tolerated by early 
life forms and may have even been advantageous for shaping the cel-
lular machinery to its current state. However, in order to account for its 
universality, the code was thought to be frozen to its existing form once 
a certain level of cellular complexity was reached. The already improved 
accuracy of protein synthesis at that stage, along with any further struc-
tural and functional refinement of the translation apparatus from there 
on, would preclude additional codon reassignments because they would 
inevitably lead to disruption of an organism's whole proteome; the vast 
production of misfolded and aberrant proteins would greatly challenge 
survival of any such organism. 
It was only 15 years after its deciphering that the discovery of devia-
tions from the universal code in vertebrate mitochondria (where AUA 
was found to code for methionine and UGA for tryptophan) challenged 
the concept of a frozen, nonevolving genetic code. Further genome analy-
ses have revealed ten codon reassignments in prokaryotic and eukaryotic 
nuclear codes and 16 changes in mitochondrial codes (reviewed in refs. 
9-12) (Fig. 1). The correlation of mRNA codons with amino acids is the 
product of the interpretation of the code by the translational machinery, 
and therefore it is only static as long as the components of this machinery 
do not change and evolve. It is not surprising then that the documented 
codon reassignments can always be traced back to alterations in the 
components of the translational apparatus that are primarily involved 
in the decoding process: the aaRSs, which ensure correct acylation of 
each tRNA species with its cognate amino acid1; the tRNA molecules, 
whose anticodon base pairs with the correct mRNA codon by the rules 
of the wobble hypothesis at the ribosome13'14; and the peptide chain 
termination factors that recognize the termination codons15. 
Interestingly, the same codon reassignments have been observed 
in organisms from different lineages, and a predisposition for fre-
quent reassignment of certain codons to several alternatives has also 
been documented. This is particularly true for the termination (stop) 
codons UAG, UAA and UGA, whose single occurrence per gene renders 
them particularly good candidates for reassignment given that such a 
change would cause minimal damage to the proteome. Examination 
of Escherichia coli laboratory strains in the 1960s led to the discov-
ery of nonsense suppression caused by tRNA species able to recog-
nize the codons UAG (amber suppressor), UAA (ochre suppressor) or 
UGA (opal suppressor) (reviewed in ref. 16). UGA is the only codon 
NATURE CHEMICAL BIOtOGY VOtUME 3 NUMBER! JANUARY 2007 29 
PERSPECTIVE 
Figure 1 Summary of genetic code changes. Codons not affected by 
reassignments are in black. Shown in red are codons that also have changed 
assignments to the amino acids shown in the outer circle in blue (standard 
amino acids) or red (noncanonical amino acids). Filled squares denote stop 
codons. The blue asterisk indicates codons that may be unassigned in some 
organisms or organelles. 
with an ambiguous meaning in organisms from all three domains of 
life; apart from functioning as a stop codon, an in-frame UGA also 
encodes selenocysteine (Sec), the 21st cotranslationally inserted amino 
acid17, through a recoding mechanism that requires a tRNA with a 
UCA anticodon (tRNASec)18, a specialized translation elongation factor 
(SelB) and an mRNA stem-loop structure known as the selenocysteine 
insertion sequence element (SECIS)19. UAG is also ambiguous in the 
Methanosarcinaceae, where in addition to serving as a translational stop 
it also encodes pyrrolysine (Pyl), the 22nd cotranslationally inserted 
amino acid20'21; in this case, a new tRNA synthetase, pyrrolysyl-tRNA 
synthetase (PylRS)22'23, is essential for this recoding event. 
The aforementioned genetic and biochemical studies of the trans-
lation machinery over the past four decades and the recent genome 
analyses have made it clear that the genetic code is still evolving, even 
though fixation of mutations that lead to codon reassignment is not 
favored10. We should note that, curiously enough, the ten nuclear code 
changes are a subset of the 16 mitochondrial ones; that is, every single 
nuclear codon alteration has been observed in mitochondria as well. 
Thus, the same type of changes seem to occur through a conserved 
codon reassignment process for both nuclear and mitochondrial codes, 
though mitochondrial idiosyncrasies, such as the small genome (for 
example, 16 kilobases in humans) and the compartmentalized nature 
of the organelle, may account for the different rate of such changes. 
The mitochondrial genome is thought to be under significant pres-
sure for genome minimization, and as such loss of a tRNA gene would 
reduce genome size by about 1% and bestow any such organism with 
a significant replication advantage. In fact, mammalian mitochondria 
have only 22 tRNA species. This is explained by the wobble rules: if a 
single tRNA can recognize up to three codons, then translation of the 
61 sense codons requires a minimum of 32 tRNA species. Furthermore, 
the unmodified uracil present in the first anticodon position of many 
mitochondrial tRNAs can read all four codons in a box, thereby reducing 
the required number to 24 (ref. 24); sequence analysis of the Neurospora 
crassa mitochondrial genome revealed 27 tRNA genes. Lastly, mitochon-
dria have only one tRNAMet (serving as initiator and elongator tRNA) 
and decode AUA as methionine (with no need for a second tRNAIle). 
In addition, the codon-anticodon pairing rules have been stretched by 
the realization that anticodon conformation is shaped by the anticodon 
loop and stem structure25, which is critically dependent on nucleotide 
modification (reviewed in ref. 26). Moreover, targeting of tRNA modi-
fication enzymes or edited tRNAs to mitochondria allows for codon 
reassignments specifically within this organelle without any effect in 
the nuclear codes. This is indeed the case for the 7-mefhylguanosine 
modification at the first anticodon position of tRNASerGCU that expands 
its decoding from AGU to AGN and thus reassigns the arginine codons 
AGA and AGG to serine in squid mitochondria27. A similar situation has 
been documented in echinoderm mitochondria for the pseudouridine 
modification at position 35 of the tRNAAsn anticodon that reassigns the 
lysine AAA codon to asparagine28. 
The above observations underscore the importance of tRNA modifi-
cations for the generation of alternate codon assignments (Table 1). RNA 
versatility, through post-transcriptional tRNA base modifications, thus 
accounts for the generation of most of the nonstandard codes. Codon 
reassignment in such a case would have to occur through an ambigu-
ous decoding step in which mischarged tRNAs (if modification alters 
the specificity of the aminoacylation reaction) or misreading tRNAs (if 
modification alters codon recognition) compete with wild-type tRNAs 
for mRNA codon binding at the ribosomal A site. This, in turn, implies 
that reassignment also depends on the capacity of the organism to tol-
erate a somewhat destabilized proteome, which has traditionally been 
thought to decrease survival fitness. In fact, ambiguous decoding may 
not be as detrimental as it was once thought. The proteome of Candida 
albicans is unstable because the tRNAo^j decodes the CUG codon as 
both serine and leucine; this tRNA can be charged by both seryl-tRNA 
synthetase (SerRS) and leucyl-tRNA synthetase29. Under environmental 
stress, a destabilized proteome seems to be beneficial for such species29. 
E. coli is able to cope with some mis-made proteins via an upregulated 
heat shock response (B. Ruan and S.R, unpublished data) when subjected 
to the survival stress of correcting the missense mutation in an essential 
enzyme30. This indicates that ambiguous decoding is not necessarily 
lethal and may even prove advantageous under certain conditions. The 
flexibility that the genetic code can attain through tRNA modifications 
and the cellular tolerance of an altered proteome has made possible the 
engineering of microorganisms that can incorporate non-natural amino 
acids into their protein repertoire31. 
As a final point, we should note that a recently proposed theory of 
collective evolution32 can account for the genetic code's universality and 
optimality (with respect to codon assignments and amino acid relat-
edness) without prohibiting the propensity for additional evolvability. 
In this theory, an innovation-sharing principle is proposed to govern 
survival in the primordial communal world through horizontal gene-
transfer events involving translational components that would provide a 
selective evolutionary advantage for the community as a whole. The uni-
versality of the code established at this stage provides the lingua franca 
for efficient genetic information exchange. Darwinian vertical evolution 
and its "survival of the fittest" dictum would in this case stem not from a 
single organism but from a dynamically interacting, gene-sharing com-
munity that comprises the last universal common ancestor. 
Selenocysteine: a versatile amino acid 
Selenium is a dietary trace element required for animal and human 
health. Its antioxidant properties account for its numerous health ben-
efits. Selenium offers protection from diverse human ailments including 
adverse mood states, cardiovascular disease, viral infections and cancer33. 
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Selenium carries out its functions in proteins in the form of selenocys-
teine, in which the sulfur-containing thiol group of cysteine has been 
replaced by the selenium-containing selenol moiety (Scheme l)34. 
Biochemical studies and genomic analyses have established that sele-
nocysteine and selenoproteins are found in organisms from all three 
domains of life, though not in all species. In fact, most organisms do 
not use this amino acid. Except for its occurrence in Chlamydomonas 
spp.35 and the alga Emiliana huxleyp6, and the presence of tRNASec 
in some plants37, selenocysteine is notably absent from fungi and 
selenide and ATP) the selenium donor monoselenophosphate44. This 
compound reacts with the SelA-bound dehydroalanyl-tRNASec to form 
Sec-tRNA. Thus, selenocysteine is made by a tRNA-dependent amino 
acid modification process. 
Recoding of UGA as selenocysteine requires the presence of the SECIS 
stem-loop mRNA structure and the specialized translation elongation 
factor SelB. In bacteria, the SECIS element is located immediately down-
stream of the UGA codon within the selenoprotein coding region. The 
general translation elongation factor Tu (EF-Tu) does not recognize 
higher plants. Although the mammalian selenoproteome38 contains Sec-tRNASec effectively either in vivo45 or in vitro46. SelB performs two 
more than 20 members that are implicated in health (for example, the 
essential antioxidant enzyme glutathione peroxidase and the thyroid 
hormone deiodinase) and disease, only a limited number of prokary-
otes contain selenocysteine39. For instance, within the 32 archaea with 
known genomes, only three species {Methanocaldococcus jannaschii, 
Methanococcus maripaludis and Methanopyrus kandleri) encode 
tRNASec. 
Although selenium and sulfur belong to the same group of elements 
in the periodic table and hence share some chemical properties (for 
example, electronegativity and major oxidation state), it is the different 
electronic structure of these two elements that makes the selenolate 
anion more stable than the thiolate one and gives selenoproteins their 
unique selenium-derived catalytic efficiencies. Indeed, the low pKa of 
selenol relative to a thiol (5.2 versus 8.5, respectively) and selenol's lower 
redox potential (-488 mV, versus -233 mV for the thiol) renders it fully 
ionized at the physiological pH range and causes selenocysteine to be 
substantially more reactive than cysteine. Thus, it is not surprising that 
most known selenoproteins are oxidoreduc-
tases with an essential (for efficient catalysis) 
selenocysteine active site residue. A selenocys-
teine-to-cysteine mutation in such cases results 
in a > 100-fold reduction in catalytic turnover 
(reviewed in ref. 40). A recent bioinformatic 
approach took into account both the catalytic 
advantage provided by selenocysteine and its 
reactivity in the presence of oxygen to explain 
its dynamic evolution41. 
functions mat are crucial for proper UGA recoding as selenocysteine: 
(i) its N-terminal domain, which is homologous to EF-Tu, binds to 
Sec-tRNASec with high specificity—unlike EF-Tu it does not bind to any 
other aa-tRNA, and it is even able to discriminate against Ser-tRNASec 
(ref. 47); and (ii) the binding of SelB to the SECIS element through its 
C-terminal domain is required for delivery of Sec-tRNASec to the ribo-
somal A site, by outweighing release-factor binding to the UGA codon. 
Thus, the dual properties of SelB guard the fidelity of protein translation by 
ensuring that only UGA codons in selenoprotein mRNAs are recoded. 
Selenocysteine biosynthesis and incorporation in eukaryotes and 
archaea. Because a selenocysteinyl-tRNA synthetase (an enzyme that 
would directly esterify selenocysteine to its cognate tRNASec) has 
never been found, tRNA-dependent conversion of serine is assumed 
to be the route to selenocysteine in eukaryotes and archaea (Scheme 1, 
top). Indeed, serylation of tRNASec by SerRS has been shown in vitro 
in both eukaryotes48"51 and archaea52"54 and is likely to occur in vivo 
Table 1 Some tRNA modifications and their effects on codon recognition 
3rd codon position 
1st anticodon base recognized Species or organelle Structure 
U U,C, AorG 
Biosynthesis of selenocysteine and UGA 
recoding in bacteria. Pretranslational amino 
acid modification is the path to Sec-tRNASec 
(Scheme 1, top). Selenocysteine biosynthesis 
commences with SerRS acylating tRNASec 
with serine, but because of its unusual struc-
ture SerRS does so with only 1% efficiency as 
compared with the other five tRNASer isoac-
ceptors42. Based on the requirement of E. coli 
formate dehydrogenase for the presence of 
selenocysteine for activity, a genetic system 
was developed that led to the identification of 
four E. coli genes (selA, selB, selC and selD), all 
of which are essential for selenocysteine inser-
tion (reviewed in ref. 19). In addition to tRNA-
Sec (SelC), selenocysteine synthase (SelA) and 
selenophosphate synthetase (SelD) are needed 
for conversion of Ser-tRNASec to Sec-tRNASec. 
SelA is a pyridoxal phosphate (PLP)-dependent 
enzyme with a conserved lysine residue that 
catalyzes the formation of an enzyme-bound 
dehydroalanyl intermediate with elimination 






















Mitochondria of D. melanogaster, 
nematode, Bos taurus 
Echinoderm, squid mitochondria 
A 
xo5U, 5-hydroxymethyluridine derivative; xm5U, 5-methyluridine derivative; xm5s2U, 2-thio-5-hydroxymethyluridine derivative; 
k2C (L), lysidine; f5C, 5-formylcytidine; m7G, 7-methylguanosine. Only the base of the nucleotides is represented. 

























inability of the eukaryotic and archaeal homo-
log of SelB to bind to the SECIS element, and 
the identification of other SECIS-binding pro-
teins have led to the proposition of at least two 
unconfirmed models (reviewed in ref. 55) that 
may explain how the ribosome distinguishes 
a selenocysteine UGA from a termination 
codon and how the eukaryotic and archaeal 





S donor + PLP Cysteine 
Scheme 1 tRNA-dependent amino acid transformations leading to selenocysteine and cysteine. 
Top: the SelA route is the bacterial pathway19; the PSTK/SepSecS pathway is found in archaea and 
eukaryotes62. Bottom: Cys-tRNAcys synthesis in methanogenic archaea69. The chemical structures of 
selenocysteine, O-phosphoserine and cysteine are shown on the side. 
as well51,55. A recent bioinformatic analysis revealed the enzyme phos-
phoseryl-tRNASec (Sep-tRNASec) kinase (PSTK) to be present only in 
genomes of organisms that have a selenoproteome. The activity was 
characterized in vitro for both the mouse56 and the M. jannaschii52 
enzymes; this kinase phosphorylates Ser-tRNASec specifically to form 
Sep-tRNASec. This lends credence to the old finding of Sep-tRNASec in 
mammalian cell extracts57'58. From a chemical standpoint, O-phospho-
serine would provide a better leaving group (phosphate) than serine 
(water) for replacement with selenium. Given that a PLP-dependent 
selenocysteine synthase activity (as manifested by E. coli SelA44 for the 
conversion of Ser-tRNASec to Sec-tRNASec) has been elusive, the mecha-
nistically similar SepCysS enzyme59 involved in Cys-tRNACys formation 
in methanogens (see below) might engage in a tRNA-dependent synthe-
sis of selenocysteine from O-phosphoserine. Another possible enzyme 
candidate is the human protein soluble liver antigen/liver pancreas 
(SLA/LP), which forms a ribonucleoprotein antigenic complex with 
tRNASec in people suffering from an autoimmune chronic hepatitis60. 
Bioinformatic support for this idea suggested that SLA/LP, a member 
of the family of PLP-dependent transferases, may have selenocysteine 
synthase function61. Recently, biochemical and molecular genetic stud-
ies have established that human SLA/LP, as well as its M. maripaludis 
ortholog, convert Sep-tRNASec to Sec-tRNASec 
in vivo and in vitro. Thus, the enzyme is a Sep-
tRNA:Sec-tRNA synthase (SepSecS)62. The 
natural selenium donor substrate for SepSecS 
is unknown, but SPS1 and SPS2 are two mam-
malian candidate selenophosphate synthetase 
enzymes63'64. 
Regarding UGA recoding on the ribosome, 
several distinguishing features account for a 
more complex picture and a still-hazy under-
standing of the process in archaea and eukary-
otes. In particular, the established presence of 
the eukaryotic and archaeal SECIS elements in 
the 3' untranslated region of the mRNA, the 
Pyrrolysine: the 22nd amino acid 
Methanogens are anaerobic archaea that pro-
duce methane commonly from carbon diox-
ide and dihydrogen. The Methanosarcinaceae 
are unique among methanogenic archaea in 
that they are capable of methanogenesis using 
methylamines65. Methane production from 
monomethylamine, for example, requires the 
enzyme monomethylamine mefhyltransfer-
ase. The mtmBl gene encoding this enzyme 
has an in-frame UAG codon that is translated 
in the Methanosarcinaceae, thereby produc-
ing the full-length methyltransferase protein 
(MtmB)66. The crystal structure of this pro-
tein from Methanosarcina barkeri revealed that 
the UAG-encoded residue is a lysine with a pyrroline-ring derivative 
attached to its e-amino group20'67; this amino acid was named pyrroly-
sine (Scheme 2). An amino acid with the expected mass was found at this 
position in the active site of the native MtmB enzyme68; pyrrolysine is a 
crucial residue for the enzymatic reaction to proceed66. Based on the cur-
rently known genomes, pyrrolysine is found in the Methanosarcinaceae 
and in the bacterium Desulfitobacterium hafniense. 
Pyrrolysine insertion requires an orthogonal aaRS-tRNA pair. The 
discovery of a new M. barkeri amber suppressor tRNA gene suggested 
that pyrrolysine might be cotranslationally inserted into MtmBl dur-
ing protein synthesis and therefore genetically encoded by UAG21. The 
tRNAp>'1 gene (pylT) is located next to pylS, which encodes a protein 
similar to a class II aaRS. These two genes precede the pylB, pylC and 
pylD genes21. 
Initial experiments21 suggested that Pyl-tRNAp>'1 synthesis proceeds 
via Lys-tRNAp>'1 (formed by PylS) and a subsequent tRNA-dependent 
amino acid modification. Support for a possible indirect route was also 
provided by the finding that Lys-tRNAp>'1 can be made by the simul-
taneous action of class I and class II lysyl-tRNA synthetases (LysRSs) 





Scheme 2 Schematic representation of Pyl-tRNApy' formation. Chemical structures of lysine and 
pyrrolysine are shown on the side. 
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charging of pyrrolysine onto tRNAPyl could 
not be overlooked, in particular because the 
pylS gene product, which has all the features 
of a bona fide class II aaRS, was a plausible 
candidate for this task. Indeed, in vitro stud-
ies using synthetic pyrrolysine subsequently 
showed that the PylS protein can charge pyr-
rolysine directly to tRNA1^1; lysine was not 
a substrate for this enzyme22,23 (Scheme 2). 
The reaction also occurs in vivo23. Because of 
this enzymatic activity, the product of the py/S 
gene was named pyrrolysyl-tRNA synthetase 
(PylRS)22'23. This enzyme is the first example 
of a tRNA synthetase that is specific for a 
modified amino acid, and PylRS and tRNA-
Pyl are a naturally occurring aaRS-tRNA pair 



















Pyrrolysine biosynthesis. Attempts at predict-
ing the genes involved in pyrrolysine biosyn-
thesis rested on the idea that, like pylS and py/T, 
their occurrence should be restricted to pyr-
rolysine-incorporating organisms; only pylD 
has these characteristics70. Although pylB and 
pylC were found to have homology to biotin 
synthase and D-alanine-D-alanine ligase, respectively, their conserved 
presence in the same transcriptional unit as pylT and pylS suggests some 
level of functional relevance to pyrrolysine metabolism or biosynthesis. 
Given the D stereoconformation of the pyrrolysine pyrroline ring, it is 
tempting to speculate that PylC may be responsible for the ligation of 
the pyrroline ring to the E-amino group of lysine. Although the pyrroline 
ring shares strong structural homology with the direct proline precursor 
A'-pyrroline-S-carboxylate (Scheme 3), the absence of homology of 
pylB and pylC to the proline biosynthetic genes (y-glutamylphosphate 
reductase and y-glutamyl kinase on one hand and ornithine amino-
transferase on the other) might indicate that proline and pyrrolysine 
pyrroline ring biosynthesis do not share the same glutamate or ornithine 
precursors. It is interesting to speculate whether the pyrroline ring is 
instead derived from the metabolite D-isoleucine (Scheme 3), which 
would free the organism of the need to conduct a difficult methylation 
step. The S-methyl-A'-pyrroline-S-carboxylate species, a regioisomer of 
the pyrrolysine precursor, has been previously obtained from L-leucine 
by a chemically analogous route71. The pyrrolysine precursor might 
also potentially be obtained from the catabolism of D-proline (Scheme 
3). This reaction may be carried out by proline dehydrogenase72, which 
performs this function for L-proline and whose gene is present in the 
Methanosarcinaceae genomes. 
A stem-loop structure in mRNA is not essential for UAG recoding. A 
currently unanswered question is whether the mtmBl UAG codon is 
actively recoded to pyrrolysine (as is the case with UGA recoding to sele-
nocysteine19) or whether this is a standard nonsense suppression16 event 
in which the presence of charged suppressor tRNA is sufficient to ensure 
a certain degree of UAG read-through70. An active recoding mechanism 
requires additional components (specific proteins or RNA elements) that 
a normal suppression event does not require. The cotranslational insertion 
of pyrrolysine into M. barkeri MtmB observed in E. coli2i implies that bac-
terial elongation factors deliver Pyl-tRNA1^1 to the ribosome. This is also 
supported by the fact that Thermus thermophilus EF-Tu can bind in vitro a 
mutant tRNA^1 (with a UUU anticodon) aminoacylated with lysine73. 
D-Pro D-Orn 
Potential Pyl precursors 
Scheme 3 Comparison of proline biosynthesis and potential pyrrolysine precursors. Intermediate 
metabolites in proline biosynthesis ((SSJ-A^pyrroline-S-carboxylate) and pyrrolysine biosynthesis 
((4S,5/?)-4-methyl-A1-pyrroline-5-carboxylate) that share structural homology are boxed. 
PYLIS elements (RNA structures resembling SECIS elements) were 
identified in M. barker?* and D. hafniense2 methylamine methyltrans-
ferase genes immediately downstream of the in-frame UAG codon. 
A synthetic oligonucleotide with sequence corresponding to the 
M. barkeri mtmBl PYLIS element did fold in the predicted secondary 
structure75. However, a bioinformatic analysis of the regions surround-
ing putative SECIS and PYLIS elements suggested that selenocysteine 
and pyrrolysine have different decoding strategies70 and questioned 
the functional significance of PYLIS elements. A recent study demon-
strated successful suppression of lacZ and rrpA amber mutants in E. 
coli strains transformed with M. barkeri pylS and pylT and grown in 
a medium supplemented with N-e-cyclopentyloxycarbonyl-lysine, an 
analog that substitutes for the commercially unavailable pyrrolysine76. 
The production of active P-galactosidase and tryptophan synthetase 
enzymes in the absence of PYLIS elements suggests that this RNA motif 
is not essential (at least in an E. coli context) to achieve sufficient UAG 
suppression. Future genetic studies in Methanosarcina spp. will provide 
a definitive answer to the question of the physiological significance of 
PYLIS elements. 
Sep-tRNA: precursor to Cys-tRNA in methanogenic archaea 
Cysteine is part of the 20-canonical-amino-acid repertoire ubiquitously 
used for protein synthesis. Though cysteine is present in proteins of M. 
jannaschii, Methanothermobacter thermautotrophicus and M. kandleri to 
an extent similar to that in other organisms, the genomes of these metha-
nogens do not encode a canonical cysteinyl-tRNA synthetase (CysRS). 
This puzzle was solved when a new pathway (Scheme 1, bottom) for pre-
translational amino acid modification was discovered for Cys-tRNACys 
synthesis in these organisms59. The first enzyme, an unusual aaRS that 
is homologous to the phenylalanyl-tRNA synthetase a subunit, accu-
rately and selectively acylates tRNAc>'s with O-phosphoserine. A second 
enzyme then converts Sep-tRNA0^ to Cys-tRNA^ in the presence of 
PLP and a still-unidentified sulfur donor. The two enzymes were named 
phosphoseryl-tRNA synthetase (SepRS, encoded by sepS) and Sep-
tRNA:Cys-tRNA synthase (SepCysS), respectively. Searches in genomic 
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databases revealed the presence of homologs of these proteins not only 
in M. jannaschii, M. kandleri and M. thermautotrophicus but also in 
genomes of other archaea such as M. maripaludis, Methanococcoides 
burtonii, Methanospirillum hungatei, Archaeoglobus fulgidus and the 
Methanosarcinaceae, organisms that also have the canonical CysRS59. 
Biochemical examination showed that SepRS is a typical class II aaRS 
specific solely for its substrates O-phosphoserine and tRNACys. After 
PylRS, this is now the second natural aaRS that evolved for activating a 
modified amino acid. 
An indication of the physiological and evolutionary significance of 
the SepRS/SepCysS pathway in these organisms has been provided by 
genetic experiments in M. maripaludis. This organism contains CysRS, 
horizontally transferred from bacteria, in addition to the indirect path-
way of Cys-tRNA formation77. Although the inactivation of the cysS 
gene encoding the canonical CysRS had no effect on cell growth in 
different media78, an M. maripaludis strain containing a sepS deletion 
showed cysteine auxotrophy59. The dispensability of the canonical 
CysRS together with the auxotrophic nature of the M. maripaludis sepS 
knockout strain demonstrates that (i) in the presence of exogenous cys-
teine the SepRS/SepCysS pathway and CysRS are functionally equiva-
lent in Cys-tRNA synthesis, and (ii) the indirect route to Cys-tRNA is 
the sole source of free cellular cysteine in this organism59. Thus, in M. 
maripaludis the SepRS/SepCysS pathway provides the cell with both 
Cys-tRNA^ and free cysteine. 
Because M. maripaludis contains both CysRS and SepRS, the single 
M. maripaludis tRNAcys species is aminoacylated by the two unrelated 
synthetases—the class II enzyme SepRS (with O-phosphoserine) and 
the class I enzyme CysRS (with cysteine). The existence of two unrelated 
decoding systems allows a reexamination of the role of aaRSs in the 
evolution of the genetic code. Biochemical analysis has established that 
the major tRNACys identity elements are shared by both synthetases, 
even though they belong to different classes79. In three other similar 
cases distinct aaRSs recognize common major identity elements in tRNA 
(tRNA1-^ (ref. 80), tRNASer (ref. 81) and tRNA01'' (refs. 82,83)). The evi-
dence indicates convergence of the aaRSs to recognize a preestablished 
tRNA identity. This RNA record supports the idea that the universal 
genetic code evolved in the RNA world79. 
Discovery of the tRNA-dependent cysteine biosynthetic route in M. 
jannaschii may have implications that reach far beyond the problem of 
how Cys-tRNACys is formed in three methanogenic archaea. Indeed, 
the fact that cysteine biosynthesis in M. jannaschii proceeds via Sep-
tRNA0^ and a subsequent conversion of O-phosphoserine to cysteine 
catalyzed by SepCysS suggests that the same (or a similar) enzyme may 
also carry out the transformation of O-phosphoserine to selenocyste-
ine59 in archaea and eukaryotes, as discussed above. 
Outlook 
It is exciting to know that RNA modifications and specialized RNA 
structures are essential in defining the coding response by fine-tuning 
codon-anticodon interactions and by recoding stop codons, and it is 
fascinating to visualize some of these structures in detail84. Indeed, 
tRNA modifications seem to coevolve with the pattern of codon usage 
seen in different organisms, thus facilitating codon identity change. 
Imbalance of the proteome was once thought to be the prohibitive 
factor in the introduction of new amino acids to the standard alpha-
bet. The absence of a selenocysteinyl-tRNA synthetase and the use of 
intricate machinery for selenocysteine incorporation was regarded 
as further proof that the current code and amino acid repertoire are 
hard to change. The ability of Candida spp. and E. coli to tolerate and 
even benefit from a destabilized proteome and the unexpected exis-
tence of aaRSs specific for the noncanonical amino acids pyrrolysine 
and O-phosphoserine have revealed that the code can be adaptive to 
evolutionary innovations. This, in turn, raises the possibility that addi-
tional encoded amino acids with particular functions might exist in 
still-uncharacterized genomes. 
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ABSTRACT 
The micronutrient selenium is present in proteins 
as selenocysteine (Sec). In eukaryotes and archaea, 
Sec is formed in a tRNA-dependent conversion 
of O-phosphoserine (Sep) by O-phosphoseryl-
tRNA:selenocysteinyl-tRNA synthase (SepSecS). 
Here, we present the crystal structure of 
Methanococcus maripaludis SepSecS complexed 
with PLP at 2.5 A resolution. SepSecS, a member 
of the Fold Type I PLP enzyme family, forms an (1x2)2 
homotetramer through its N-terminal extension. 
The active site lies on the dimer interface with 
each monomer contributing essential residues. In 
contrast to other Fold Type I PLP enzymes, Asn247 
in SepSecS replaces the conserved Asp in binding 
the pyridinium nitrogen of PLP. A structural com-
parison with Escherichia coli selenocysteine lyase 
allowed construction of a model of Sep binding 
to the SepSecS catalytic site. Mutations of three 
conserved active site arginines (Arg72, Arg94, 
Arg307), protruding from the neighboring subunit, 
led to loss of in vivo and in vitro activity. The lack 
of active site cysteines demonstrates that a 
perselenide is not involved in SepSecS-catalyzed 
Sec formation; instead, the conserved arginines 
may facilitate the selenation reaction. Structural 
phylogeny shows that SepSecS evolved early in 
the history of PLP enzymes, and indicates that 
tRNA-dependent Sec formation is a primordial 
process. 
INTRODUCTION 
The indirect tRNA-dependent pathways of aminoacyl-
tRNA formation, in which a noncognate amino acid 
bound to tRNA is converted to the cognate one, are 
widely distributed in nature. In fact, the tRNA-dependent 
pathways for Gin and Asn formation are evolutionarily 
older than the corresponding direct aminoacylation 
route catalyzed by the aminoacyl-tRNA synthetases (1). 
Although selenocysteine occurs in organisms from all 
three domains of life (2,3), Sec-tRNA is synthesized solely 
by the indirect route; actually it is the only natural amino 
acid found in proteins for which a cognate aminoacyl-
tRNA synthetase did not evolve. Seryl-tRNA synthetase 
(SerRS) forms Ser-tRNASec in bacteria (4), archaea (5,6) 
and eukaryotes (7). Using the selenium donor selenopho-
sphate bacteria convert this misacylated aminoacyl-tRNA 
species to Sec-tRNASec by the action of the SelA protein, a 
PLP-dependent selenocysteine synthase (3). Some metha-
nogenic archaea harbor a gene that was thought to encode 
a SelA homolog (e.g. MJ0158), but its product is unable to 
synthesize Sec-tRNASec in vitro (6). 
On the other hand, eukaryotes and archaea require an 
additional phosphorylation step catalyzed by O-phospho-
seryl-tRNASec kinase (PSTK) (8-10) and convert the 
resulting Sep-tRNASec to Sec-tRNASec by Sep-tRNA: Sec-
tRNA synthase (SepSecS) (11,12). An unexpected and 
important property of the human SepSecS protein is the 
fact that it is the target antigen for soluble liver antigen/ 
liver-pancreas (SLA/LP) autoantibodies (13-15) that are 
found in about a quarter of the patients with autoimmune 
hepatitis (16). The reactions catalyzed by PSTK and 
SepSecS are reminiscent of the indirect pathway of 
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Scheme 1. Graphic representation of the reaction schemes. (A) 
MMPSepSecS catalyzes the conversion of tRNASec-bound Sep to Sec. 
(B) AFSepCysS mediates the tRNACys-dependent transformation of 
Sep to Cys. (C) ECCsdB converts selenocysteine to alanine and 
elemental selenium. (D) ECIscS converts cysteine to alanine and 
elemental sulfur. 
Cys-tRNACys synthesis in archaeal methanogens (17) 
where Sep-tRNACys is converted to Cys-tRNACys by 
Sep-tRNA:Cys-tRNA synthase (SepCysS), a PLP-depen-
dent enzyme carrying out a P-replacement on tRNA-
bound Sep. The crystal structure of Archaeoglobus 
fuldgidus SepCysS has been reported (18). 
The initial characterization of SepSecS revealed that 
this protein is a PLP-dependent enzyme (11,12). In nature 
such enzymes are abundant; in some microbial genomes 
they represent as much as 1.5% of all genes (19). They 
have many diverse functions and are often involved in 
amino acid biosynthesis (20). The structures of three other 
PLP-dependent enzymes that use substrates (selenocys-
teine, cysteine) chemically similar to those of SepSecS 
have been solved. One is the A. fulgidus SepCysS 
(AFSepCysS) (18), while another one is Escherichia coli 
selenocysteine lyase (ECCsdB) (21), an enzyme that 
converts selenocysteine to alanine and elemental selenium 
(22). The last enzyme is the E. coli cysteine desulfurase 
(ECIscS) that catalyzes the desulfuration of cysteine (23). 
The reactions catalyzed by these enzymes are illustrated in 
Scheme 1; SepSecS and SepCysS carry out P-replacements 
on tRNA-bound Sep, while selenocysteine lyase removes 
the (3-substituent of Sec to form elemental selenium, 
and cysteine desulfurase catalyzes the fragmentation of 
cysteine to alanine and elemental sulfur. Biochemical data 
on SepSecS and SepCysS currently do not exist. 
Here, we report the crystal structure of Methanococcus 
maripaludis SepSecS (MMPSepSecS) at 2.5 A resolution 
and perform a structural comparison with ECCsdB and 
AFSepCysS. We propose active site residues important for 
the enzymatic function of MMPSepSecS by employing a 
combination of mutational in vivo and in vitro activity 
analyses. Finally, we present a structural phylogeny of the 
Fold Type I family of PLP-dependent enzymes that 
documents the evolutionary history of SepSecS. 
MATERIALS AND METHODS 
General 
Oligonucleotide synthesis and DNA sequencing was 
performed by the Keck Foundation Biotechnology 
Resource Laboratory at Yale University. [14C]Serine 
(163mCi/mmol) and [oc-32P]ATP (lOmmol/uCi) were 
obtained from Amersham Pharmacia Biosciences 
(Piscataway, NJ, USA). The E. coli BL21-CodonPlus 
(DE3)-RIL strain and the pUC18 vector were from 
Stratagene (LaJolla, CA, USA). The pET15b and the 
pACYC184 vectors were from Novagen (San Diego, CA, 
USA). Nickel-nitriloacetic acid agarose was from Qiagen 
(Valencia, CA, USA). Nickel-sepharose and Resource 
PHE were from GE Healthcare Bio-Sciences KK (Tokyo, 
Japan). 
Bacterial strains and plasmids 
Construction of the E. coli AselA deletion strain JS1 
(DE3), cloning of the M. maripaludis SepSecS gene 
(MMP0595) and the E. coli SelD gene into the pET15b 
vector, of the M. maripaludis tRNASec gene into the 
pUC18 vector, and of the M. jannaschii PSTK gene into 
the pACYC184 vector were described previously (11). The 
M. maripaludis SepSecS mutants R72A, R72Q, R72K, 
R94A, R94Q, H166A, H166F, H166Q, R307A, R307Q, 
R307K, Q102A, K278A, N247A, D277A, and K278A 
were generated using the QuikChange site-directed muta-
genesis kit (Stratagene) and cloned into the pET15b vector 
with an N-terminal His-tag. An N-terminal Ai_34SepSecS 
deletion mutant was constructed by PCR using the 
primers 5'-CCGCTCGAGCATCGGAAAATTCCTGA 
AAACGGAATTGATGACG-3' and 5'-GCTAGTTAT 
TGCTCAGCGGTGGCAGC-3' and the PET15b-
sepsecS plasmid DNA as the template. The resulting 
DNA fragment was digested with BamHI and Xhol and 
re-inserted into the pET15b vector. 
Protein expression and purification 
Expression and purification of the M. maripaludis wild-
type and mutant SepSecS proteins and the E. coli SelD 
(used for biochemical experiments) was done as described 
previously using Ni-NTA column chromatography (11). 
Purification of the wild-type SepSecS used for crystal-
lization involved two chromatographic steps. Briefly, 
pET\5b-sepsecS was transformed into the E. coli BL21-
CodonPlus (DE3)-RIL strain, cells were grown to 
A^oo = 0.6 and gene expression was induced with 
0.4 mM IPTG. After growth for 17 h at 20°C, cells were 
harvested, resuspended in 50 mM Tris-HCl (pH 7.0), 
300 mM NaCl, lOuM PLP, 5mM 2-mercaptoethanol, 
10% glycerol, 1 mM PMSF and gently sonicated. After 
centrifugation at 14000g for 30min, the supernatant was 
collected and purified by sequential passage through a 
Ni-Sepharose and a Resource PHE chromatography 
column. 
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Table 1. Data collection and phasing statistics 
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Gel filtration of MMPSepSecS 
A 0.5 ml sample of a 1.5mg/ml purified solution of 
selenomethionine-labeled MMPSepSecS was loaded onto 
a HiPrep 16/60 Sephacryl S-300 HR column (GE 
Healthcare). The column was run at 0.5ml/min in the 
same buffer as crystallization, containing 20 mM HEPES 
(pH 7.0), 300 mM NaCl, 10 uM PLP and 5mM DTT. The 
elution volume of MMPSepSecS was compared to the 
elution volumes of other oligomeric proteins according to 
the GE healthcare web site (http://www.gelifesciences. 
co .jp/catalog/pdf_attach/1810608 8 AC .pdf). 
Crystallization, structure determination and refinement 
The purified SepSecS was dialyzed against crystallization 
buffer, containing 20 mM HEPES-NaOH (pH 7.0), 10 uM 
PLP and 5 mM DTT, 300 mM NaCl and was concentrated. 
Crystals of M. maripaludis SepSecS were grown within a 
day at 20°C by the sitting-drop vapor diffusion method. 
Drops were prepared by mixing equal volumes of the 6 mg/ 
ml SepSecS solution and the reservoir solution, containing 
45 mM HEPES-NaOH (pH 7.0), 10 mM MES-HC1 (pH 
6.5), 90 mM KC1, 9mM CaCl2, 160 mM MgS04 and 10% 
PEG550MME. Selenomethionine-labeled SepSecS was 
prepared by the conventional method and was purified in 
the same manner as the wild-type. 
The SepSecS crystals were flash-cooled in a nitrogen 
stream at 100 K. All diffraction data sets were collected 
at the BL41XU at SPring-8 (Harima, Japan), and were 
processed with the HKL2000 suite. The crystals belong to 
the primitive monoclinic space group P2\, with unit-cell 
parameters a = 75.7, ZJ = 108.1, c=110.4A, (3 = 97°. 
There are four SepSecS molecules in the asymmetric 
unit. A multiwavelength anomalous dispersion (MAD) 
data set of the selenomethionine-substituted crystals was 
collected, and was used to search for the locations of 
the selenium atoms by using the program SnB (24). 
Subsequent phase refinements were performed with the 
program SHARP (25), and the model was manually built 
into the electron density maps by using the program O 
(26). The model was refined against reflections up to 2.5 A 
resolution by using the program CNS (27). The backbones 
of all residues were clearly defined in the final 2F0—FC 
electron density maps. Graphic representations were 
prepared with CueMol (http://www.cuemol.org). 
Statistics on data collection, phasing and refinement are 
shown in Tables 1 and 2. 
In vivo SepSecS assay 
The M. maripaludis wild-type and mutant SepSecS genes 
were transformed into the AselA E. coli JS1 strain with 
or without the M. jannaschii PSTK gene. Aerobic over-
night cultures were streaked in aerobic conditions on 
LB-agar plates supplemented with 0.01 mM IPTG, 1 uM 
Na2Mo04 , 1 uM Na2Se03 and 50 rnM sodium formate. 
The plates were placed in an anaerobic incubation jar that 
was flushed with an N2: C02 : H2 (90: 5: 5) gas mix three 
times to give an anaerobic atmosphere and then grown for 
16 h at 37°C and 36 h at 30°C. The plates were then overlaid 
with agar containing 1 mg/ml benzyl viologen (BV), 0.25 M 
sodium formate and 25 mM KH 2P0 4 adjusted to pH 7.0. 
The appearance of a blue/purple color is the indication of 
active formate dehydrogenase H (FDHH). 
Preparation and purification of tRNA gene transcripts 
The M. maripaludis tRNASec used as substrate in the 
in vitro assays was synthesized by in vitro T7 RNA 
polymerase run-off transcription as described (28). 
The tRNASec gene together with the T7 promoter was 
constructed from overlapping chemically synthesized 
oligonucleotides, cloned into the pUC18 plasmid and 
purified from E.coli DH5a transformants using a 
MaxiPrep plasmid purification kit (Qiagen). The purified 
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Table 2. Structure refinement statistics 
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of total 
Sep-tRNASec was ethanol precipitated at -20°C for 
45min and collected as a pellet by centrifugation at 
lOOOOg at 4°C for 30min. After washing the pellet with 
70% ethanol, it was allowed to dry on ice in order to avoid 
deacylation. 
To check levels of serylation and Ser-^-Sep conversion 
1 ul aliquots at the start and end of the reaction were 
quenched on ice with 3ul of lOOmM sodium citrate 
(pH 4.75) and 0.66mg/ml of nuclease PI (Sigma). 
Following nuclease PI digestion at room temperature 
for 1 h, 1.5 ul of the sample was spotted onto polyethyl-
eneimine (PEI) cellulose 20 cm x 20 cm thin layer chroma-
tography (TLC) plates (Merck). To separate the 
Sep-[32P]AMP spot from [32P]AMP and any remaining 
Ser-pP]AMP the plates were developed for 75min in 
buffer containing lOOmM ammonium acetate, 5% acetic 
acid. The plates were exposed on an imaging plate 
(FujiFilms) for 14h, scanned using a Molecular 
Dynamics Storm 860 scanner and quantified using the 
ImageQuant densitometry software. The amount of 
Sep-tRNASec formed can be calculated by dividing the 
intensity of the Sep-[32P]AMP spot by the sum of the 
intensities of all spots (Sep-[32P]AMP, [32P]AMP and 
r32-Ser-["P]AMP). 
LScc 
plasmid was digested with BstNl at 55°C for 16 h. 
The in vitro transcription reaction was performed at 
37°C for 5 h in buffer containing 40 mM Tris-HCl (pH 8), 
22 mM MgCl2, 25 mM DTT, 2mM spermidine, 50ug/ml 
BSA, O.lmg/ml pyrophosphatase, 4mM of each 
nucleoside triphosphate, BstNI-digested vector containing 
the tRNASec gene (60Lig/ml) and 1 mM T7 RNA 
polymerase. The tRNA ec transcript was purified by 
electrophoresis on a 12% denaturing polyacrylamide gel. 
Full-length tRNA was eluted and desalted on Sephadex 
G25 Microspin columns (Amersham). The tRNA 
transcripts were refolded by heating for 5min at 70°C 
in buffer containing lOmM Tris-HCl (pH 7.0), followed 
by addition of 5mM MgCl2 and immediate cooling 
on ice (5). 
Preparation of 32P-labeled Sep-tRNASec 
Refolded tRNASec transcript was 32P-labeled on the 
3' terminus by using the E. coli CCA-adding enzyme and 
[a-32P]AMP (Amersham) as previously described with 
some modifications (29). Briefly, 6ug of tRNASec trans-
cript was incubated with the CCA-adding enzyme and 
[oc- P]ATP (50 uCi) for 1 h at room temperature in buffer 
containing 50 mM Tris-HCl (pH 8.0), 20 mM MgCl2, 
5mM DTT and 50 uM sodium pyrophosphate. After 
phenol/chloroform extraction the sample was passed over 
a Sephadex G25 Microspin column (Amersham) to 
remove excess ATP (30). 
The recovered [32P]-labeled tRNASec was serylated and 
phosphorylated by M. maripaludis SerRS (5 uM) and 
M. jannaschii PSTK (1 uM) for 75min at 37°C in buffer 
containing 50mM HEPES (pH 7.5), lOmM MgCl2, 
20mM KC1, ImM DTT, 1 mM serine and lOmM ATP. 
After phenol/chloroform extraction aminoacylated 
In vitro conversion of Sep-tRNAsec to Cys-tRNA 
Purified wild-type or mutant MMPSepSecS (1 uM) was 
incubated with 1 uM 32P-labeled Sep-tRNASec in buffer 
containing 50mM HEPES (pH 7.0), 20mM KC1, lOmM 
MgCl2, 5mM DTT, 2uM PLP and 500 uM sodium 
thiophosphate. Reactions were carried out anaerobically 
at 37°C over 40min. At each time point taken, 1 ul 
reaction aliquots were quenched on ice with 3 ul of 
100 mM sodium citrate (pH 4.75) and 0.66mg/ml of 
nuclease PI (Sigma). Following nuclease PI digestion, 
1.5 ul of the sample was spotted onto PEI cellulose TLC 
plates that were developed, scanned and quantified as 
described above. To separate the Cys-[32P]AMP spot from 
the Sep-[32P]AMP, the [32P]AMP and any remaining 
Ser-[32P]AMP spots the plates were developed for 75 min 
in buffer lOOmM ammonium acetate, 5% acetic acid. The 
plates were exposed on an imaging plate (FujiFilms) for 
14h, scanned using a Molecular Dynamics Storm 860 
scanner and quantified using the ImageQuant densitome-
try software. The amount of Cys-[32P]AMP formed was 
calculated by dividing the intensity of the Cys-[32P]AMP 
spot by the sum of the intensities of all spots 
(Cys-[32P]AMP, Sep-[32P]AMP, [32P]AMP and Ser-
[32P]AMP). The added elevated concentration of PLP 
was used to assure that the mutant enzymes were 
saturated with the cofactor. 
In vitro conversion of Sep-tRNAScc to Sec-tRNASec 
The Sep-to-Sec conversion reaction was carried out as 
described before (11). Briefly, purified tRNASec (10 uM) 
was incubated with M. maripaludis SerRS (6uM) and 
M. jannaschii PSTK (3 uM) in reaction buffer containing 
100 uM [14C]Ser, lOOmM HEPES (pH 7.0), lOmM KC1, 
lOmM magnesium acetate, ImM DTT and O.lmg/ml 
BSA at 37°C for 1 h. The aminoacylated Sep-tRNASec 
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products were purified by phenol extraction followed 
by passage over a Sephadex G25 Microspin column 
(Amersham) and ethanol precipitation. Purified wild-type 
SepSecS or the R72Q mutant was incubated with 10 uM 
Sep-tRNASec and 100 uM purified E. coli SelD in reaction 
buffer containing lOOmM HEPES pH 7.0, 300 mM KC1, 
lOmM MgCl2, ImM DTT and 250 uM Na2Se03 . All 
buffers were prepared anaerobically and the reaction was 
carried out in an anaerobic chamber at 37°C. After 30min 
incubation the reaction was stopped by phenol extraction 
and the tRNAs were purified by application on a 
Sephadex G25 Microspin column (Amersham) and 
ethanol precipitation. Purified tRNA products were 
deacylated in 20 mM NaOH at room temperature for 
lOmin. The released amino acids were oxidized with 
performic acid and spotted onto silica gel 60 TLC 
aluminium sheets (Merck) that were subsequently devel-
oped in 85% ethanol. 
Alignment and phylogeny 
The STAMP (31) structural superposition algorithm in 
the Multiseq 2.0 module of VMD 1.8.6 (32) was used to 
establish a structure-based alignment between SepSecS 
and the other members of the fold type I PLP-dependent 
family. The structural similarity measure QH (33) was 
used to determine evolutionary distances between 
members of the fold type I group for the structural 
phylogeny shown in Figure 8. The tree was drawn using 
the programs NEIGHBOR and DRAWTREE in the 
Phylip 3.66 package (34). A similar structure-based 
alignment was used for the structure-based sequence 
alignment shown in Figure 2. First, SepSecS was 
structurally aligned to SepCysS, IscS and CsdB. This 
structure-based alignment was then supplemented with 
three additional SepSecS sequences, which had been 
previously aligned to MMPSepSecS with CLUSTAL 
(35). Some alignment ambiguities were corrected by 
manual adjustment to the structure-based sequence 
alignment. 
Accession numbers 
The Protein Data Bank (http://www.rscb.org/pdb) acces-
sion number for the coordinates of MMPSepSecS 
conjugated with PLP is 2Z67. 
RESULTS 
Experimental outline 
The MMPSepSecS protein was overproduced in E. coli, 
then purified by two column chromatographic steps, and 
crystallized. Using selenomethionine-labeled protein the 
structure was solved by the MAD method. The complex of 
SepSecS with covalently-bound PLP was refined to an 
.Rfree of 26.9% at 2.5 A resolution. 
In this first characterization of M. maripaludis SepSecS 
(MMPSepSecS) activity, we used the genetic complemen-
tation of an E. coli AselA deletion strain as an in vivo test. 
When grown anaerobically, E. coli produces the selenium-
dependent formate dehydrogenase FDHH . Its activity 
enables the cells to reduce benzyl viologen (BV) in the 
presence of formate; this is usually observed by a blue/ 
purple color in agar overlay plates under anaerobic 
conditions (36). Furthermore, we employed two in vitro 
tests. The first detects the enzyme's final reaction product, 
Sec-tRNASec, as determined by TLC of Sec released 
from tRNASec (11). Given the difficulty in working with 
selenophosphate (availability and oxygen sensitivity) we 
used thiophosphate as a surrogate substrate to measure 
the time course of Cys-tRNA ec formation by SepSecS. 
In this assay, 32P-labeled Sep-tRNASec was incubated 
anaerobically with wild-type or mutant SepSecS proteins 
and thiophosphate. After nuclease PI digestion of the 
tRNA in the reaction mixture, the product Cys-[32P]AMP 
was separated from Sep-[32P]AMP by TLC and 
quantitated. 
Overall structure of M. maripaludis SepSecS 
The MMPSepSecS protein adopts an L-shaped structure 
consisting of the N-terminal extension domain (1-130), 
a catalytic domain (131-309) and a C-terminal domain 
(353-436) (Figure 1A). Long, kinked helices (310-352) 
connect the catalytic and C-terminal domains. The PLP 
molecule is covalently bound to the conserved Lys residue 
K278 (Figure 2) at the active site. As can be seen in 
Figure 1, the overall architecture of MMPSepSecS is 
similar to the Fold Type I (20) PLP enzymes AFSepCysS 
(18) and ECCsdB (21) (Figure 1). These enzymes consist 
of a catalytic domain similar to that of MMPSepSecS, and 
a 'small domain', formed by the N-terminal polypeptide 
and C-terminal polypeptide, which also resembles the 
MMPSepSecS C-terminal domain (Figure IB and C) 
(18,21). We constructed a structure-based sequence 
alignment (Figure 2) in order to accurately compare 
MMPSepSecS to three PLP enzymes, AFSepCysS, 
ECCsdB and ECIscS, that act upon chemically similar 
substrates. According to structural similarity measures 
SepCysS, CsdB and IscS are significantly more closely 
related to each other than they are to SepSecS (Figure 3). 
Sequence relationships show a similar trend with SepCysS, 
CsdB and IscS sharing 24 identical residues while these 
proteins have only 8 residues in common with SepSecS 
(Figure 2). The alignment also shows that the archaeal 
SepSecS proteins lack the C-terminal extension that 
has been identified as the major antigenic region for the 
SLA/LP autoantibodies (37). 
In solution, SepSecS is a tetramer as revealed by gel 
filtration (Figure 4E). The asymmetric unit of the crystal 
contains four SepSecS molecules (chains A, B, C and D) 
related by non-crystallographic symmetry, suggesting that 
SepSecS forms a homotetramer (dimer of homodimers) 
(Figure 4A). The four molecules are mostly identical, with 
root mean square (RMS) deviations of about 0.5 A 
between the subunits. The N-terminal extension domain 
of each subunit plays a pivotal role in the tetrameric 
organization of SepSecS. These domains interact with 
each other to form a hydrophobic core (chain A with 
chain D, and chain B with chain C), which involves 
inward-facing hydrophobic residues protruding from the 
helices, otl, 0(2 and cx4 (Figure 4B). Thus, the N-terminal 
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Figure 1. The overall architectures of SepSecS and related enzymes. 
(A) Stereo view of the MMPSepSecS structure. The N-terminal domain 
(residues 1-130), the catalytic domain (residues 131-309), the linker 
helix (310-352) and the C-terminal domain (residues 353^134) are 
colored yellow, green, blue and pink, respectively. The carboxy-
terminal two residues are disordered. The PLP molecule bound to the 
active site is shown as a ball and stick model. (B) Stereo view of the 
AFSepCysS structure in the same orientation as (A) (18). The small 
domain, the linker helices and the catalytic domain are colored pink, 
blue and green, respectively. (C) Stereo view of the ECCsdB structure 
in the same orientation as (A) (21). The coloring scheme is the same 
as in (B). 
extension facilitates tetramer formation and its deletion is 
predicted to produce a dimeric SepSecS. Interestingly, 
AFSepCysS (18) and ECCsdB (21) lack the N-terminal 
extension domain and form dimers (Figure 4C and D). 
We investigated whether SepSecS would be active in a 
homodimeric form by assaying the enzymatic activity of 
an MMPSepSecS protein that lacks the N-terminal 
extension residues 1-34. The A1_34SepSecS enzyme did 
not form Sec-tRNASec in vivo (Figure 5). It was not able to 
rescue selenoprotein biosynthesis in our in vivo comple-
mentation test of the E.coli AselA deletion strain. Since the 
active site of SepSecS, like other PLP enzymes, is formed 
at the dimer interface it is clear that SepSecS would not 
function as a monomer. Why the tetrameric organization 
of SepSecS is critical for function remains unclear, but it is 
possible that the quaternary structure of SepSecS is 
important for tRNA recognition. In such a scenario, 
when a tRNA acceptor stem is bound to the active site of 
one dimer, the other dimer in the tetramer could be 
interacting with other regions of the tRNA. 
Recognition of PLP 
As in other Fold Type I PLP enzymes the active sites of 
MMPSepSecS lie on the dimer interface with each 
monomer contributing essential residues (20). The active 
site of chain A is formed by chains A and B that both 
recognize the PLP molecule (Figure 6). The catalytic 
domain harbors a seven-stranded (3-sheet, with only the 
sixth (3-strand being antiparallel; this is a common feature 
of Fold Type I PLP enzymes (20,38) including 
AFSepCysS (18) and ECCsdB (21). In the MMPSepSecS 
structure, PLP is covalently bound via a Schiff base to the 
strictly conserved Lys278 (chain A) (Figure 2), which is 
located between the sixth and seventh (3 strand in the 
active site (Figure 6A). Indeed, a Lys278Ala mutation 
abolishes MMPSepSecS catalytic activity as shown both 
in vivo by the lack of BV reduction by FDHH (Figure 5), 
and in vitro by the inability of the Lys278Ala mutant to 
form Cys-tRNASec (Figure 7). 
All known Fold Type I PLP enzymes possess a critical 
aspartate that contacts the Nl atom of the pyridine ring 
(39), which is thought to further increase the electron sink 
character of the PLP cofactor. SepSecS is an exception 
to this paradigm, Asn247 is found in the correspond-
ing position, and it forms a hydrogen bond with the 
pyridinium nitrogen (Figure 6). The other 'noncon-
forming' enzyme is SepCysS where the structure also 
reveals a similar Asn contact with PLP (18). The 
replacement of Asn247 with the uncharged Ala247 yields 
a partially active enzyme (Figures 5 and 7). The phosphate 
moiety of Sep appears to be such a good leaving group 
that the presence of an Asp or Asn residue is not required 
for the catalytic activity of SepSecS. 
The aromatic pyridine ring of PLP is sandwiched 
between His 166 (chain A) and Ala249 (chain A) through 
hydrophobic interactions at the bottom of the catalytic 
site (Figure 6). This recognition mode is commonly 
observed in the structures of Fold Type I PLP enzymes 
where the His residue increases the electron sink character 
of PLP's pyridine ring through the stacking interactions 
with it and may also play a role in substrate activation and 
acid base catalysis. In the latter case, the His residue 
makes a direct hydrogen bond with the critical aspartate 
that contacts the Nl atom of the coenzyme pyridine ring 
in all Fold Type I PLP enzymes (see above discussion) and 
is thus thought to assist in the dissipation of the negative 
charge generated around PLP's ring during catalysis (40). 
Furthermore, the phosphate moiety hydrogen bonds with 
the main-chain amide and carbonyl groups of Glyl40 and 
Serl68, respectively (Figure 6B). The MMPSepSecS 
mutant Hisl66Ala was partially active in forming Sec-
tRNASec in vivo (Figure 5). In vitro, the Hisl66Ala 
MMPSepSecS mutant was partially active in forming 
Cys-tRNASec as can be seen by the increase in intensity of 
the Cys-[32P]AMP spot and the concomitant decrease of 
the Sep-[32P]AMP spot during the course of the reaction 
(Figure 7B). Obviously, the mutant enzyme with Alal66 
has PLP still in a partially functional position. A mutation 
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Figure 2. Structure-based amino acid sequence alignment. The alignment includes representative SepSecS sequences from two archaea 
(M. maripaludis and M. kandleri) and two eukaryotes (H. sapiens and T. thermophila) as well as A. fulgidus SepCysS, E. coli IscS and E. coli 
CsdB. Amino acids are colored according to residue types, and strictly conserved residues are marked (*). The secondary structure of MMPSepSecS 
is illustrated above the alignment, and the active site arginines are highlighted in blue. The autoimmune antigenic region of human SepSecS (37) and 
a eukaryotic specific insertion are shown in gray boxes. 
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Figure 3. Structural phylogeny of the Fold Type I PLP-dependent enzyme family. The phylogenetic tree depicts the evolutionary history of the Fold 
Type I family. Branch lengths in the tree are proportional to structural differences between the members of the family according to the structural 
similarity measure QH (see 'Materials and methods' section). The subfamily clusters are denoted by arced lines and under each subfamily name 
(e.g. AT I) a representative enzyme name (e.g. aspartate aminotransferase) is given in parentheses. Isofunctional subfamilies are labeled only by their 
corresponding enzyme names. Protein structures used to build the tree are noted according to PDB (46) or SCOP (47) codes. 
of the corresponding His residue (position 143) in E. coli 
aspartate aminotransferase also led to a functional enzyme 
(40). In contrast, both the Hisl66Gln and Hisl66Phe 
mutants were inactive in vivo (Figure 5). The lack of 
enzymatic activity of the Hisl66Phe mutant implicates 
His 166 in the catalytic mechanism and not only in 
structural ring stacking interactions with the pyridine 
ring of PLP. It is interesting to note that with the 
exception of Plasmodium all known eukaryotic SepSecS 
proteins contain Gin at a homologous position to 166 in 
their sequences (Figure 2 and data not shown). 
Since the catalytic pocket is formed in the dimerization 
interface, chain B also contributes residues that participate 
in PLP recognition. In particular, the guanidinium group 
of Arg72 and the main-chain amide group of Arg307 
(from chain B) hydrogen bond to the phosphate moiety of 
PLP (Figure 6B). Mutations of Arg72 and Arg307 to Ala, 
Gin or Lys resulted in MMPSepSecS mutants that were 
significantly less active in Sec-tRNASec formation in vivo 
(Figure 5) and Cys-tRNASec formation in vitro 
(Figure 7C). We also show that the Arg72Gln mutant 
enzyme is unable to form Sec-tRNASec in vitro 
(Figure 7A). 
Such PLP recognition differs from that of AFSepCysS 
(18) and ECCsdB (21) (Figure 8). Unlike in the 
MMPSepSecS structure, the adjacent subunit of 
ECCsdB does not come close to the active site. In 
ECCsdB, an additional Poc(3 structural motif covers the 
active site, presumably to stabilize the PLP and Sec 
substrates inside the pocket. This motif also precludes 
interaction between residues from the neighboring subunit 
and the active site (Figure 8D). Although the active site of 
AFSepCysS is formed by residues from chains A and B, 
the chain B amino acids are located too distant for PLP 
recognition (Figure 8E). The active sites of MMPSepSecS 
and AFSepCysS are spacious enough to accommodate the 
O-phosphoseryl-CCA end of the tRNASec or tRNACys 
species, respectively. 
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Phosphoserine binding model 
Our crystallization solution contained 10 mM magnesium 
sulfate. In the present structure, a strong electron density 
(4.5cr), presumably corresponding to a sulfate ion, was 
observed adjacent to the PLP molecule of chains A and B 
(Figure 8A). The sulfate ion is recognized by Arg94, 
Ser95, Gin 102 and Arg307 of chain B (Figure 8A). The 
structure of ECCsdB with Sec bound to the active site 
(Figure 8D) was reported (21). Using the CE program (41) 
we superposed the active site structure of MMPSepSecS 
onto that of ECCsdB. This allowed modeling of Sec from 
CsdB into the MMPSepSecS active site (Figure 8B). The 
distance between the selenium atom of the modeled Sec 
and the sulfur atom of the bound sulfate is 3.74 A. We 
overlaid a Sep molecule on the position of the modeled Sec 
in the active site. The phosphate moiety of this modeled 
Sep overlapped with the bound sulfate, suggesting that 
this sulfate mimics the phosphate moiety of Sep attached 
to tRNASec. This allowed us to construct the Sep-binding 
model of MMPSepSecS (Figure 8C). Mutations of Arg94, 
Gin 102 and Arg307 residues that according to our 
Sep-binding model recognize the phosphate moiety of 
Sep significantly decreased the catalytic activity of 
MMPSepSecS both in vivo (Figure 5) and in vitro 
(Figure 7). While the distance of the Schiff base linkage 
between the C4oc atom of PLP and the N£ atom of Lys278 
is 1.74 A, the PLP C4oe atom is 2.19 A away from the 
amino group of the modeled Sep; thus, the amino group of 
Sep forms a Schiff base with PLP as a reaction 
intermediate. 
The active site 
We should first note that the active site of MMPSepSecS 
lacks a Cys residue. In contrast, the crystal structures of 
ECCsdB (21) and of AFSepCysS (18) each possess a 
cysteine-active site residue; Cys364 in ECCsdB and 
Cys247 in AFSepCysS (Figure 8). As revealed by a 
structural study (21), Cys364 of ECCsdB recognizes Sec 
and withdraws its selenium to form perselenide as an 
intermediate. Cys364 of ECCsdB resides in the Pa(3 
structural motif which does not exist in MMPSepSecS. 
On the other hand, Cys247 (from the neighboring subunit) 
of AFSepCysS is the candidate residue that forms a 
Figure 5. In vivo assays of SepSecS mutants. Formation of Sec-tRNASec in vivo is assayed by the ability of the wild-type MMPSepSecS and its 
mutant variants (N-terminal deletion Al-34, R72A, R72Q, R72K, R94A, R94Q, H166A, H166F, H166Q, R307A, R307Q, R307K, Q102A, K278A, 
N247A, D277A, K278A) to restore the BV reducing activity of the selenoprotein F D H H in the E.coli selA deletion strain JS1. Cotransformation of 
the PSTK gene (indicated with + ) from M. jannaschii is required for the formation of the Sep-tRNASec intermediate. 
Figure 4. The oligomeric states of SepSecS and related enzymes. 
(A) The overall architecture of the MMPSepSecS tetramer. Chains A 
and B, and chains C and D form dimers, respectively. The PLP 
molecules bound to each subunit are shown as ball and stick models. 
Chain A, chain B, chain C and chain D are colored pink, blue, green 
and yellow, respectively. (B) The N-terminal extension domains of 
chains B and C form a hydrophobic core that stabilizes the tetrameric 
state of MMPSepSecS. Three a-helices (cd,a2,a4) are labeled. Chains B 
and C are colored blue and green, respectively. (C) Stereo view of the 
AFSepCysS dimer in the same orientation as (A) (18). Chains A and B 
are colored pink and blue, respectively. The PLP molecules are shown 
as ball and stick models. (D) Stereo view of the ECCsdB dimer in the 
same orientation as (A) (21). The coloring scheme and the PLP repre-
sentation are the same as in (C). (E) Gel filtration of selenomethionine-
labeled SepSecS on Sephacryl S-300. Absorbance at 280 nm is shown as 
a blue line. The elution volumes of other oligomeric proteins are 
indicated in the chromatogram. The molecular weight of the 
MMPSepSecS monomer is 50kDa. MMPSepSecS eluted at the size 
expected for a tetrameric species. 
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persulfide that is the sulfur source for enzyme-catalyzed 
Cys-tRNACys formation (18). The absence of such a Cys 
active site residue indicates that the reaction mechanisms 
and chemistries of SepSecS are fundamentally different 
from those of CsdB and SepCysS. Interestingly, SepSecS 
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Figure 6. PLP recognition. Stereo views of (A) Ribbon representation 
of the active site of MMPSepSecS in the dimer interface between chains 
A and B that are colored pink and blue, respectively. The PLP 
molecule is covalently bound to Lys278 of chain A. The F0—Fc omit 
map of the PLP molecule, contoured at 3.5 a, is shown. (B) The amino 
acid residues that recognize the PLP molecule. The residues of chains 
A and B are colored pink and blue, respectively. The F0—Fc omit map 
(contoured at 3.5 o~) of all of the residues and PLP is shown. 
has an active site arginine (Arg307) in a homologous 
position to Cys247 in SepCysS (Figure 2). 
The MMPSepSecS structure reveals three conserved 
arginines (Arg72, Arg94 and Arg307) that are located in 
proximity of each other and close to the active site; they 
recognize the phosphate groups of PLP and presumably of 
Sep acylated to tRNASec (Figures 2 and 8A-C). Mutations 
of Arg72, Arg94 and Arg307 to Ala, Gin or Lys yielded 
MMPSepSecS enzymes that were unable to form Sec-
tRNASec in vivo (Figure 5). Asp277 interacts electrostati-
cally with Arg72, and the Asp277Ala enzyme was also 
inactive in vivo (Figure 5). The Arg72Gln, Arg94Gln and 
Arg307Gln MMPSepSecS mutants were inactive in 
forming Cys-tRNASec in vitro (Figure 7). In addition to 
the PLP-conjugated Lys278, Sep-binding arginines may 
also facilitate general acid/base catalysis as was shown for 
the tRNA modification enzyme TrmH where an arginine 
activated by a phosphate group acts as a general base (42). 
DISCUSSION 
The mechanism 
SepSecS is a PLP enzyme catalyzing a (3-replacement 
(Scheme 1), leading to the exchange of a phosphate group 
for a selenol moiety. We were interested to see if SepSecS 
might employ a perselenide intermediate during catalysis, 
which would require the presence of an active site cysteine. 
There are four moderately-to-highly conserved cysteine 
residues in the SepSecS sequences, which are found in 
35-97% of the SepSecSs. Three of these cysteines (Cysl46, 
Cys214 and Cys237 in MMPSepSecS) are distant from the 
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Figure 7. In vitro conversion of Sep-tRNASec to Sec-tRNASec or Cys-tRNASec. (A) Phosphorimages of TLC separation of [14C]Sep and [MC]Sec 
recovered from the aa-tRNAs of the SepSecS activity assay (see 'Materials and methods' section). Sec was analyzed in its oxidized form as 
selenocysteic acid (Secya). Lane 1, Ser marker; lane 2, Sep marker; lane 3, Sep-tRNAScc with wild-type MMPSepSecS; lane 4, Sep-tRNAScc with the 
R72Q MMPSepSecS mutant. (B) Representative phosphorimage for the H166A SepSecS mutant of the separation of Ser-[32P]AMP, Cys-[32P]AMP, 
[32P]AMP and Sep-[32P]AMP. At the indicated time points aliquots of the SepSecS reaction were quenched, digested with nuclease PI and spotted 
onto PEI-cellulose TLC plates as described in the 'Materials and methods' section. (C) Plot of Cys-tRNAScc formed versus time with 1 uM of wild-
type and mutant SepSecS enzymes using Sep-tRNASec (1 uM) and thiophosphate (500 uM) as substrates. Following quantification of the intensities of 
Ser-[32P]AMP, Cys-[32P]AMP, [32P]AMP and Sep-[32P]AMP using ImageQuant, the concentration of Cys-tRNA8" formed at each time point was 
calculated by dividing the intensity of the Cys-f P]AMP spot by the total intensity. The experiment was carried out in duplicate. 
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Figure 8. The active site. Close-up stereo views of the active site regions 
in MMPSepSecS, ECCsdB, and AFSepCysS. Chains A and B are 
colored pink and blue, respectively. The PLP molecule (shown as a ball 
and stick model) is covalently bound to chain A. (A) The recognition 
manner of the sulfate ion in the active site of MMPSepSecS. The 
sulfate ion is shown as a ball-and-stick model. The F0—Fc omit map of 
the sulfate ion, contoured at 4.5 a, is shown. (B) Sec docking model 
of MMPSepSecS, based on the structural comparison with ECCsdB. 
(C) Sep binding model of MMPSepSecS, based on the locations of the 
sulfate ion and Sep. (D) Close-up view of the active site region in 
ECCsdB. The PLP molecule is covalently bound to Lys226 of chain A. 
The orientation of the PLP molecule is the same as that in (A). 
The chain A residues that recognize PLP are shown. The PLP molecule 
is covered by the (3a(3 structural motif. (E) Close-up view of the 
active site region in AFSepCysS. The PLP molecule is covalently 
bound to Lys209 of chain A. The orientation of PLP is the same as 
that in (A). The chain A residues that recognize PLP and sulfate are 
shown. 
The least conserved of these residues is a strictly conserved 
proline (Pro 169) in the archaeal sequences, while the 
residue is conserved as a cysteine in 78% of the eukaryotic 
sequences. Interestingly, Pro 169 in MMPSepSecS is in the 
active^ site and in close contact with the PLP moiety 
(3.77 A at closest approach), which would then mean that 
most eukaryotic SepSecSs have a cysteine adjacent to 
the PLP. It is unclear whether the eukaryotic sequences 
make use of this cysteine in catalysis; nevertheless, this 
position is an intriguing candidate for mutagenesis in the 
eukaryotic context. 
Concerning the archaeal SepSecSs, there are no cysteine 
residues that could be involved in the formation of a 
catalytically important perselenide intermediate. In con-
trast, SepCysS is proposed to use a persulfide mechanism 
(18). Thus, SepSecS and SepCysS, two related PLP 
enzymes that perform chemically analogous tRNA-
dependent transformations of Sep to Sec or Cys, 
respectively, proceed with different selenium and sulfur 
transfer mechanisms. Based on the observed active site 
residues we propose that the arginine residues, that bind 
the phosphate groups of PLP and of Sep, also recruit the 
selenium donor selenophosphate. In this context, Arg307 
in the present structure resides at a similar position to that 
of Cys364 in ECCsdB and of Cys247 in AFSepCysS. 
Structural phylogeny of Fold Type I PLP enzymes 
SepSecS belongs to the largest and most diverse family of 
PLP-dependent enzymes found in nature. The evolution-
ary history of the Fold Type I PLP-dependent enzymes, 
also referred to as the oc-family, has been studied in 
detail with sequence-based phylogenetic methods (43). By 
applying the family profile analysis (FPA) technique (44), 
the authors were able to use sequence-based phylogenetics 
to partially capture the distant evolutionary events 
recorded in the sequences of the members of this family, 
some of whom share only 5% sequence identity. However, 
the low level of sequence similarity may lead to artifacts in 
the tree reconstruction process. Since crystal structures for 
most members of this protein family exist, we applied 
the technique of structural phylogeny (45) to explore the 
history of the Fold Type I family. This technique derives 
phylogenetic information directly from three-dimensional 
structures and thus allows an accurate reconstruction 
of the most distantly detectable evolutionary events. Our 
structural phylogeny (Figure 3) is largely in agreement 
with the previous sequence-based work, but some 
significant rearrangements in the tree can be seen. For 
example, the DC I and DC II subfamilies coalesce into a 
single subfamily according to structural similarity, and the 
y-lyase and CYS groups are not one but two evolutionary 
distinct subfamilies. 
There are two kinds of subfamilies in the Fold Type I 
group. The first type includes several proteins with distinct 
but related functions, which may have descended from a 
progenitor with a promiscuous enzymatic function. 
Examples of these progenitor enzymes include the four 
distinct aminotransferases (AT I-AT IV), an amino acid 
decarboxylase (DC I/II), a persulfide forming cysteine 
desulfurase/sulfhydrylase and finally separate (3- and 
1198 Nucleic Acids Research, 2008, Vol. 36, No. 4 
y-amino acid lyases. Subsequent evolution in each of these 
subfamilies ultimately produced the specific enzymatic 
functions observed in modern PLP-dependent enzymes. 
The second kind of subfamilies are those that include a 
set of isofunctional enzymes. The modern enzymes in 
these subfamilies trace back to ancestors that had already 
evolved their modern enzymatic specificity in the initial 
evolutionary radiation of the Fold Type I family. These 
isofunctional subfamilies include serine hydroxymethyl 
transferase, alliinase and an archaeal SelA-like protein 
(MJ0158), which is of unknown function. 
Importantly, the structural phylogeny allows the 
accurate placement of SepSecS within its family tree and 
reveals how this enzyme came into being. SepSecS is also a 
founding member of the Fold Type I family. It shows no 
specific relationship to any of the other subfamilies and 
emerges near the root of its family tree. While SepCysS, 
CsdB and IscS are part of a multifunctional subfamily 
(CYS in Figure 8) and these proteins have chemically 
similar substrates to SepSecS, there is no special relation-
ship between SepSecS and the CYS subfamily. This result 
indicates that SepSecS is truly an ancient enzyme, and thus 
tRNA-dependent selenocysteine biosynthesis is a primor-
dial process. 
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Summary 
Selenocysteine (Sec) is the 21st genetically encoded amino 
acid found in organisms from all three domains of life. Sec bio-
synthesis is unique in that it always proceeds from an amino-
acyl-tRNA precursor. Even though Sec biosynthesis in bacteria 
was established almost two decades ago, only recently the path-
way was elucidated in archaea and eukaryotes. While other 
aspects of Sec biology have been reviewed previously (Allmang 
and Krol, Biochimie 2006;88:1561-1571, Hatfield et al., Prog 
Nucleic Acid Res Mol Biol 2006;81:97-142, Squires and Berry, 
IUBMB Life 2008;60:232-235), here we review the biochemistry 
and evolution of Sec biosynthesis and coding and show how the 
knowledge of an archaeal cysteine biosynthesis pathway helped 
to uncover the route to Sec formation in archaea and 
eukaryotes. © 2008 IUBMB 
IUBMB Life, 61(1): 35-39, 2009 
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INTRODUCTION 
Since its identification as an element, selenium was only fa-
mous for its toxicity to animals and plants. Yet in 1954 sele-
nium was found to be required for formate dehydrogenase ac-
tivity in bacteria (1) and its presence in glutathione peroxidase 
was demonstrated in 1973 (2). The occurrence of selenocys-
teine (Sec) as the selenium moiety in naturally occurring pro-
teins was first discovered in 1976 (3). Subsequent work docu-
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mented the necessity of Sec in additional bacterial and eukary-
otic proteins (4). Later Sec was identified as the catalytic 
residue in the active site of glutathione peroxidase in 1978 (5). 
Without the extensive genomic data on hand today the authors 
already concluded that "it is highly unlikely that Se-Cys is 
incorporated specifically via normal transcription and transla-
tion" (5). 
Although later it was shown that Sec corresponds to certain 
UGA codons (6), the final proof that Sec is a cotranslationally 
incorporated amino acid came when the tRNAScc in Esche-
richia coli was identified in 1988 (7). Many of the basic ques-
tions in this area (8) were addressed in the following years, 
including elucidation of Sec biosynthesis and encoding in bac-
teria. There are several special requirements for Sec encoding 
to occur: a PLP-dependent selenocysteine synthase (SelA) that 
catalyzes the conversion of Ser-tRNASec to Sec-tRNAScc (9, 
10) (Fig. IB), an mRNA secondary structure element (SECIS) 
{11), an elongation factor (SelB) specific for Sec-tRNAScc (12, 
13), and an enzyme (SelD) the produces selenophosphate (14). 
Even though the counterparts of SelB, SelD, and SECIS have 
all been found in archaea and eukaryotes (15, 16), the mecha-
nism of Sec biosynthesis, however, remained unclear until 
2006. 
RNA-DEPENDENT CYSTEINE BIOSYNTHESIS 
IN ARCHAEA 
Cysteine (Cys) biosynthesis is one of the critical metabolic 
processes. The two well-known Cys biosynthesis pathways are 
the sulfur assimilation pathway, which is the sole route of mak-
ing cysteine in most bacteria, all known plants, and at least one 
fungus; and the trans-sulfuration pathway, which is present in 
most fungi, nematodes, and vertebrates. In both cases Cys is 
synthesized through multiple enzymatic steps, one of which is 
catalyzed by a pyridoxal-phosphate (PLP)-dependent enzyme. 
Following its synthesis, Cys is charged to tRNACys by cys-
ISSN 1521-6543 print/ISSN 1521-6551 online 
DOI: 10.1002/iub.l36 
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Figure 1. A: Cys-tRNACys formation via the archaeal route, O-phosphoseryl-tRNA synthetase (SepRS) forms the intermediate Sep-
tRNACys and the PLP-dependent enzyme Sep-tRNA:Cys-tRNA synthetase (SepCysS) catalyzes formation of the cognate pair Cys-
tRNACys. B: In bacterial selenocysteine biosynthesis, SelA catalyzes the direct formation of Sec-tRNASec from Ser-tRNAScc, which 
is produced by seryl-tRNA synthetase (SerRS). C: Like Cys-tRNA formation in archaea, the archaeal and eukaryotic route for Sec-
tRNA synthesis utilizes a Sep-tRNAScc intermediate produced by phosphoseryl-tRNAScc kinase (PSTK) and the PLP-dependent 
enzyme Sep-tRNA:Sec-tRNA synthetase (SepSecS) gives Sec-tRNASec. The initial substrate, Ser-tRNASec, is generated by SerRS. 
teinyl-tRNA synthetase (CysRS) to make Cys-tRNACys, which 
then enters ribosomal translation. 
When the genomes of some methanogenic archaea, including 
Methanocaldococcus jannaschii (17), Methanothermobacter 
thermautotrophicus (18), and Methanopyrus kandleri (19), were 
sequenced, cysS was not found. It was believed then that CysRS 
was present but not yet identified. Thus much effort was applied 
in finding this mysterious CysRS. Two proteins, ProRS (20, 21) 
and MJ1477 (22), were proposed to be the missing CysRS 
based on in vitro charging experiments and in vivo complemen-
tation of an E. coli cysS mutant strain. Later findings placed the 
complementation data into a different light because the strain 
retained low CysRS activity (23). In addition, some of these 
methanogens lacked recognizable cysteine biosynthesis genes 
(24). 
In 2005, the mystery was finally solved. By purification 
coupled with enzymatic assays, our group identified two pro-
teins in Methanocaldococcus jannaschii that work together to 
make Cys-tRNACys (25). The first protein (a class II tRNA syn-
thetase) ligates activated phosphoserine (Sep) onto tRNACys, 
while the second protein is a PLP-dependent enzyme that con-
verts Sep-tRNACys to Cys-tRNACys (Fig. 1A). These two pro-
teins were thus named O-phosphoseryl-tRNA synthetase 
(SepRS) and Sep-tRNA:Cys-tRNA synthase (SepCysS). Dele-
tion of SepRS in Methanococcus maripaludis yielded a cysteine 
auxotroph, indicating that the RNA-dependent Cys-tRNACys 
synthesis pathway is the sole route for Cys biosynthesis in 
Methanococcus maripaludis. 
SepCysS belongs to the fold Type I PLP-dependent enzyme 
family, more specifically, the cysteine desulfurase subfamily, 
based on sequence and structure comparisons (26, 27). With so-
dium sulfide present, SepCysS catalyzes the sulfuration of the 
phosphoserine moiety of Sep-tRNACys. The natural sulfur donor 
in this reaction remains unknown. Cysteine desulfurase cata-
lyzes the removal of S or Se from Cys or Sec, utilizing a con-
served Cys residue to form a persulfide or perselenide, respec-
tively. These S or Se relay mechanisms in related proteins may 
also operate in SepCysS, which contains several conserved Cys 
residues in the vicinity of the active site (26, 27), some which 
are required for its activity (unpublished data, (26, 27)). 
SELENOCYSTEINE BIOSYNTHESIS IN HUMANS 37 
SEP-tRNA IS AN INTERMEDIATE IN SEC 
BIOSYNTHESIS IN EUKARYOTES AND ARCHAEA 
As early as 1964, Sep-tRNA was found in chicken liver (28). 
Later studies confirmed this finding (29) and suggested that Sep-
tRNA was formed by phosphorylation of Ser-tRNA, not by direct 
acylation of phosphoserine onto tRNA (30). In 1981, RNA 
sequencing showed that the Sep moiety was carried by a putative 
suppressor tRNASer (31), which was later identified as tRNASec 
(32). Following the landmark discovery of E. coli tRNASec in 
1988 (7), it was speculated that Sep-tRNA might be an interme-
diate in Sec-tRNAScc formation (8). In vitro synthesis of glutathi-
one peroxidase in mouse extracts suggested that this was the case 
(33). However, the successful identification and characterization 
of E. coli SelA, the selenocysteine synthase that catalyzes Sec-
tRNASec formation directly from Ser-tRNASec (Fig. IB), showed 
that the bacterial pathway does not involve Sep-tRNA (10). This 
result may have influenced the interpretation of another study of 
mammalian Sec-tRNA synthesis that concluded that the mamma-
lian mechanism does not proceed through Sep-tRNA, and is simi-
lar to that in E. coli (34). 
During the next decade little progress was made concerning 
Sec-tRNASec formation in eukaryotes and archaea. A SelA-like 
protein from M. jannaschii was investigated and even crystal-
lized, but then shown to lack the hypothesized Sec synthase ac-
tivity (35). As more genomic data became available, an in silico 
search first identified a kinase that was only present in Sec-
decoding archaea (36). In vitro characterization of the mouse 
enzyme, now called phosphoseryl-tRNAScc kinase (PSTK), 
showed that it converted Ser-tRNAScc to Sep-tRNASec in an 
ATP and Mg2+-dependent reaction (36). Yet the description of 
this important enzyme did not resolve mammalian Sec forma-
tion, but deferred to future studies (36). However, the Sep moi-
ety was again implicated as an intermediate in Sec synthesis, 
when the two-step tRNA-dependent Cys biosynthesis pathway 
(Fig. 1A) in archaea was discovered (25); the need for Sep-
tRNA*^, the required precursor for Cys-tRNACys formation, 
suggested that a similar mechanism may exist for Sec-tRNAScc 
formation in archaea and eukaryotes (25). 
Given the chemical similarity between Cys and Sec, the 
reaction from Sep-tRNA to Sec-tRNA seemed plausible, and 
a single PLP-dependent enzyme could catalyze such a reac-
tion. The soluble liver antigen/liver pancreas antigen (SLA/ 
LP) protein had long been suspected to be the missing Sec 
synthase. SLA/LP coprecipitated with Sec-tRNASec by autoan-
tibodies from autoimmune chronic hepatitis patients (37). 
Although by the year 2000, the cDNA sequence of SLA/LP 
was available (38, 39), workers in the field could only con-
clude that SLA/LP might be the Sec-tRNA synthase, a human 
analog of the translation factor SelB, or perhaps a selenium-
tRNA protecting factor (37-39). In the following year, using 
a fold recognition algorithm, a bioinformatics analysis was 
able to correctly classify SLA/LP as a PLP-dependent enzyme 
and the group predicted its involvement in Sec-tRNA synthe-
sis (40). 
Archaeal cysteine biosynthesis provided the conceptual 
template for Sec-tRNA formation in archaea and eukaryotes, 
and it quickly became clear that these two domains of life 
share a homologous mechanism for Sec-tRNA formation that 
was inherited from their distant common ancestor. Using an 
in vivo complementation assay, we showed that SLA/LP is re-
sponsible for Sec-tRNAScc formation (41). When grown under 
anaerobic atmosphere E. coli produces the selenoprotein for-
mate dehydrogenase, which reduces benzyl viologen in the 
medium in the presence of formate. Reduced benzyl viologen 
is clearly visible due to its purple color and can be used to 
monitor selenoprotein biosynthesis inside E. coli cells. We 
complemented a selA deletion strain of E. coli with archaeal 
PSTK, with archaeal SLA/LP, or with both proteins, and 
monitored the formate dehydrogenase activity. Only when 
both PSTK and SLA/LP were present, the formate dehydro-
genase activity was recovered from the AselA E. coli cells, 
indicating that PSTK and SLA/LP constituted a two-step path-
way to make selenocysteine. Metabolic labeling of the same 
cells with Se supported the result, showing 75Se incorpora-
tion into proteins only in the presence of both PSTK and 
SLA/LP. These data established that the archaeal SLA/LP, 
which was appropriately renamed Sep-tRNA: Sec-tRNA syn-
thase (SepSecS), converts Sep-tRNAScc to Sec-tRNAScc (41). 
Having established the archaeal system, we then tested the 
mammalian SLA/LP protein. The human SLA/LP displayed 
similar results in both the benzyl viologen and the 75Se label-
ing assays, showing that mammals and archaea share a com-
mon mechanism for Sec biosynthesis. In vitro assays, both in 
our laboratory (41) and independently by another group (42), 
showed that SepSecS is responsible for the final step of Sec-
tRNASec formation. 
Recently it was established that SepSecS is in the same 
enzyme family as SepCysS (27, 41, 42) through phylogenetic 
analyses based on both its sequence and structure from mouse 
(43) and archaea (41), revealing an evolutionary linkage 
between the tRNA-dependent Cys and Sec formation. 
SEC ENCODING WAS AN ANCIENT BUT "LATE" 
ADDITION TO THE GENETIC CODE 
The discovery of Sec argues against components of two of 
Crick's famous hypotheses: the wobble hypothesis (44) and the 
"frozen accident" theory (45). Crick maintained that the wobble 
hypothesis "does not permit UGA to code for any amino acid 
other than cysteine or tryptophan." While Cys and Sec are 
chemically similar, they are not universally interchangeable. 
The substitution of Cys for Sec at a critical active site location 
can have a severe effect on catalytic efficiency (46, 47). The 
"frozen accident" theory states that "the code is universal 
because at the present time any change would be lethal, or at 
least very strongly selected against." If Sec encoding emerged 
before the code was "frozen," then the code obviously has 
never been "frozen" because it was shown that Sec decoding 
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was later lost in certain organisms (48); if Sec encoding 
emerged after the "freezing" of the genetic code, then the code 
was not "frozen" per se. Our understanding of Sec evolution 
based on phylogenetic data (27, 41, 49-52), indicates that the 
genetic code expanded to include Sec at the time of the last uni-
versal common ancestor and was then independently lost in 
many lineages during evolution. 
Among the 22 known ribosome-incorporated amino acids, 
including pyrrolysine, only Sec lacks its own aminoacyl-tRNA 
synthase. A SecRS has apparently never evolved (and perhaps 
never will) because typical protein substrate recognition, which 
depends on distinct differences between the shape and charge of 
cognate versus noncognate substrates, cannot differentiate Cys 
from Sec (53, 54). The indirect route for Sec-tRNA formation 
evolved, therefore, to ensure that critical Sec codons were read 
with an exceedingly high fidelity by eliminating or minimizing 
the possibility that Cys-tRNAScc would be formed. Similarly, 
since CysRS cannot discriminate Sec from Cys and can easily 
form Sec-tRNACys, the presence of excessive free selenocys-
teine might be unfavorable for positions in the peptide chain 
that require Cys instead of Sec. The Sec codon has a dual 
meaning (also functioning as a stop codon), so the special trans-
lational components (SelB, SECIS) evolved to ensure that trans-
lation did not stop at Sec codons and that it terminated properly 
in response to UGA stop codons. 
Although Sec encoding is ancient, the evolution of the 
genetic code is yet an older event; the biochemical and phylo-
genetic data indicate that Sec was a late addition to the code. 
For the reasons mentioned above, it seems clear that Sec was 
introduced only after UGA had acquired the termination mean-
ing and possibly after Cys was added to the code. The addi-
tional coding machinery for Sec hints that Sec decoding repre-
sents a complication or addition to a pre-existing, simpler cod-
ing process—such as that applied to the 20 canonical amino 
acids. 
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The micronutrient selenium is found in proteins as selenocysteine 
(Sec), the 21st amino acid cotranslationally inserted in response to 
a UGA codon. In vitro studies in archaea and mouse showed that 
Sec-tRNASec formation is a 3-step process starting with serylation 
of tRNASec by seryl-tRNA synthetase (SerRS), phosphorylation of 
serine to form phosphoserine (Sep)-tRNASec by phosphoseryl-
tRNASec kinase (PSTK), and conversion to Sec-tRNASec by Sep-
tRNA:Sec-tRNA synthase (SepSecS). However, a complete study of 
eukaryotic selenoprotein synthesis has been lacking. Here, we 
present an analysis of Sec-tRNASec formation in the parasitic 
protozoon Trypanosoma brucei in vivo. Null mutants of either PSTK 
or SepSecS abolished selenoprotein synthesis, demonstrating the 
essentiality of both enzymes for Sec-tRNASec formation. Growth of 
the 2 knockout strains was not impaired; thus, unlike mammals, 
trypanosomes do not require selenoproteins for viability. Analysis 
of conditional RNAi strains showed that SerRS, selenophosphate 
synthase, and the Sec-specific elongation factor, EFSec, are also 
essential for selenoprotein synthesis. These results with T. brucei 
imply that eukaryotes have a single pathway of Sec-tRNASec 
synthesis that requires Sep-tRNASec as an intermediate. 
phosphoseryl-tRNASec kinase | selenocysteine tRNA | 
Sep-tRNA:Sec-tRNA synthase | Trypanosoma brucei | selenoprotein 
Selenium is an essential dietary trace element. It is present in proteins as selenocysteine (Sec), a cotranslationally-inserted 
amino acid encoded by UGA. Sec is not attached directly to 
tRNASec, but is formed by the tRNA-dependent conversion of 
serine (reviewed in refs. 1-4). In the first step tRNAScc is 
misacylated by seryl-tRNA synthetase (SerRS). The subsequent 
conversion to Sec proceeds by 2 different pathways in nature. In 
bacteria Ser-tRNASet is directly transformed to Sec-tRNASec in 
a pyridoxal-5'-phosphate-dependent reaction by Sec synthase, 
the selA gene product (5). Archaea and eukaryotes require an 
additional step, the formation of the intermediate phospho-
serine (Sep) by phosphoseryl-tRNAScc kinase (PSTK). The 
resultant Sep-tRNASec is then converted into the Sec-tRNASec by 
the pyridoxal-5'-phosphate-dependent enzyme Sep-tRNA:Sec-
tRNA synthase (SepSecS) (6, 7). The Se donor for this reaction, 
selenophosphate, is synthesized by selenophosphate synthase 
(SPS2) (8). Then EFSec, the tRNASec-specific elongation factor, 
carries the Sec-tRNASec to the ribosome (9) where a transla-
tional recoding process allows UGA to be read as Sec (Fig. 1). 
Selenoproteins are found in organisms from all 3 domains of life. 
Humans have 25 selenoproteins, many of them are essential for 
organismal viability (10). Some selenoproteins are predicted to 
be redox proteins containing catalytic Sec residues (e.g., gluta-
thione peroxidase or thioredoxin reductase). 
Most of our knowledge of eukaryotic Sec-tRNASec formation 
comes from in vitro reconstitution experiments using compo-
nents of mammalian cells (7). In vivo formation of eukaryotic 
Sec-tRNAScc has been addressed in a study that showed that 
RNAi-mediated ablation of SepSecS in mammalian cells did not 
completely abolish selenoprotein expression (11). Thus, the 
existence of an alternative SepSecS-independent pathway for 
Sec-tRNASec formation could not be excluded. Moreover, the in 
vivo role of PSTK has not yet been analyzed. 
Here, we present a comprehensive analysis of the in vivo role 
of the 5 major proteins required for eukaryotic Sec-tRNASec 
formation and function. The study was done in the insect form 
of the parasitic protozoon Trypanosoma brucei as double allelic 
KO cell lines can easily be produced in this system by homolo-
gous recombination-directed gene replacements (12). Because 
T. brucei is diploid, double KO cell lines are null mutants in both 
alleles. Furthermore, RNAi-based methods for highly efficient 
inducible ablation of proteins are also available (13). Moreover, 
T. brucei is an excellent model for exploring eukaryotic diversity. 
It represents a different branch of the eukaryotic evolutionary 
tree than the phylogenetically more closely related classical 
model organisms (e.g., mouse, Drosophila, Caenorhabitits 
elegans, and yeast) (14). 
Results 
7". brucei Components Involved in Selenoprotein Formation. A bioin-
formatic analysis of the T. brucei genome predicts 3 selenopro-
teins. They include distant homologs of mammalian SelK and 
SelT and a selenoprotein, termed SelTryp, that is specific for the 
kinetoplastid line (15). Moreover, in silico screens by several 
groups have identified Tb-tRNAScc, Tb-SerRS, Tb-PSTK, Tb-
SepSecS, Tb-SPS2, and Tb-EFSec, the trypanosomal ortho-
logues of essentially all major components of the Sec-inserting 
system (16). However, of these only Tb-SerRS, Tb-tRNASec 
(16-18), and Tb-SPS2 (19) have been subject to preliminary 
experimental analyses. 
To analyze the Sec-tRNASec formation pathway in vivo and 
establish its physiological importance for T. brucei vie. used RNAi 
cell lines allowing inducible ablation of Tb-SerRS, Tb-SPS2, and 
Tb-EFSec. Moreover, we prepared KO cell lines that lack either 
Tb-PSTK or Tb-SepSecS, the 2 core components of the eukary-
otic Sec-tRNASec formation pathway (Fig. SI). All cell lines were 
analyzed for selenoprotein synthesis by labeling with radioactive 
75Se (Fig. 2). The Tb-SerRS-RNAi cell line had been analyzed 
before by other methods, and it was shown that Tb-SerRS 
activity is required to charge the Tb-tRNASec with serine (18). 
Labeling of uninduced Tb-SerRS-RNAi cells with 75Se and 
subsequent analysis by Tris-Tricine polyacrylamide gels revealed 
3 bands whose molecular mass are consistent with the 3 pre-
dicted trypanosomal selenoproteins SelK, SelT, and SelTryp 
(Fig. 2A). SelTryp migrated in some experiments slightly faster 
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Fig. 1. tRNASec-dependent amino acid transformations leading to Sec in eukaryotes as elucidated by using recombinantly produced mammalian components 
(6, 7). 
than expected (Fig. 2 B and C). We do not know why but the 
simplest explanation is proteolytic clipping during sample prep-
aration, which could also account for the simultaneous presence 
of both bands as seen in Fig. 2B, lane 2d. 
Induction of Tb-SerRS-RNAi causes, in line with the role of 
SerRS in serylation of tRNASec, an efficient but incomplete 
reduction of the selenoprotein labeling (Fig. 24). This finding is 
in contrast to the Tb-PSTK KO and Tb-SepSecS KO cell lines in 
which the labeling of the 3 selenoproteins was abolished (Fig. 
2B). Moreover, tetracycline-inducible ectopic expression of Tb-
SepSecS in the Tb-SepSecS KO cell line restored 75Se labeling 
of all 3 proteins. In the case of SelTryp and SelT the restoration 
was to wild-type level, whereas in the case of SelK the comple-
mentation was not quantitative. These experiments show that 
both Tb-PSTK and Tb-SepSecS are indispensable for seleno-
protein synthesis. 
Next, we isolated and analyzed aminoacylated tRNAs from 
the different cell lines by acid urea polyacrylamide electrophore-
sis (Fig. 2E) (20). This technique allows the separation of the 
faster-migrating Sep-tRNASec from the slower-migrating Ser-
SelTryp 








Fig. 2. Selenoprotein expression in various T. brucei cell lines. Expression was analyzed by 75Se labeling of living cells and subsequent analysis of the labeled 
proteins by 10-20% polyacryamide Tris-Tricine gels. The following cell lines were analyzed. (A) Uninduced and induced Tb-SerRS-RNAi cells. (6) WT427 cells, 
Tb-PSTK KO cells (Tb-PSTK-/-), Tb-SepSecS KO cells (Tb-SepSecS-/-), and a Tb-SepSecS KO cell line allowing inducible ectopic expression of Tb-SepSecS 
(Tb-SepSecS - / - complem.). ( 0 Uninduced and induced Tb-SPS2-RNAi cells. (D) Uninduced and induced Tb-EFSec-RNAi cells. For the RNAi and the complemented 
Tb-SepSecS - / - cell lines days of induction (d) by tetracycline are indicated. The putative identity of the 3 labeled selenoproteins and their molecular mass as 
predicted insilico are indicated on the left. Molecular mass markers are indicated on the right. Segments of the tubulin region (=50-80 kDa) of the corresponding 
Coomassie-stained gels are shown as loading controls, (f) Total RNA isolated for the cell lines analyzed in 6 and a Tb-SepSecS KO line capable of RNAi-mediated 
ablation of Tb-PSTK (Tb-SepSecS -/-:Tb-PSTK RNAi) was separated on a long acidic urea gel and analyzed for the presence of the different forms of tRNASec by 
Northern analysis (18). The positions of the Sep-tRNASec and the comigrating Ser/Sec-tRNASec are indicated. 
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Fig. 3. Trypanosoma! selenoproteins are not essential. (A) Representative growth curves in standard culture medium SDM-79 of uninduced and induced (-Tet, 
+Tet) clonal RNAi cell lines for Tb-SerRS (redrawn from ref. 18), Tb-SPS2, and Tb-EFSec. The Northern blots verifying mRNA ablation are indicated for the cell 
lines not showing a growth arrest, (fi) (Left) Comparisons of doubling times of the Tb-PSTK KO cell line (Tb-PSTK-/-) and the parent WT strain 427 (WT). (Right) 
Comparisons of doubling times of the Tb-SepSecS KO cell line (Tb-SepSecS-/-) and the corresponding cell line allowing tetracycline-dependent ectopic 
Tb-SepSecS expression (SepSec - / - plus or minus complem.). The parent cell line for the Tb-SepSecS KO strain is T. bruce/29-13 that has a longer doubling time 
than T. brucei 427. Standard errors (n = 6) are indicated. 
tRNASec and Sec-tRNASec species. Distinction between the 
latter 2 species is not possible as they comigrate. The Northern 
blot analysis in Fig. 2E shows 2 tRNASec bands in wild-type cells. 
The lower one corresponds to Sep-tRNASec and the upper 
corresponds to Sec-tRNASec (as inferred from the pattern 
observed in the PSTK and SepSecS KO cell lines). In the 
Tb-PSTK KO cell line only the upper band is detected, which 
most likely represents the Ser-tRNASec form, because this spe-
cies is expected to accumulate in the absence of PSTK activity 
(see Fig. 1). In the Tb-SepSecS-KO cell line, however, only the 
Sep-tRNASec band is detected. Moreover, if Tb-PSTK is de-
pleted by inducible RNAi in the Tb-SepSecS-KO cell line, a 
time-dependent partial recovery of the upper band is observed, 
which indicates that Ser-tRNASec accumulates as would be 
expected in the absence of both PSTK and SepSecS. Moreover, 
the upper band, which is absent in the KO cells, reappears if the 
KO cell line is complemented by inducible ectopic expression of 
Tb-SepSecS. Thus, the accumulation of distinct intermediates of 
the Sec-tRNASet synthesis pathway in the 2 KO cell lines 
together with the 75Se-labeling experiments show that the Tb-
PSTK and Tb-SepSecS act sequentially in the indicated order 
(Fig. 1). 
SPS2 generates selenophosphate, the Se donor required by 
SepSecS. Mammalian SPS2, which itself is a selenoprotein, is 
essential for selenoprotein synthesis in vivo (8). Tb-SPS2 an SPS2 
orthologue capable of complementing SelA-deficient Esche-
richia coli has been identified in trypanosomatids (19). Like the 
E. coli orthologue, but in contrast to its mammalian counterpart, 
Tb-SPS2 is not a selenoprotein. Fig. 2C shows that RNAi-
mediated ablation of the Tb-SPS2 severely impairs selenoprotein 
synthesis, indicating that SPS2 (with a cysteine in place of the 
Sec) is catalytically active in trypanosomes. Surprisingly, even 
before the induction of RNAi we reproducibly see labeling of 
SelTryp and SelT but not of SelK. It is possible that the 
SPS2-RNAi cell line is leaky and that even in the absence of 
tetracycline a fraction of the SPS2 mRNA is partially down-
regulated. If SelK labeling is more sensitive to SPS2 levels than 
labeling of the other 2 trypanosomal selenoproteins its absence 
could be explained. Indeed selenium labeling of SelK shows a 
larger variation in the different cell lines than that of the other 
2 selenoproteins, indicating that it might be quite sensitive to 
small changes of the labeling conditions (compare Fig. 2A, lane 
0 with Fig. IB, lane WT). However, without further experiments 
this explanation must remain speculative at present. 
Sec-tRNASec is an elongator tRNA; however, it does not 
interact with elongation factor la but requires its own elongation 
factor, EFSec. Consequently, ablation of Tb-EFSec by RNAi 
essentially abolishes selenoprotein synthesis (Fig. 2D). 
Selenoprotein Synthesis in T. brucei Is Not Essential. Selenoproteins 
are found in all 3 domains, indicating that they were acquired 
early in the evolution of life (4). However, in all domains there 
are many species that then lost the Sec-inserting system (e.g., 
fungi and plants), which raises the question of whether organisms 
that possess a Sec-inserting system require selenoproteins for 
viability. Clearly, this is the case in mammals, because a tRNASec 
KO mouse has an embryonic lethal phenotype (21). In other 
systems, however, this question has not been rigorously ad-
dressed. With our T. brucei cell lines described above we now can 
ask whether selenoproteins are essential for this unicellular 
eukaryote. Therefore, we analyzed the effects RNAi-mediated 
ablation of Tb-SerRS, Tb-SPS2, and Tb-EFSec (Fig. 3/4) and the 
effects the complete lack of Tb-PSTK and Tb-SepSecS (Fig. 3B) 
have on T. brucei growth. Ablation of Tb-SerRS caused a growth 
arrest, which can be explained by the down-regulation of Ser-
tRNASer levels with concomitant reduction and cessation of 
protein synthesis (18). Growth of all other RNAi and KO cell 
lines was not or only marginally impaired. For the RNAi cell lines 
this is not very informative because of the possible residual 
activity of the ablated enzymes. However, the normal growth of 
the Tb-PSTK and Tb-SepSecS double KO cell lines clearly 
demonstrates that T. brucei does not depend on selenoproteins. 
Conserved Sec-tRNASec Formation in Eukaryotes and Archaea. When 
grown anaerobically E. coli produces selenium-dependent for-
mate dehydrogenase (FDH). Its activity can easily be visualized 
on plates overlaid with benzyl viologen, because in the presence 
of formate active FDH reduces benzyl viologen to a blue 
substance (22). Using this assay it was shown that an E. coli selA 
deletion strain could be rescued by coexpression of archaeal 
PSTK and human or archaeal SepSecS (6). We extended these 
studies and showed that Tb-PSTK in combination with either 
endogenous T. brucei SepSecS or the corresponding archaeal or 
human enzymes reconstitute selenoprotein synthesis in an E. coli 
selA deletion strain (Fig. 4). Likewise, archaeal PSTK and 
Tb-SepSecS also restored FDH activity in the special E. coli 
strain. Taken together, these results underscore the highly 
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Fig. 4. Expression of SepSecS together with PSTK restores FDH activity in an 
anaerobically-grown E. coli selA deletion strain. The indicated genes of the 
following organisms were tested: T. brucei (Tb-PSTK, Tb-SepSecS), the 
Archeaon Methanocaldococcus jannaschii (Mj-PSTK, Mj-SepSecS), and hu-
mans (Hs-SepSecS). 
conserved nature of the PSTK/SepSecS pathway of Sec-tRNASec 
formation in Archaea and eukaryotes. 
Discussion 
In vitro experiments indicate that PSTK and SepSecS are the 
core components for Sec biosynthesis in eukaryotes (6, 7). 
However, the in vivo analysis of Sec-tRNASec formation in 
eukaryotes has been hampered by the lack of a suitable system. 
Here, we have used T. brucei to produce KO cell lines for the 
trypanosomal orthologues of PSTK and SepSecS. Analysis of 
these cell lines has shown that formation of Sec-tRNASec in living 
T. brucei requires the sequential action of Tb-PSTK and Tb-
SepSecS. It remains unknown why eukaryotes use the additional 
phosphorylation step and thus require 2 enzymes, even though 
direct conversion of Ser-tRNASec to Sec-tRNASec is possible, as 
exemplified in bacteria (5). 
Our results also show that no alternative pathway for Sec-
tRNASec formation exists that is independent of Tb-SepSecS and 
Tb-PSTK. Interestingly, RNAi-mediated ablation of SepSecS 
had only a marginal effect on mammalian selenoprotein synthe-
sis (11). However, the results obtained in T. brucei might not be 
readily comparable with the study in mammalian cells for the 
following reason. In T. brucei selenoprotein synthesis was as-
sayed in a double KO cell line completely devoid of Tb-SepSecS, 
whereas in mammalian cells the analysis might have been 
obscured by the fact that RNAi cannot be relied on to completely 
deplete protein levels. Thus, it is likely that even in mammalian 
cells, just as in T. brucei, only a single pathway for Sec-tRNASec 
formation is operational. 
Insect-stage T. brucei lacking selenoproteins grew as well as 
wild type in standard medium SDM-79, which shows that normal 
growth of T. brucei does not require selenoproteins and indicates 
that neither Tb-PSTK nor Tb-SepSecS have a second essential 
role that is unlinked to Sec-tRNASec formation. The unimpaired 
growth of selenoprotein-lacking T. brucei was unexpected, be-
cause it had been reported that both insect- and bloodstream-
stage T. brucei cells were sensitive to nanomolar concentrations 
of auranofin, a compound suggested to inactivate selenoproteins 
(15). T. brucei is the causative agent of human sleeping sickness. 
Based on the reported auranofin experiments it was proposed 
that selenoprotein synthesis might be a novel target for devel-
opment of an antiparasitic drug (15). Because auranofin inter-
acts with selenol and thiol groups (23), we suggest that aurano-
fin-induced cell death might have been caused by the drug's 
interaction with thiols. All of our experiments were carried out 
in insect-stage T. brucei cells; therefore it is still possible that Sec 
is essential in T. brucei bloodstream forms, but it seems unlikely 
because all 3 predicted selenoproteins are already expressed in 
the insect-stage form. Thus, the prospect of using the pathway of 
Sec or selenoprotein synthesis as drug targets against T. brucei 
is questionable. However, because T. brucei in its normal habitat 
adapts to situations and environments that are difficult to 
reproduce in the laboratory, selenoproteins may play a role 
under such conditions. 
In summary, this work illustrates that T. brucei is an experi-
mentally highly-tractable system for examining the in vivo 
formation of eukaryotic Sec-tRNASec. Our analysis revealed the 
presence of a single pathway for Sec-tRNASec synthesis involving 
SerRS, PSTK, and SepSecS and strengthens the notion that all 
eukaryotes have only a single route to Sec. Furthermore, we 
show that selenoproteins are dispensable for insect-stage T. 
brucei under standard growth conditions. 
Materials and Methods 
Cell Culture. Procyclic T. brucei, strain 427 and strain 29-13, and the corre-
sponding transgenic cell lines were grown at 27 °C in SDM-79 (24) supple-
mented with 5% and 15% FCS, respectively. 
Transgenic Cell Lines. RNAi cell lines were produced by using pLew-100-based 
stem loop constructs containing the puromycin resistance gene (25-27). As inserts 
we used a 451-bp fragment (nucleotides 181-632) for the Tb-SPS2 gene and a 
528-bp fragment of the Tb-EFSec gene (nucleotides 1-528). Production and initial 
characterization of Tb-SerRS RNAi cell line has been described (18). The double 
allelic replacements of the Tb-PSTK gene, in T. brucei 427, and of the Tb-SepSecS 
gene, in T. brucei 29-13, are described in Fig.SL Inducible ectopic expression of 
Tb-SepSecS was done by using pLew-100 carrying the phleomycin resistance gene 
(25). Transfection, selection of transformants, and production of clonal cell lines 
were done by using standard procedures as described (12). 
"Selenium Labeling. A total of 5 x 107 cells was resuspended in 0.5 mL of 
FCS-supplemented SDM-79. The cultures were labeled with 9.6 ,̂Ci of Hepes-
neutralized [75Se] selenite (University of Missouri Research Reactor, Columbia) 
in the presence of 100 ng/mL cysteine at 27 °C for 3 h (forthe KO strains) or 1 h 
(for the RNAi cell lines). After the labeling, the culture was washed with PBS, 
and the resulting pellet was resuspended in sample buffer and heated to 
100 °C for 10 min. Finally, the labeled proteins (=»107 cell equivalents) were 
analyzed on 10-20% Tris-tricine gels (Ready gel; Bio-Rad) and visualized with 
a phosphoimager. 
Acid Gel Analysis of tRNASK Population. Total RNA was isolated as described 
(29) and resupended in 10 mM Na-acetate, pH 4. Isolated RNA corresponding 
to 8 x 106 cell equivalents was run on a 50-cm-long acidic sequencing gel as 
described (20). The gel was run at 4 °C in 0.1 M Na-acetate, pH 5 until the 
xylene blue front migrated to «=28 cm from the top. The section of the gel 
containing the RNA was blotted to a Genescreen plus membrane and analyzed 
by Northern blots using oligonucleotide hybridization as described (28). 
Benzyl Viologen Assay for Active FDH. Benzyl viologen-dependent FDH assays 
were performed as described (6). The PSTK and SepSecS genes of the different 
species were cloned into the pACYCDuet-1 and pET15b expression vectors 
(Novagen), respectively. In strains expressing only 1 gene, the corresponding 
empty plasmid was cotransformed as a control. 
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The Human SepSecS-tRNASec 
Complex Reveals the Mechanism of 
Selenocysteine Formation 
Sec is UGA, which is normally a translational 
stop signal (/). During translation of selenopro-
tein mRNAs, UGA is recoded by the interaction 
of a specialized elongation factor, SelB in bacteria 
and EFsec in humans, with a downstream Sec-
insertion sequence element that forms a stem 
loop (/, 3). 
The first step in Sec formation involves the 
Sotiria Palioura,1 R. Lynn Sherrer,1 Thomas A. Steitz,1'2'3 Dieter Soil,1'2* Miljan Simonovic4* misacylatjon of tRNAScc by seryl-tRNA synthetase 
Selenocysteine is the only genetically encoded amino acid in humans whose biosynthesis occurs on 
its cognate transfer RNA (tRNA). 0-Phosphoseryl-tRNA:selenocysteinyl-tRNA synthase (SepSecS) 
catalyzes the final step of selenocysteine formation by a poorly understood tRNA-dependent 
mechanism. The crystal structure of human tRNASec in complex with SepSecS, phosphoserine, 
and thiophosphate, together with in vivo and in vitro enzyme assays, supports a pyridoxal 
phosphate-dependent mechanism of Sec-tRNASec formation. Two tRNASec molecules, with a fold 
distinct from other canonical tRNAs, bind to each SepSecS tetramer through their 13-base pair 
acceptor-TfC arm (where 4* indicates pseudouridine). The tRNA binding is likely to induce a 
conformational change in the enzyme's active site that allows a phosphoserine covalently attached 
to tRNASec, but not free phosphoserine, to be oriented properly for the reaction to occur. 
The 21st amino acid, selenocysteine (Sec), is distinct from other amino acids not only because it lacks its own tRNA synthetase, 
but also because it is the only one that is syn-
thesized on the cognate tRNA in all domains of 
life [reviewed in (1-4)] in a process that is rem-
iniscent of the tRNA-dependent synthesis of glu-
tamine, asparagine, and cysteine in prokaryotes 
(4). The importance of Sec is illustrated by the 
embryonic lethal phenotype of the tRNAScc knock-
out mouse (5) and by the presence of Sec in the 
active sites of enzymes involved in removing re-
active oxidative species and in thyroid hormone 
activation (6, 7). It is intriguing that the codon for 
(SerRS) to give Ser-tRNA^ [reviewed in (3, 8)]. 
Although the tertiary structure of tRNASec was 
unknown, it was proposed that the mischarging 
reaction is possible because of similarities be-
tween the tRNA860 and tRNAScr structures (3, 8). 
In archaea and eukaryotes, the y-hydroxyl group of 
Ser-tRNA560 is subsequently phosphorylated by 
O-phosphoseryl-tRNA kinase (PSTK) (9) to give 
O-phosphoseryl-tRNA800 (Sep-tRNASec), which 
is then used as a substrate for the last synthetic 
department of Molecular Biophysics and Biochemistry, 
Yale University, New Haven, CT 06520, USA. department 
of Chemistry, Yale University, New Haven, CT 06520, 
USA. 3Howard Hughes Medical Institute, Yale University, 
New Haven, CT06520, USA. 4Department of Biochemistry 
and Molecular Genetics, University of Illinois at Chicago, 
Chicago, IL 60607, USA. 
*To whom correspondence should be addressed. E-mail: 
dieter.soll@yale.edu (D.S.); msimon5@uic.edu (M.S.) 
Variable B 






*»''' ' fwi 





Fig. 1 . Structure of human SepSecS in complex with unacylated tRNA ec. 
(A) Surface representation of the physiological complex of SepSecS with 
tRNASec. The subunits of the catalytic dimer are dark and light blue, those 
of the noncatalytic dimer are dark and light red; the backbone and the 
bases of tRNASec are green and gray, respectively. (B) The catalytic dimer 
interacts with the acceptor arm of tRNA through helices otl4 and a l5 
Anticodon 
arm 
(blue). The a l helix (red) of the noncatalytic dimer interacts with the rest of 
the acceptor-TTC arm. The regions of tRNASec that interact with SepSecS are 
shown in orange; the rest is green. One tRNASec molecule is shown for 
clarity. (C) Interactions between the discriminator base G73 and the con-
served Arg398 in the a l 4 - p i l loop. The protein side chains are gold, and 
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enzyme, SepSecS (5, 10). SepSecS catalyzes 
the conversion of the phosphoseryl moiety into 
the selenocysteinyl group by using selenophos-
phate as the selenium donor. An early observa-
tion that autoantibodies isolated from patients 
with type I autoimmune hepatitis targeted a ribo-
nucleoprotein complex containing tRNASec led 
to the identification and characterization of the 
archaeal and the human SepSecS (2, 77). The 
crystal structures of the archaeal and murine 
SepSecS apo-enzymes and phylogenetic analysis 
suggested that SepSecS forms its own branch 
in the family of fold-type I pyridoxal phosphate 
(PLP) enzymes that goes back to the last uni-
versal common ancestor (12, 13). 
Anticodon 
arm " 
F i g . 2 . Structure of human tRNASec. (A) Ribbon diagram of the human tRNASec molecule observed in 
complex wi th SepSecS. The major structural elements are colored as fol lows: the acceptor arm is red, the 
D-arm is blue, the anticodon arm is l ight blue, the variable arm is orange, and the f P C arm is dark red. 
(B) The view is rotated by - 9 0 ° clockwise around the vert ical axis. (C) Secondary structure diagram of 
human tRNASec derived f rom the crystal structure. 
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Catalytic active site 
Fig. 3. Ligand binding A . . . B 
to the active sites in the 
SepSecS-tRNASec com-
plex. In (A), (C), (D), (E), 
and (F), the catalytic PLP-
monomer is purple, the 
P-loop monomer is light 
blue, Sep is gold, tRNA 
is green, and PLP is ma-
genta. In (A) and (B), 
the unbiased omit elec-
tron density map (green 
mesh) is contoured at 3.5 
a. (A) Phosphoserine binds 
to the catalytic sites in 
two orientations (Sepp and 
SepN). (B) Thiop (orange) 
binds only to the non-
catalytic site. The PLP-
monomer is brown, and 
the P-loop monomer is 
pink. (C) The SepN amino 
group is -12 A away from 
the Schiff base. Arg97, 
Gin105, and Arg313 co-
ordinate phosphate, and 
the carboxyl group inter-
acts with Lys173. (D) The 
amino group of Sepp in-
teracts with Gin17 and 
is 3.5 A away from the 
Schiff base. The carbox-
yl group interacts with 
Gin172, whereas Ser98, 
Gin105, and Arg313 coordinate phosphate. (E) The P-loop adopts different con-
formation after tRNASec binding. The noncatalytic dimer is pink, the catalytic 
dimer is light blue. Steric clashes between the noncatalytic P-loop and SepN 
Non-catalytic active site 
v Lys28« 
) A 
Non-productive binding of Sep 
Productive binding of Sep Catalytic site conformational 
change 
are shown (double arrow). (F) 
active site. A76 binds between 
C75 interacts wi th A rg 9 7 . 
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In contrast to its closest homologue, SepCysS, 
which functions as a dimer to convert Sep-tRNACys 
to Cys-tRNA^ in archaea (14,15), SepSecS forms 
a stable tetramer (12,13). SepSecS acts on phos-
phoserine that is linked to tRNASec and not on 
free phosphoserine or Ser-tRNASec (8,13). How-
ever, the molecular basis for substrate discrimi-
nation and the roles of PLP and tRNASec in the 
mechanism of Sep to Sec conversion are not clear. 
To explore these questions, we have determined 
the crystal structure of the quaternary complex 
between human SepSecS, unacylated tRNASec, 
and a mixture of 0-phosphoserine (Sep) and thio-
phosphate (Thiop) to 2.8 A resolution. The ob-
served intensity divided by its standard deviation 
[I/a(I)] of the x-ray diffraction data are 2 at 3.0 A 
resolution, but the data out to 2.8 A resolution, 
where I/a(l) drops to 1, were included in the struc-
ture refinement. 
Human SepSecS forms a tetramer that is 
bound to two tRNASec molecules in the crystal 
(Fig. 1, A and B, and fig. SI). Computational 
modeling suggests that the tetrameric enzyme 
could potentially bind up to four tRNASec mole-
cules (fig. S2), but these additional tRNA-
binding sites are blocked by crystal packing in 
our crystal (16). Electron density for the 23 
N-terminal and 15 C-terminal residues of SepSecS, 
as well as for the anticodon loop (nucleotides 31 
to 38) and A76 of tRNASec, was of poor quality, 
and these residues were not included in the final 
model. Each SepSecS monomer has a PLP co-
factor covalently linked to the Ne-amino group of 
the conserved Lys284 by means of formation of 
a Schiff base (internal aldimine). Two SepSecS 
monomers form a homodimer, and two active 
sites are formed at the dimer interface. The two 
homodimers associate into a tetramer through in-
teractions between the N-terminal al-loop-a2 
H m* .—s ,->. p - M i 
nv_ \̂ 
Fig. 4 . The PLP-dependent mechanism of Sep to Sec conversion. (A) The phos-
phoseryl moiety of Sep-tRNA^ is bound to the active site similar to Sepp. The 
amino group is oriented for attack on the Schiff base, whereas the phosphoryl 
group is stabilized by the side chains of Ser98, Gin105, and Arg313. Hydrogen 
bonds are shown in dashed lines. (B) After the formation of the external 
aldimine, the side chain of Lys284 rearranges and abstracts the Cot proton from 
Sep. The protonated pyridine ring of PLP stabilizes the carbanion. (C) Electron 
delocalization leads to a rapid (3-elimination of phosphate and to the formation 
tRNAs 
of dehydroalanyl-tRNA5™. Free phosphate dissociates, and selenophosphate binds 
to the active site. (D) An unidentified base t B ) activates water that hydrolyzes 
selenophosphate. Free phosphate dissociates again, and selenium attacks the 
dehydroalanyl-tRNASec. Lys284 returns the proton to the Ca carbon, and the 
selenocysteinyl moiety is formed. (E) The reaction of reverse transaldimination is 
shown. Lys forms the Schiff base, with PLP leading to a release of the oxidized 
form of Sec-tRIMA^ (red box). (F) The free amino group of Sec-tRNA^ is pro-
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motifs (Fig. IB). Given that SepCysS is a dimer 
and that the active sites of one homodimer do 
not communicate with the active sites of the 
other homodimer in the apo-SepSecS tetramer 
(12, 13), the reason for the tetrameric organiza-
tion of SepSecS was not known. The mode of 
tRNAScc binding to SepSecS provides an answer 
to this question. 
The CCA ends of both tRNASec molecules 
point to the active sites of the same homodimer, 
which we shall refer to as the catalytic dimer (Fig. 
1 A). The other homodimer, which we shall refer 
to as the noncatalytic dimer, serves as a binding 
platform that orients tRNA " for catalysis (Fig. 
1A). The structure reveals that SepSecS binds 
only to the acceptor-, T'PC-, and variable arms of 
tRNASec (Fig. IB and fig. S3 A). (¥, pseudo-
uridine.) The tip of the acceptor arm interacts 
with the C terminus of the catalytic dimer, where-
as the rest of the acceptor-, TTC-, and variable 
arms wrap around a monomer from the noncat-
alytic dimer (Fig. 1, A and B, and fig. S3 A). The 
most important binding element is an interaction 
between the discriminator base G73 of fRNAScc 
and the conserved Arg of the catalytic dimer 
(Fig. 1C). The guanidinium group of Arg398 forms 
hydrogen bonds with the Hoogsteen face of 
G73. The discriminator base G73 of tRNASec is 
universally conserved in archaea and eukaryotes. 
Neither adenine nor cytidine in position 73 could 
form hydrogen bonds with Arg because they 
have amino groups instead of the keto group. 
Also, if a cytidine or uridine were in position 73, 
the C5 and C6 atoms of the pyrimidine ring would 
clash with the side chain of Thr397 and thus pre-
vent the interaction of these bases with Arg398. 
Moreover, the side chain of Lys463 from the 
C-terminal helix al5 forms a hydrogen bond 
with the backbone oxygen of G69 from the ac-
ceptor arm. We propose that autoantibodies bind 
to an interface that lies between the al5 helix 
of SepSecS and the tip of the acceptor arm of 
tRNASec (Fig. IB), which enables them to pre-
cipitate the entire ribonucleoprotein complex (77). 
The interaction of the antibody with a region that 
lies close to the acceptor stem-active site interface 
may inhibit the function of SepSecS. This would be 
similar to the mechanism of autoimmune hepatitis 
type 2, where LKM-1 autoantibodies (anti-liver-
kidney microsomal antibodies) inhibit cytochrome 
P450 isoenzyme 2D6 (CYP2D6) and contribute 
to the pathogenesis of the disease (17). 
The tRNASec molecule is anchored to the 
SepSecS tetramer, on one end by interactions 
between the tip of its acceptor arm (G73) and 
the catalytic dimer (Arg398) (Fig. 1C) and on the 
other end by interactions between its variable arm 
(C46L) and the noncatalytic dimer (Arg271) (fig. 
S3B). The rest of the interactions between the 
al helix of the noncatalytic dimer of SepSecS 
(Arg26, Lys38, and Lys40) and the acceptor-T^C 
arm (C2, G50, and C64) further stabilize the 
complex (fig. S3C). For instance, the side chain 
of Arg26 forms hydrogen bonds with the phos-
phate backbone of C2-C3 of the acceptor arm 
and the Ne-amino group of Lys is within the 
hydrogen bonding distance from both the 02'-
hydroxyl group and the 02 atom of C64 (fig. 
S3C), whereas the side chain of Lys interacts 
with the phosphate oxygen of G50 from the T*FC 
arm (fig. S3C). The interactions between SepSecS 
and tRNA cc seen in the crystal are consistent 
with in vivo activity assays of SepSecS mutants 
(fig. S4A) (16). For example, replacing Arg398 
with either alanine or glutamate renders the en-
zyme completely inactive, which suggests that 
the interaction between the discriminator base 
and the highly conserved Arg of the catalytic 
dimer is critical for tRNA860 recognition (fig. S4A). 
Human tRNAScc contains 90 nucleotides rather 
than the conventional 75 nucleotides of canon-
ical tRNA molecules. The structure shows that 
human tRNASec adopts a unique 9/4 fold with a 
13-base pair (bp) acceptor-T'FC arm (where 9 
and 4 reflect the number of base pairs in the ac-
ceptor and T4*C arms, respectively) and a long 
variable arm (Fig. 2) (16). This resolves a con-
troversy between conflicting models in which 
the 7/5 model suggested 12 bp in the acceptor-
T¥C arm, as found in all known tRNA structures 
(18), whereas the 9/4 model suggested a unique 
13-bp acceptor-TFC arm (19). The 13-bp acceptor-
TTC arm and a long variable arm are distinct 
structural features that serve as major recogni-
tion motifs for binding to SepSecS (Fig. 1, A 
and B, and fig. S3). Indeed, based on our mod-
eling analysis with tRNA sp, we suggest that 
tRNASer, which contains both the G73 discrim-
inator base and a long variable arm, is not able to 
bind to SepSecS because of its shorter acceptor-
T'FC arm (fig. S5, A, B, and C). This is reminis-
cent of the rejection of tRNA860 by bacterial EF-Tu 
(20). However, modeling of the SerRS-tRNA800 
complex based on the crystal structure of the 
bacterial SerRS in complex with tRNASer (21) 
suggests that SerRS can recognize the variable 
arm of tRNASec similarly to tRNASer, which pro-
vides an explanation for the inability of SerRS 
to discriminate between tRNAScr and tRNAScc 
(fig. S5D). Finally, the observations that the 
archaeal PSTK and SepSecS can act on E. coli 
tRNASec in vivo; that human SepSecS can use 
E. coli tRNASec in vivo, as well as the archaeal 
tRNA500 in vitro (8); and that the bacterial seleno-
cysteine synthase can use both archaeal and mu-
rine tRNASoc in vitro (70) suggest that the length 
of the acceptor-TVC arm of tRNASec, the posi-
tion of the variable arm, and the mode of tRNASec 
recognition are likely to be conserved in all do-
mains of life. 
To explore the mechanism by which the 
phosphoryl group is converted to the selenocys-
teinyl moiety, we soaked crystals of the binary 
SepSecS-tRNASec complex in a solution con-
taining a mixture of O-phosphoserine and thio-
phosphate. Sep and Thiop were used as mimics 
of the phosphoseryl group attached to tRNASec 
and selenophosphate, respectively. Although 
both ligands were used in the soaking experi-
ments, Sep bound only to the active sites of the 
catalytic dimer (Fig. 3A), whereas Thiop bound 
only to the active sites of the noncatalytic dimer 
(Fig. 3B), i.e., Sep can bind to an active site 
only in the presence of tRNASec. Both Thiop 
and the phosphoryl group of Sep bind to the 
same binding pocket (Fig. 3, A and B), which 
suggests that a specific active site can accom-
modate only one ligand at a time. Sep binds to 
the catalytic active site in either of two different 
orientations (Fig. 3A). The phosphoryl group 
occupies a similar location in the two orienta-
tions, whereas the seryl moieties are rotated by 
~90° around the phosphate group. In the non-
productive orientation of Sep (SepN), its seryl 
group is sandwiched between the side chains of 
Arg97 and Lys173 at the catalytic dimer inter-
face, whereas its amino group lies ~12 A away 
from the PLP Schiff base (Fig. 3C). Thus, it is 
unlikely that SepSecS would act on SepN, unless 
a PLP-independent mechanism is utilized. In 
the productive-like orientation of Sep (Sepp), 
the amino group of Sep is ~3.5 A away from 
the Schiff base, yet it is not positioned for at-
tack because of a hydrogen bond with Gin'72 
(Fig. 3D). The carboxyl group of Sepp also forms a 
hydrogen bond with the side chain of Gin17 , 
whereas its phosphoryl group anchors the lig-
and into the active site through its interactions 
with the side chains of Ser98, Gin105, and Arg313. 
That the phosphoryl group is required to prop-
erly position the ligand for catalysis explains 
why the obligate substrate for SepSecS is Sep-
tRNASec and not Ser-tRNASec, which is the phys-
iological substrate for the bacterial selenocysteine 
synthase. 
A comparison of the catalytic and noncata-
lytic sites reveals that Sep binds to the active site 
only in the presence of tRNA ^ because the con-
formation of the P-loop (residues Gly96 to Lys107) 
differs between the two active sites (Fig. 3E). In 
the noncatalytic dimer, the guanidinium group of 
Arg97 and the side chain of Gin105 are rotated 
toward the phosphate-binding groove, where they 
coordinate Thiop (Fig. 3, B and E). in the catalytic 
dimer, the side chain of Arg97 rotates away from 
the phosphate-binding groove and forms a hydro-
gen bond with the 2'-OH group of C75. Gin105 also 
rotates away from the phosphate, and this concerted 
movement of Arg97 and Gin1 5 in the P-loop on 
tRNA860 binding allows Sep to bind to the active 
site (Fig. 3E). Free Sep enters the active site through 
the gate formed by the side chains of Arg97, Gin105, 
and Lys173 and gets trapped in the SepN orientation. 
Electron density for both the amino and the car-
boxyl groups of Sep is weak, which suggests 
higher mobility in this part of Sepp, presumably be-
cause of free rotation around the Ca-Cp" bond. This 
explains why the free amino group of Sepp cannot 
be positioned appropriately for attack onto the 
Schiff base and why the reaction does not occur 
in the crystal. Thus, the covalent attachment of 
Sep to tRNASec is necessary for the proper place-
ment of the Sep moiety into the active site and for 
orienting the amino group of Sep for attack onto 
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We used both in vivo and in vitro activity as-
says to investigate the mechanism of Sep-tRNA 
to Sec-tRNA conversion by human SepSecS. First, 
the reduction of the Schiff base by sodium boro-
hydride to form a chemically stable secondary 
amine and thus to cross-link PLP to Lys284 ren-
ders SepSecS completely inactive in vitro (fig. 
S4B). The catalytic activity of SepSecS is also 
quenched on removal of PLP by treatment with 
hydroxylamine (fig. S4B). Some residual activity 
that is observed after hydroxylamine treatment is 
probably because of incomplete removal of PLP 
(fig. S4B). Second, we show that the Arg75Ala, 
Glnl05Ala, and Arg313Ala mutants are inactive 
in vivo (fig. S4A). These residues are involved in 
coordinating either the phosphate group of PLP 
or that of Sep. Finally, the in vivo activities of the 
Arg97Ala, Arg97Gln, Lys 173Ala, and Lysl73Met 
mutants are indistinguishable from that of the 
wild-type enzyme, which confirms that Arg and 
Lys173 are involved only in the nonproductive 
binding of free Sep (fig. S4A). 
On the basis of our findings, we propose the 
following PLP-based mechanism of Sep-tRNA to 
Sec-tRNA conversion. The reaction begins by the 
covalently attached Sep being brought into the 
proximity of the Schiff base when Sep-tRNA860 
binds to SepSecS. The amino group of Sep can 
then attack the Schiff base formed between Lys284 
and PLP, which yields an external aldimine (Fig. 4, 
A and B). The reoriented side chain of Lys ab-
stracts the Ca proton from Sep (Fig. 4C), and the 
electron delocalization by the pyridine ring assists 
in rapid ^-elimination of the phosphate group, 
which produces an intermediate dehydroalanyl-
tRNASec (Fig. 4, C and D). After phosphate dis-
sociation and binding of selenophosphate, the 
concomitant attack of water on the selenophos-
phate group and of the nucleophilic selenium onto 
the highly reactive dehydroalanyl moiety yield an 
oxidized form of Sec-tRNASec (Fig. 4D). The pro-
tonated Lys284, returns the proton to the Ca carbon 
and then attacks PLP to form an internal aldimine 
(Fig. 4E). Finally, Sec-tRNASec is released from 
the active site (Fig. 4F). 
This mechanism is clearly distinct from the 
persulfide-intermediate mechanism in the Sep-
tRNA*^ to Cys-tRNACys reaction (22) and ex-
plains why SepSecS does not group together with 
its closest homolog, SepCysS, in the family tree 
of fold-type I PLP enzymes (72). Moreover, the 
proposed mechanism for SepSecS is similar to 
the one used by the bacterial SelA that also pro-
ceeds through a dehydroalanyl-tRNASec interme-
diate (23). SepSecS therefore uses a primordial 
tRNA-dependent catalytic mechanism in which 
the PLP cofactor is directly involved, while using 
a tetrameric fold-type I architecture as the scaf-
fold for binding the distinct structure of tRNASec. 
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a Tiger Moth Jams Bat Sonar 
Aaron ]. Corcoran,1* Jesse R. Barber,2 William E. Conner1* 
In response to sonar-guided attacking bats, some tiger moths make ultrasonic clicks of their own. 
The lepidopteran sounds have previously been shown to alert bats to some moths' toxic chemistry 
and also to startle bats unaccustomed to sonic prey. The moth sounds could also interfere with, or 
"jam," bat sonar, but evidence for such jamming has been inconclusive. Using ultrasonic recording 
and high-speed infrared videography of bat-moth interactions, we show that the palatable tiger 
moth Bertholdia trigona defends against attacking big brown bats (Eptesicus fuscus) using 
ultrasonic clicks that jam bat sonar. Sonar jamming extends the defensive repertoire available to 
prey in the long-standing evolutionary arms race between bats and insects. 
The ability to pinpoint airborne insects in darkness, by echolocation (1), allowed bats to master nocturnal insectivory (2) and set 
the stage for the evolution of defensive counter-
measures by insect prey (3). Some insects gained 
ears (4) and evasive maneuvering (5). Tiger moths 
(Lepidoptera: Arctiidae) developed the ability to 
click ultrasonically in response to attacking bats 
(6, 7). Decades of research on moth click de-
fenses have led to three, not mutually exclusive, 
hypotheses regarding their function—startle (8), 
acoustic aposematism ("warning") (8-14), and 
sonar interference ("jamming") (15-17). When 
ultrasonic clicks are paired with unpalatable prey, 
bats learn to perceive clicks as a warning of un-
profitability (8, 10-14). Moth clicks also startle 
inexperienced bats or bats that have not heard 
clicks for multiple days (8). Because bats habit-
uate to startle quickly, its effectiveness as a de-
fense requires clicking moths to be rare. This 
situation does not appear typical in nature (12). 
Finally, moth clicks may disrupt the sonar of 
an attacking bat (15-17). Clicks might diminish 
a bat's acuity in determining target distance 
(17-19) or feign echoes from objects that do not 
exist (15). However, evidence that moth clicks 
can disrupt bat attacks by jamming sonar is lack-
ing. One recent study found that moth clicks had 
no discernible effect on attacking bats unless 
clicks were paired with defensive chemistry (13). 
All previous studies, however, tested moths with 
relatively low duty cycles, or sound production 
per unit time (20). High-duty-cycle moth clicks, 
such as those of Bertholdia trigona (Fig. 1 and 
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SUPPORTING ONLINE MATERIAL 
Results and Discussion 
The 9/4 fold of human tRNASee. The linker between the acceptor- and the D-stem is two residues long 
(A8-U9) as was proposed earlier (7). The base of A8 interacts with the sugar-phosphate backbone of both 
the variable and T^C arms, while the base of U9 stacks with A49 from the variable arm-TTC linker. The 
first pair of the D-arm is a loose C10-G24 couple followed by a C11-G23 pair (Fig. 2C). A U12-G22 
wobble pair follows and here the only hydrogen bond is formed between 02-U12 and N2-G22. This obser-
vation agrees well with the earlier findings that N3-U12 is reactive toward carbodiimide (7). Further, the D-
stem contains a C13-U21 pair, and A14-C20 and G15-U19 wobble pairs (Fig. 2C). These interactions 
explain why N1-A14, N1-G15 and N3-U21 were not reactive towards various chemical probes under native 
conditions (7). Three nucleotides U16, G17 and G18 form the D-loop and they interact with C56, A57, A58 
and U59 from the TYC loop closing the cloverleaf structure as proposed (7). The linker between the D-arm 
and the anticodon stem is one residue longer than in the theoretical 9/4 model and is composed of two 
unpaired nucleotides, G25 and U26. The anticodon arm begins with the G26-U43 base pair, whereas the 
anticodon loop is disordered in our crystal. A44 and G45 link the anticodon and variable arms and are 
modeled as single stranded. The rest of the tRNASec structure agrees well with the proposed model (7). 
Results of the in vivo activity assays are consistent with the SepSecS-tRNASec interactions observed in 
the crystal. Analyzing the activity of the SepSecS mutants in vivo assessed the importance of interactions 
other than Arg398-G73, which is described in the main text. We find that the Thr397Ala mutant is com-
pletely active, Thr397Val is partially active, and Thr397Glu is inactive in vivo (Fig. S4A). Thus, Thr397 
strengthens the interaction of the acceptor arm with the a l 4 helix through its interactions with Arg398. In 
addition, the mutant Arg271Glu is partially active suggesting that the interaction between the variable arm 
and the non-catalytic dimer is important for complex formation as well (Fig. S4A). When Lys38 is replaced 
by Glu, the enzyme is partially active in vivo, whereas both the Arg26Ala and Arg26Glu mutants are com-
pletely active (Fig. S4A), suggesting that the Arg26-C2 interaction alone is not critical for complex forma-
tion. Finally, the human and archaeal SepSecS enzymes are completely inactive in vivo when the a l helix 
is deleted (Fig. S4A) (2). 
SepSecS, PSTK and tRNASec may form a ternary complex in vivo. The mode of tRNASec recognition by 
human SepSecS is reminiscent of the tRNA-dependent amidotransferases GatDE and GatCAB that also 
recognize only the acceptor stem of the cognate tRNA (tRNAGln) (3, 4). Given that SepSecS only binds to 
one side of the acceptor-T^C arm of tRNASec it is plausible that PSTK would bind to a different side of the 
1 
acceptor-T*FC arm or to the D-stem as is proposed for the archaeal and human enzymes, respectively (5). 
This would then allow PSTK, SepSecS and tRNASec to form a ternary complex in vivo similar to that of the 
transamidosome involved in prokaryotic tRNA-dependent asparagine biosynthesis (6) or the SepRS, 
SepCysS, tRNACys components engaged in Cys-tRNA formation in methanogens (7). 
Canonical tRNAs with the G73 discriminator base cannot bind to SepSecS due to the shorter accep-
tor-'PFC arm. The structure of the human SepSecS in complex with tRNASec along with the in vivo muta-
genesis data reveal that SepSecS can bind tRNASec only as a tetramer. We propose that the interaction 
between Arg398 and G73 along with the longer 13 bp acceptor-TTC arm and the variable arm of tRNASec 
secure binding of the tRNA to the enzyme. The only tRNA with a G73 discriminator base and a long varia-
ble arm yet with a 12 bp acceptor-T*PC arm is tRNASer. However, neither unacylated tRNASer nor Ser-
tRNASer is able to bind to SepSecS (8). To examine the importance of the length of the acceptor-T*PC arm 
for SepSecS binding, we superimposed tRNAAsp onto tRNASec. The tRNAAsp was chosen because it is a ca-
nonical tRNA molecule with G73 as discriminator base and because the complete structure of the tRNASer 
is not available. We used two approaches for superimposing the two tRNAs. In the first approach the atoms 
of the sugar-phosphate backbone of the acceptor-, TTC- and anticodon arms were superimposed. Although 
the secondary structure elements of tRNAAsp were oriented as observed in tRNASec, we find that G73 of the 
tRNAAsp cannot reach Arg398 due to its shorter acceptor-TTC arm (Fig. S5A, B). In the second approach, 
the discriminator base of tRNAAsp was first modeled to form hydrogen bonds with Arg398 with its Hoog-
steen face, and then the tips of the acceptor arms (nucleotides 1-3 and 70-73) were superimposed. In this 
case, we find that both the anticodon and variable arms oftRNAAsp are positioned away from the enzyme, 
whereas its T*FC arm clashes with the al helix of the non-catalytic dimer (Fig. S5C), thus preventing the 
formation of the SepSecS-tRNAAsp complex. In addition, the absence of a long and properly oriented vari-
able arm in tRNAAsp diminishes further its capacity for interaction with SepSecS (Fig. S5A, C). 
Asn252 in SepSecS plays a role of the conserved Asp252. From a mechanistic standpoint, SepSecS and 
SepCysS are the only Fold Type I PLP enzymes that possess an asparagine in contact with the Nl atom of 
the PLP pyridine ring (2). All other known Fold Type I PLP enzymes have an aspartate in the correspond-
ing position that is critical for catalysis since it increases the electron sink properties of the PLP cofactor (9, 
10). To test whether this Asn252 is also responsible for the discrimination that SepSecS exhibits towards 
Ser-tRNASec we mutated it to an Asp. Finally, the replacement of Asn252 with Ala renders the enzyme 
inactive, whereas the Asn252Asp mutant is completely active (Fig. S4A). Asn252, thus, plays the role of 
the highly conserved Asp252 in the Fold Type I PLP enzymes, which protonates the pyridine ring of PLP. 
2 
The protonated PLP is critical for the stabilization of the covalently attached carbanion intermediate in the 
reaction pathway. Though still active towards Sep-tRNASec, the Asn252Asp human SepSecS mutant is 
inactive towards Ser-tRNASec (Fig. S4A). 
Materials and Methods 
Expression and purification of human SepSecS. The human SepSecS gene was cloned into the pET15b 
(Novagen) expression vector with an N-terminal His-tag as described previously (77) The construct was 
transformed into BL21(DE3) cd+ expression strain. Cells were grown in LB media at 37°C to A60o = -0.6 
at which point the culture was induced with 0.5mM IPTG for an overnight expression at 15°C. The cells 
were harvested by centrifugation at 5,000 rpm for 15 minutes and resuspended in 20 mM Tris, pH 8.0, 50 
mM NaCl, 10% (v/v) glycerol, 1 mM 2-mercaptoethanol, 10 uM PLP in the presence of the protease inhi-
bitor cocktail (Complete EDTA-free, Roche). The cell paste was lysed using a microfluidizer, the insoluble 
material was separated by centrifugation at 32,000 rpm for 40 minutes, and the cleared supernatant was 
loaded onto a Ni-IDA (GE-Healthcare) column pre-equilibrated with 20 mM Tris-HCl, pH 8.0, 300 mM 
NaCl, 10 mM imidazole, 1 mM 2-mercaptoethanol, 10 (iM PLP. Any non-specifically bound protein was 
washed away with 50 mM imidazole, while the His6-SepSecS was eluted with 500 mM imidazole. The 
protein sample was diluted three-fold with 20 mM Tris-HCl, pH 8.0, 100 mM NaCl, 1 mM DTT, 10 uM 
PLP, concentrated to 3 mL and loaded onto a S-200pg size-exclusion column. The protein eluted as a 
tetramer, it was concentrated to ~2 mg/mL, flash frozen in liquid nitrogen and stored at -80°C. 
In vitro transcription and purification of human tRNASec. The human tRNASec was cloned into pUC19, 
expressed in E. coli DH5a and synthesized by in vitro T7 RNA polymerase run-off transcription as 
described (72). The transcription reaction was performed at 37°C for 2h in buffer containing 40 mM Tris-
HCL pH 8.1, 22 mM MgCl2, 10 mM DTT, 1 mM spermidine, 0.01% Triton X-100, 50 ug/ml BSA, 4 mM 
of nucleoside triphosphate, 16 mM GMP, BstNI-digested vector containing the tRNASec gene (70 ug/ml) 
and 3 mM T7 RNA Polymerase. The reaction was briefly centrifuged to pellet the formed pyrophosphate, 
the supernatant reaction mixture was loaded onto a Resource-Q column (GE-Healthcare) and tRNASec was 
purified using a linear gradient of NaCl (0.2-1 M) in 20 mM Tris-HCl, pH 8.0. Human tRNASec eluted at 
-0.6 M NaCl. The purity of the tRNASec-containing fractions was checked by electrophoresis on a 12% 
denaturing polyacrylamide gel. Pure tRNA ec fractions were ethanol precipitated and kept at -80°C. 
Purification and crystallization of the SepSecS-tRNASec complex. The complex was prepared by mixing 
SepSecS with a 1.5-fold molar excess of tRNASec. Thus, for each SepSecS tetramer there were 6 molecules 
of tRNASec available. The mixture was concentrated to -1 mL, loaded onto a S-200pg column (XK 16/60) 
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and eluted with 20 mM Tris-HCl, pH 8.0, 100 mM NaCl, 1 mM DTT, 10 uM PLP. The first peak contained 
the SepSecS-tRNASec complex, whereas the second peak contained the unbound tRNASec. The complex was 
concentrated to ~7.5 mg/mL. The complex was crystallized by sitting-drop vapor-diffusion method at 12°C 
by mixing equal volumes of the complex sample with the well buffer containing 0.3 M tri-lithium citrate, 
18% (w/v) PEG 3,350. Addition of various additives to the mother liquor such as sorbitol, D-galactose, 
NDSB-201, Cymal-7, MPD and phenol improved both the crystal size and the quality of diffraction. 
Ligand soaks and data collection. A mixture of thiophosphate and phosphoserine was added to the binary 
complex crystals to the final concentration of 1 mM and incubated for lh prior to freezing. Crystals were 
cryoprotected for 5 minutes in the presence of 20% (v/v) ethylene-glycol and then frozen in liquid propane. 
Data were collected at the NE-CAT 24IDE beamline (APS, Argonne National Laboratory, Chicago) and 
processed using HKL2000 (Supplementary Table 1) (13). 
Structure determination and refinement. The crystal structure of the complex between human SepSecS 
and tRNASec was solved by molecular replacement using Phaser (14) and by using a monomer of the mu-
rine SepSecS (PDBID: 3BC8) (15) as a search model. The asymmetric unit contained four SepSecS mole-
cules, which we shall refer to as the crystallographic tetramer (Fig. SI A). After a round of rigid-body re-
finement strong positive electron density peaks for tRNASec, Thiop and Sep appeared in the Fo-Fc electron 
density map. The tRNASec molecule was bound to the crystallographic tetramer in two alternate orientations 
and both orientations were modeled and refined (Fig. SI A). The actual physiological tetramer contains a 
half of the crystallographic tetramer and two other symmetry related SepSecS molecules (Fig. SIB). Con-
sequently, the actual physiological SepSecS tetramer has two tRNASec molecules bound each with half 
occupancy. The physiological tetramer is discussed in the manuscript. Structure refinement was done in 
Phenix (16), while model and map inspection was done in Coot (17). The final model had an excellent 
geometry with 94% and 6% residues in preferred and allowed regions of the Ramachandran plot, respec-
tively. The final RciySt was 20.3% and Rfree was 23.8% (Table 1). All figures were generated in Pymol (18). 
Modeling of the SepSecS-tRNAAsp and SerRS-tRNASec complexes. A model of SepSecS-tRNAAsp was 
generated using the crystal structure of AspRS-tRNAAsp (PDBID: 1C0A) (19). tRNAAsp was superimposed 
onto tRNASec using two approaches. On one hand the atoms of the sugar-phosphate backbone of the 
acceptor-, T*PC- and anticodon arms were used for superpositioning, whereas in the other approach, G73 of 
tRNAAsp was first modeled as found in tRNASec and then only the nucleotides 1-3 and 70-73 were superim-
posed. The CCA-end of both tRNAAsp and tRNASec was excluded from the calculation. A model of SerRS-
tRNASec complex was generated using the crystal structure of SerRS-tRNASer complex (PDBID: 1SER) 
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(20). The atoms of the sugar-phosphate backbone of tRNA ec were superimposed onto the corresponding 
atoms of tRNASer. The tip of the acceptor arm (nucleotides 1-2, 71-76) was excluded from the calculation. 
All calculations were done in Lsqman (21). 
Modeling of CCA-Sepp in the catalytic site of SepSecS. Modeling of CCA-Sepp was done in Coot (17). 
The 03'-hydroxyl group of A76 replaced the carboxyl oxygen of Sepp, thus forming an ester bond. The 
base of A76 was positioned between the side-chains of Arg97 and Lysl73, while the side-chain of Arg97 
and the entire P-loop was kept is in the same conformation as found in the catalytic active site. 
In vivo SepSecS assay. The human SepSecS mutants (R26A, R26E, K38A, K38E, R75A, R97A, S98A, 
Q105A, K173A, K173M,N252A, N252D, R271A, R271E, R313A, T397A, T397E, T397V, R398A and 
R398E) were generated using the QuikChange site-directed mutagenesis kit (Stratagene) and cloned into 
the pET15b vector with an N-terminal His-tag. An N-terminal Ai_37SepSecS deletion mutant was 
constructed by PCR with the pET\5b-sepsecS plasmid as the template and with the following primers: 5'-
GGAATTCC ATATGAAGGGC AAGTGTCC AGAGAATGGCTGGGATGAAAGTACAC-3', and 5' -
CGCGGATCCTCATGAAGAAGCATCCTGGTATGTGTCAAGAAGTACATTATC-3'. The resulting 
DNA fragment was subcloned into the pET20b vector (Novagen) with a C-terminal His-tag. Construction 
of the E. coli AselA deletion strain JS1 (DE3) and cloning of the M. jannaschii PSTK gene into the 
pACYC-Duet vector were described previously (77). The human wild type and mutant SepSecS genes were 
transformed into the E. coli AselA deletion strain JS1 (DE3) with or without the M. jannaschii PSTK gene. 
Aerobic overnight cultures were streaked on LB-agar plates and/or M9 minimal medium-agar plates sup-
plemented with 0.01 mM IPTG, 1 uM Na2Mo04, 1 uM Na2Se03 as described previously (2, 11). The LB-
agar plates also contained 50mM sodium formate. The cells were grown anaerobically for 5h at 37°C and 
20h at 30°C. The plates were then overlaid with agar containing 1 mg/ml benzyl viologen, 0.25 M sodium 
formate, and 25 mM KH2PO4, pH 7.0. The appearance of a blue/purple color is the indication of active 
formate dehydrogenase H. 
In vitro SepSecS assay. For this assay, following in vitro transcription as described above, the human 
tRNASec transcript was purified by electrophoresis on a 12% denaturing polyacrylamide gel. Full-length 
tRNA was eluted and desalted on Sephadex G25 Microspin columns (Amersham). The tRNASec was 
refolded by heating for 5 min. at 70°C in buffer containing 10 mM Tris-HCl (pH 7.0), followed by addition 
of 5 mM MgCL: and immediate cooling on ice. Refolded tRNASec (10 pM) was serylated and phosphory-
lated by M. maripaludis SerRS (5 uM) and M. jannaschii PSTK (3 uM) for 75 min. at 37°C in buffer 
containing 50 mM HEPES (pH 7.2), 10 mM MgCl2, 20 mM KC1, 1 mM DTT, 10 mM ATP and 300 uM 
5 
[ C]Ser. After phenol/chloroform extraction Sep-tRNA ec was purified by application on a Sephadex G25 
Microspin column (Amersham) and ethanol precipitation. The conversion of Sep to Cys was done under 
anaerobic conditions using wild-type human SepSecS and human SepSecS treated with either hydroxyl-
amine or NaBH4. For the hydroxylamine treatment the SepSecS sample was dialyzed for 5 hr against the 
buffer containing 50 mM HEPES pH 7.2, 250mM NaCl, ImM DTT, 7.5 mM hydroxylamine, whereas for 
the borohydride treatment the SepSecS sample was incubated in the dark for 1 hr in the presence of 100 
mM NaBfLt. The excess of hydroxylamine and borohydride was removed from the samples by dialysis 
against 50 mM HEPES pH 7.2, 250 mM NaCl, 1 mM DTT. SepSecS (20 ug) was incubated with 10 uM 
Sep-tRNASec in buffer containing 50 mM HEPES pH 7.2, 20 mM KC1, 10 mM MgCl2, 1 mM DTT and 250 
uM sodium thiophosphate. All buffers were prepared anaerobically and the reaction was carried out at 37°C 
inside an anaerobic chamber over 40 min. The reaction was stopped by phenol/chloroform extraction, the 
aqueous phase was applied to a Sephadex G25 Microspin column (Amersham) and the eluted aminoacyl-
tRNAs were ethanol precipitated. The purified aa-tRNAs were deacylated in 20 mM NaOH for 10 min at 
22°C. The released amino acids were oxidized with performic acid as described previously (22). The final 
samples were spotted onto silica gel 60 TLC aluminium sheets (Merck) that were developed in 85% etha-
nol. To detect the labelled amino acids the TLC plate was dried and then exposed on an imaging plate 
(FujiFilms) for 60 hr. The imaging plate was scanned using a Molecular Dynamics Storm 860 scanner. 
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Supporting Figure legends 
Figure SI. Asymmetric unit of the SepSecS-tRNASec complex crystal. (A) Ribbon diagram of the crys-
tallographic tetramer composed of two halves of the physiological SepSecS tetramer with one tRNASec 
molecule bound in two alternate orientations. Catalytic monomers are colored in blue, non-catalytic mono-
mers are shown in red, and the two conformations of tRNASec are colored in green and orange. The defini-
tion of the monomers is as in the text. The cofactor PLP is shown as sticks and colored in red and blue in 
the catalytic and non-catalytic active sites, respectively. (B) A half of the asymmetric unit and two symme-
try related molecules (shown in light blue and light pink) make up the physiological SepSecS tetramer. 
Figure S2. The SepSecS tetramer can accommodate four tRNASec molecules. (A) Ribbon diagram of 
the physiological SepSecS tetramer in a putative complex with four tRNASec molecules bound. The cata-
lytic dimer (blue) with two tRNASec molecules (green) bound was superimposed onto the non-catalytic 
dimer (red) and the complex was generated. The generated tRNASec molecules are shown in orange. (B) 
The view in B is rotated -90° clock-wise around the vertical axis relative to A. The SepSecS-tRNASec 
complex is in the same orientation as in Figure 1 of the manuscript. 
Figure S3. Interactions between SepSecS and the "PFC- and variable arms of tRNASec. (A) The ribbon 
diagram of the complex showing interactions between parts of the variable arm of tRNASec (orange) and the 
a9 helix (red) of SepSecS. The rest of the tRNASec is green. The view is rotated -90° clockwise around the 
vertical axis relative to Fig. 1A. (B) Arg271 (a9) in the non-catalytic dimer interacts with the variable arm 
(nucleotides C46L-A47). (C) The side-chains of Lys38 and Lys40 (al-a2 loop) interact with the T*FC arm. 
Lys38 and Lys40 interact with C64 and G50, respectively. In B and C, tRNASec is green and the protein 
side-chains are gold. 
Figure S4. In vivo formation of Sec-tRNASec by SepSecS mutants and in vitro conversion of Sep-
tRNASec to Cys-tRNASec by wild type and PLP-cross-linked SepSecS. (A) In vivo assays of SepSecS 
mutants. Formation of Sec-tRNASec in vivo is assayed by the ability of the wild-type human SepSecS and its 
mutant variants (N-terminal deletion Al-37, R398A, R398E, R26A, R26E, K38A, K38E, T397A, T397E, 
T397V, R271A, R271E, K173A, K173M, S98A, R97A, Q105A, R313A, R75A, N252 and N252D) to 
restore the benzyl viologen reducing activity of the selenoprotein FDHH in the E. coli selA deletion strain 
JS1. The M. jannaschii PSTK is co-transformed, except where indicated with a "-", to provide the neces-
sary Sep-tRNASec intermediate. (B) In vitro assays of SepSecS. Phosphorimages of TLC separation of 
[14C]Sep and [l4C]Cys recovered from the aminoacylated-tRNAs of the SepSecS activity assays. Cysteine 
was analyzed in its oxidized form as cysteic acid (Cya). Lane 1, Ser marker; lane 2, Sep marker; lane 3, 
Cys marker; lane 4, Sep-tRNASec with human SepSecS in the absence of thiophosphate; lane 5, Sep-
tRNASec with wild-type human SepSecS; lane 6, Sep-tRNASec with human SepSecS treated with 7.5 mM 
hydroxylamine; lane 7, Sep-tRNASec with human SepSecS treated with 100 mM sodium borohydride. 
Figure S5. Selectivity of SepSecS and SerRS. (A) Modeling of the complex between SepSecS and 
canonical tRNAs. tRNAAsp (orange) was superimposed onto tRNASec (green) using the sugar-phosphate 
backbone atoms of the acceptor-, T*FC- and anticodon arms. The long variable arm of tRNASec interacts 
with the non-catalytic dimer of SepSecS (shades of red). The box delineates the close-up view shown in B. 
(B) The short acceptor-TTC arm of canonical tRNAs prevents binding to SepSecS. G73 of tRNAAsp 
(orange) cannot reach Arg398. (C) Steric clashes (asterisk) between the a l helix of the non-catalytic-dimer 
of SepSecS (shades of red) and the W C arm of tRNAAsp (orange) prevent the SepSecS-tRNAAsp complex 
formation. G73 from tRNAAsp was modeled to form hydrogen bonds with Arg398 using its Hoogsteen face. 
Only the tip of the acceptor arm (nucleotides 1-3 and 70-73) was used in the superposition. Arrows show 
the movement of both the anticodon and T^C arms in tRNAAsp relative to its orientation shown in A. (D) 
Modeling of the SerRS-tRNASec complex. tRNASec was superimposed onto the tRNASer that is in complex 
with SerRS. SerRS is a non-discriminating aminoacyl-tRNA synthetase because it recognizes variable arms 
of both tRNASer (red) and tRNASec (green). 
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Stop codon re-coding 
Natural suppression 
A B S T R A C T 
Selenocysteine and pyrrolysine, known as the 21st and 22nd amino acids, are directly inserted into 
growing polypeptides during translation. Selenocysteine is synthesized via a tRNA-dependent path-
way and decodes UGA (opal) codons. The incorporation of selenocysteine requires the concerted 
action of specific UNA and protein elements. In contrast, pyrrolysine is ligated directly to tRNAPyl 
and inserted into proteins in response to UAG (amber) codons without the need for complex re-cod-
ing machinery. Here we review the latest updates on the structure and mechanisms of molecules 
involved in Sec-tRNA^0 and Pyl-tRNAPy> formation as well as the distribution of the Pyl-decoding 
trait. 
© 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved. 
1. Selenocysteine biogenesis 
Selenocysteine (Sec) is the major biological form of the element 
selenium, which in trace amounts is essential for human health. 
Sec is incorporated into polypeptides to form selenoproteins dur-
ing translation. The 21st amino acid is typically found in catalytic 
centers of selenoproteins where it plays a functionally essential 
role. Unlike most amino acids, Sec is universally synthesized on 
its cognate tRNA [1-4]. During translation, selenocysteinyl-tRNASec 
(Sec-tRNASec) is delivered to the ribosome by a specific translation 
factor that requires a characteristic stem-loop structure in the 
mRNA to actively recode an in-frame UGA from stop codon to 
Sec sense codon. The human genome encodes only 25 selenopro-
teins [5], yet variations in these Sec-containing proteins or their 
synthetic machinery is linked to a range of human disorders 
including cancer and numerous diseases affecting the nervous, im-
mune, and endocrine systems [6]. 
The machineries to synthesize Sec and incorporate it into sele-
noproteins are divergent in bacteria compared to archaea and 
* Corresponding authors. 
E-mail addresses: jing.yuan@yale.edu (J. Yuan), patrick.odonoghue@yale.edu (P. 
O'Donoghue). 
1 Both authors contributed equally. 
eukaryotes. In bacteria, serine (Ser) as the precursor of Sec is ini-
tially attached to tRNASec by seryl-tRNA synthetase (SerRS). The 
resulting Ser-tRNASec is then converted to Sec-tRNASec by seleno-
cysteine synthase (SelA) in the presence of the selenium donor 
selenophosphate. This pathway has been well characterized in 
Escherichia coli [7] and extensively reviewed before [8,9]. 
The pathway for Sec biosynthesis in archaea and eukaryotes 
(Fig. 1) was revealed only in the last few years. The missing com-
ponent was an archaeal/eukaryotic analog of SelA, since no clear 
sequence-based homolog could be found. An additional enzymatic 
step is involved in Sec biosynthesis in archaea and eukaryotes. O-
phosphoseryl-tRNA kinase (PSTK) [10] catalyzes the phosphoryla-
tion of Ser-tRNASec to form 0-phosphoseryl-tRNASec (Sep-tRNASec). 
The Sep-tRNA:Sec-tRNA synthase (SepSecS), an independently 
evolved protein that is distantly related to SelA [11], then forms 
the final product Sec-tRNASec from selenophosphate and Sep-
tRNASec [2-4]. Phylogenetic analysis indicated that PSTK and Sep-
SecS co-evolved and are restricted to the archaeal and eukaryotic 
domains [2,12]. An interesting similarity, as reviewed previously 
[13], exists between the archaeal and eukaryotic Sec biosynthetic 
pathway and archaeal tRNA-dependent cysteine biosynthesis, 
which also proceeds via a Sep-tRNA intermediate [14]. In the first 
section of this paper, we focus on recent biochemical and struc-
tural work that further elucidated the mechanism and specificity 
0014-5793/S36.00 © 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved. 
doi:10.1016/j.febslet.2009.11.005 
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Fig. 1. The Sec biosynthesis pathway in archaea and eukaryotes. Sec is synthesized on tRNASec in three steps. (1) The unacylated tRNASec is serylated by SerRS; (2) the 
resulting Ser-tRNASec is phosphorylated by PSTK forming Sep-tRNASec; (3) the phosphorylated intermediate is converted to the final product Sec-tRNASec by SepSecS. The 
crystal structures of tRNA and enzymes in this pathway are presented: tRNASec (ribbon) from Homo sapiens [19], SerRS (ribbon) with AMP (stick) from Pyrococcus horikoshii 
[64], PSTK (ribbon) from M.jannaschii ]26], and SepSecS (ribbon) with tRNASec (stick, only one tRNA is shown) from Homo sapiens [18J. 
of the tRNA and enzymes involved in Sec biosynthesis in archaea 
and eukaryotes. 
2. tRNAScc has a distinct structure 
tRNASec was identified more than two decades ago [1 ]. It is the 
longest tRNA with an extended acceptor stem resulting from an 
abnormal RNase P cleavage specificity [15]. tRNASec has an 8-bp 
acceptor stem and 5-bp T-stem (a 8/5 secondary structure) in bac-
teria and a 9/4 arrangement in archaea and eukaryotes, and both 
can fold into a 13-bp long acceptor-TvPC helix (Fig. 2A). In contrast, 
canonical tRNAs typically have a 7-bp acceptor stem and a 5-bp T-
stem forming a 12-bp acceptor-T*PC helix. Several other features of 
tRNASec, including an elongated D-stem (6-bp instead of 4-bp), a 
smaller D-loop (4-bp instead of 8-bp), a long variable arm, and 
the absence of the highly conserved U8 residue, make tRNASec dis-
tinct from canonical tRNAs. 
The tertiary structures of E. coli and eukaryotic tRNASec were 
investigated by chemical and enzymatic probing during the 
1990s [16,17]. Very recently, the first tRNASec crystal structure 
was solved. The unacylated human tRNASec transcript was crystal-
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Fig. 2. Binding to SepSecS promotes a conformational change in tRNASec. (A) The secondary structure of human tRNASec with bases mentioned in the text highlighted in bold. 
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[19]. The tertiary structure confirms the predicted distinct features 
of the acceptor, T and D-stems. Compared to canonical tRNAs, the 
overall structure of tRNASec is less compact due to the lack of ter-
tiary interactions from the D-arm and the variable arm, i.e., ab-
sence of the G15:C48 base pair, which creates a hole in the 
tertiary core [18,19]. The D-stem does not stack perfectly along 
the axis formed by the anticodon stem and the T-loop and shifts 
to the minor groove side of the tRNA. The long variable arm pro-
trudes from the tertiary core on the side of tRNASec opposite from 
the D-arm [18,19]. Remarkably, despite different secondary and 
tertiary interactions, the relative position of the T-stem and the 
variable arm in the free tRNASec is almost indistinguishable to that 
in tRNASer. The variable arm is one of the major identity elements 
for the recognition of tRNA5" and tRNASec by seryl-tRNA synthe-
tase (SerRS), and these observations in part explain the dual spec-
ificity of SerRS for tRNASec and tRNASer [18]. Another model of the 
SerRS-tRNASec complex suggests that SerRS may also recognize 
both the G19:C56 base pair and the discriminator base of tRNA5"0 
[19]. Thus, all the major identity elements for tRNA serylation 
are present and can be recognized in tRNASec. 
Uridine at position 8 is highly conserved and forms a tertiary base 
pair with Al 4 in all other mature tRNAs. This conserved U8: Al 4 base 
pair defines the elbow region of the tRNA [20] and U8 acts as a sensor 
for the response mechanism to UV exposure [21 ]. The tRNASec has an 
adenosine at position 8 instead. An A8:A14:U21 base triple was sug-
gested from the chemical and enzymatic probing data [17], yet A8 
does not appear to interact with other bases in the two recently re-
ported tRNASec crystal structures [18,19]. A tertiary base interaction 
change is observed when comparing the SepSecS-bound and the 
free tRNASec crystal structures. In the unbound tRNASec, the base of 
U20 stabilizes interactions between the D and V¥C loops by forming 
a base triple with the G19:C56 Watson-Crick base pair [19]. In the 
SepSecS-bound state the base of U20 does not participate in the base 
triple. Its electron density is weak, suggesting increased mobility in 
this part of the D-loop. Thus, the base triple stabilizes an unbound 
conformation of tRNASec, whereas on binding to SepSecS the base 
triple breaks apart. Besides canonical tertiary base interactions 
(i.e., G18:U55 and G19:C56), unique tertiary interactions are pres-
ent in tRNASec such as the U16:U59 base pair, which stacks on top 
of A15:A20a and forms a 13-bp stacking helix together with the D 
and anticodon stems. 
Further analysis, based on superimposing the two solved struc-
tures of tRNASec, reveals that while the individual arms of tRNA5" 
adopt the same structure, their relative orientations differ in the 
SepSecS-bound state and unbound state. Indeed, the acceptor, T-
and variable arms undergo a conformational change upon binding 
to SepSecS (Fig. 2B): (i) the variable arm makes a 33° rotation 
around the axis that is parallel to the anticodon arm, (ii) the T-
arm moves in the same direction, but to a somewhat lesser extent 
(17°), and (iii) the acceptor arm makes a 6° rotation around the 
anticodon stem as well as a 24° rotation around the axis that is par-
allel to the variable arm (Fig. 2C). The conformational change facil-
itates the interaction between tRNASec and SepSecS and 
presumably orients the CCA end toward the active site. It will be 
interesting to see if tRNASec undergoes a similar conformational 
change as it binds to other components of the Sec biosynthetic 
apparatus and the translating ribosome. 
tRNA5" plays a pivotal role in the Sec biosynthesis pathway. It 
interacts with Sec specific proteins including PSTK and SepSecS 
in archaea and eukaryotes. The distinct structural features of tRNA-
Sec are proven to be major recognition elements throughout Sec 
biosynthesis as detailed below. It is unknown, however, if these 
features of tRNASec are also important for Sec incorporation, which 
requires the participation of multiple protein factors in Sec decod-
ing during translation. 
3. PSTK is a tRNA^-dependent kinase 
In archaea and eukaryotes, PSTK catalyzes the second step of 
Sec biosynthesis (Fig. 1, center), the phosphorylation of Ser-tRNASec 
to Sep-tRNA5ec in a reaction requiring ATP and magnesium. Such 
kinase activity was first observed in rat and rooster liver lysate al-
most 40 years ago [22,23]. In 2004, the identity of this elusive ki-
nase as PSTK was finally revealed in mouse via a comparative 
genomic approach [10]. Subsequently the archaeal homolog was 
shown to have the same activity [24], and the biochemical and 
structural properties of the Methanocaldococcus jannaschii PSTK 
(MjPSTK) have been extensively studied [12,24-26]. 
MjPSTK is a homodimeric enzyme with each monomer consist-
ing of a N-terminal kinase domain and a C-terminal domain that is 
putatively involved in tRNA binding. PSTK is a member of the P-
loop kinase family with the conserved Walker A and B motifs 
and the RX3R motif that are responsible for the recognition of the 
Mg2+-ATP complex [12,26]. Mutations to either the Walker A or B 
motifs ablate PSTK activity both in vitro and in vivo [26]. Mutagen-
esis also revealed that the distal Arg residue in the RX3R is critical 
for catalysis both in vivo and in vitro. Interestingly, the kinase 
activity is not highly specific for the phosphate donor, since all four 
rNTPs and even dATP are competent substrates [12]. Structural 
analysis of the PSTK:AMPPNP complex supported this observation 
since the adenosine ring makes few specific contacts, with the 
exception of a cation-rc interaction involving the RX3R motif [26). 
The conserved Asp residue (Asp41) in the Walker B motif plays 
an essential role in MjPSTK catalysis. Mutation of Asp41 to Asn 
leads to total loss of activity [26]. The structure shows that 
Asp41 stabilizes the ATP bound Mg2* ion via a water mediated 
hydrogen bond, while modeling of the Ser substrate suggests direct 
contact between Asp41 and the hydroxyl group of Ser [26]. Based 
on these reports, we can propose a plausible reaction mechanism 
for PSTK. The reaction begins when both substrates, Ser-tRNA5ec 
and Mg2+-ATP, are bound to the enzyme. Asp41 then attracts a pro-
ton from the hydroxyl group of the Ser in the substrate. The depro-
tonated Ser nucleophilically attacks the y-phosphate of the ATP 
yielding a pentavalent transition-state intermediate. Finally, the 
phosphodiester bond between the ji and y phosphate in the ATP 
is broken to complete the transphosphorylation reaction, and the 
product Sep-tRNASec is formed. Mg2+ aids in the departure of the 
leaving group ADP. 
The enzyme activity of PSTK is strictly tRNASec-dependent. PSTK 
does not hydrolyze ATP in the absence of tRNA nor in the presence 
of Ser-tRNASer. The binding of tRNASec, however, promotes ATP 
hydrolysis [12]. This suggests that tRNA5ec might play an essential 
role in positioning the Ser moiety for initiating phosphoryl trans-
fer. Compared to aminoacyl-tRNA synthetases, PSTK has approxi-
mately 20-fold higher affinity toward its substrate, Ser-tRNASec 
(Km = 40 nM) [12], which may compensate for the low abundance 
of tRNASec in vivo. The concentration of tRNA5ec in vivo is at least 
10-fold lower than tRNA5er in tRNASec-rich tissues such as liver, 
kidney and testis in rat [27]. 
The crystal structure of PSTK reveals an unusual large central 
groove that is formed in the MjPSTK dimer interface, a feature 
not observed in other P-loop kinases previously. The central groove 
exposes the monomer active sites at either end, and contains many 
positively charged residues. Computational docking suggested that 
the central groove provides a complementary surface for the two 
tRNASec substrates. The model places archaeal PSTK identity ele-
ments (G2:C71 and the C3:G70 [25]) within contact of the protein 
dimer interface. Interestingly, the second base pair in the acceptor 
stem is highly conserved as C2:G71 in eukaryotic tRNASec, 
and mutation of G2:C71 to C2:G71 in archaeal tRNASec resulted 
in a Ser-tRNASec variant that is phosphorylated inefficiently [25]. 
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Moreover, the eukaryotic PSTK has been reported to recognize the 
unusual D-arm of tRNASec as the major identity element for phos-
phorylation [28], and phylogeny indicates a deep divide between 
the archaeal and eukaryotic PSTK proteins [12]. Given these obser-
vations, it is quite likely that the eukaryotic PSTK/tRNA complex 
may involve interactions that are distinct from its archaeal coun-
terpart. Future co-crystal structures of tRNASec with the archaeal 
and eukaryotic PSTKs will provide a definitive picture of these 
differences. 
4. SepSecS requires Sep-tRNA561 as the precursor for Sec 
biosynthesis 
The conversion of phosphoseryl-tRNASec (Sep-tRNASec) to selen-
ocysteinyl-tRNASec (Sec-tRNASec) is the last step of Sec biosynthesis 
in both archaea and eukaryotes, and it is catalyzed by O-phos-
phoseryl-tRNA:selenocysteinyl-tRNA synthase (SepSecS). SepSecS 
forms its own branch in the phylogenetic tree of the fold type I 
family of the pyridoxal phosphate (PLP)-dependent enzymes and 
displays a distinct homotetrameric (feh) quaternary structure 
[11]. Two active sites are formed at each homodimer interface 
and each active site contains a PLP-binding pocket. Thus, the tetra-
meric SepSecS has four active sites and four PLP molecules bound. 
The PLP cofactor forms a reversible Schiff-base linkage (internal 
aldimine) with a highly conserved Lys284. The PLP-dependent en-
zymes form a functionally diverse group, which is responsible for 
more than 140 distinct activities [29]. Remarkably, almost all the 
PLP-dependent enzymes utilize a catalytic mechanism that pro-
ceeds through a carbanion intermediate, which is, in turn, stabi-
lized by PLP [30]. Based on both in vitro and in vivo activity 
assays, a catalytic mechanism of SepSecS that is dependent on 
PLP was recently proposed [11,18,31]. 
The tetrameric SepSecS is distinct from all other members of its 
family including 0-pnosphoseryl-tRNA:cysteinyl-tRNA synthase 
(SepCysS). SepCysS acts on a tRNA-based substrate (Sep-tRNACys), 
but it does so as a dimer [11]. Moreover, SepSecS is a highly specific 
enzyme that acts on Sep-tRNASec, and not on Sep-tRNACys, Ser-
tRNASec, or free Sep. Crystal structures of both the archaeal and 
murine apo-SepSecS [11,31] and that of the human SepSecS-tRNA-
Sec complex [18] have provided insights into the substrate specific-
ity and the catalytic mechanism of SepSecS. 
SepSecS binds both the unacylated tRNASec and Sep-tRNASec 
with comparable affinities in vitro [4], which presumably allowed 
crystallization of the human complex between SepSecS and unacy-
lated tRNASec. The SepSecS/tRNASec complex structure revealed 
that one SepSecS homodimer interacts with the sugar-phosphate 
backbone of both the acceptor-PFC and the variable arms of tRNA-
Sec, while the other homodimer interacts specifically with the tip of 
the acceptor arm through interaction between the conserved 
Arg398 and the discriminator base G73 of tRNASec [18]. Thus, one 
homodimer measures both the length of the acceptor-T^C arm 
and the distance between the variable arm and the CCA end, 
whereas the other homodimer ensures that the correct tRNA is 
bound to the enzyme. The latter homodimer also provides the cat-
alytic site that would act on the Sep moiety. Finally, structural 
modeling revealed that canonical tRNAs, including tRNASer (which 
is the closest structural homolog of tRNASec), cannot bind to Sep-
SecS due to the shorter acceptor-TTC arm. These observations ex-
plain why only the SepSecS tetramer can bind tRNASec and why 
SepSecS cannot bind canonical tRNAs. 
Unlike its bacterial counterpart SelA, SepSecS cannot directly 
convert Ser-tRNASec to Sec-tRNASec and has a significantly reduced 
affinity for Ser-tRNASec in vitro [4]. This argues that the phosphate 
group of Sep plays an important role in substrate binding. Indeed, 
the crystal structure of SepSecS/tRNASec complex in presence of 
free Sep shows extensive hydrogen bonding between the active 
site and the phosphate group of the free Sep [18]. This suggests 
that the phosphate group may serve as an anchor to bring Sep in 
close proximity of the cofactor PLP. However, the ot-amino group 
of the free Sep appears quite flexible in the structure and it is not 
oriented properly for the nucleophilic attack on the Schiff-base 
[18]. Thus, the covalent attachment of Sep to tRNASec may restrain 
the conformation of the Sep moiety as well as facilitate the proper 
orientation of the a-amino group for efficient PLP-dependent catal-
ysis to occur. This would explain why SepSecS could not act on 
either free Sep or Ser-tRNASec, as both molecules bear only one 
anchoring moiety. 
Sec biosynthesis in all domains of life is achieved by RNA-
dependent amino acid modification. As such it is reminiscent of 
other pathways of tRNA-dependent amino acid synthesis that form 
Asn-tRNA, Gln-tRNA and Cys-tRNA in many organisms [32]. The 
individual reactions in this stepwise process may actually be car-
ried out in a large tRNA: protein complex. One example is the tran-
samidosome [33], a complex of tRNA^", aspartyl-tRNA synthetase, 
and Asp-tRNAAsn amidotransferase, that provides an efficient route 
to bacterial Asn-tRNAAsn formation. The complex architecture 
should also aid protein quality control, as it may prevent release 
of mis-acylated aminoacyl-tRNA that would be used in protein 
synthesis. A similar complex possibly involving tRNASec, SerRS, 
PSTK and SepSecS may exist to facilitate efficient selenocysteine 
formation. 
5. Pyrrolysine, the uncommon 22nd amino acid 
Evidence for the genetic encoding of pyrrolysine (Pyl) is only 
present in 1% of all sequenced genomes thus far. The rarity of Pyl 
is matched by its unique chemical structure, a lysine in NE-linkage 
to a pyrroline ring. Pyl was first observed in a crystal structure at 
the active site of the monomethylamine methyltransferase 
(MtmBl) from the methanogenic archaeon Methanosarcina barken 
[34]. Pyl has now been characterized in three distinct methylamine 
methyltransferases from the Methanosarcinaceae that allow these 
methanogens to utilize the unique growth substrates mono-, di-
and trimethylamines [35]. Although each of the genes encoding 
these methyltransferases contains a in-frame amber (TAG) codon 
(a stop codon in most organisms) the methylamine methyltrans-
ferase genes are read-through to the next opal or ochre stop codon 
and Pyl is inserted in-response to the in-frame amber codon. Due 
to its proximity to the active site, Pyl was hypothesized to be a 
key catalytic residue in these Pyl-proteins [36]. 
While some work has attempted to address the mechanism of 
stop codon suppression in Pyl-decoding organisms [37-39], it re-
mains unclear whether all amber codons in these organisms en-
code Pyl or whether some are translational stop signals. In recent 
work [40], Pyl was also found in the tRNAHls guanylyltransferase 
(Thgl) from Methanosarcina acetivorans. Thgl is responsible for 
addition of the key identity element for His-tRNA formation, a 
Gl residue ligated to the 5'-end of immature tRNAH,s. Interestingly, 
Pyl does not play a role in the catalytic action of Thgl and repre-
sents the first example of a dispensable Pyl residue. Efficient 
read-through of the in-frame amber codon in Thgl, without the 
apparent presence of re-coding signals, indicates that Pyl insertion 
may be more similar to natural stop codon suppression [41 ] than 
to the more elaborate re-coding of UGA codons that is known to oc-
cur for selenocysteine [9]. 
Previous reviews focused on how Pyl enters the genetic code 
[42,43], namely by the catalytic action of a pyrrolysyl-tRNA syn-
thetase (PylRS) that ligates pyrrolysine to the amber codon decod-
ing tRNA^1 [44,45]. Since that time the most dramatic advances 
have been the structural characterization of PylRS and tRNAPyl. This 
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work, which is reviewed in detail below, revealed the unique nat-
ure of the Pyl binding pocket and provided atomic detail for the 
PylRS/tRNAPyl interaction which underlies the specific and exclu-
sive association between the protein and tRNA. This section of 
the review concludes with an overview of an expanded number 
of possible Pyl-decoding organisms uncovered from recently se-
quenced genomes and metagenomic surveys. 
6. Recognition of Pyl by PylRS 
While PylRS was first crystallized in 2006 [46], the first struc-
ture was solved independently the following year [47]. This struc-
ture of PylRS was determined in complex with Pyl and the Pyl 
analog N-E-[(cyclopentyloxy)carbonyl]-L-lysine (Cyc). As for all 
PylRS structures reported to date the highly insoluble N-terminal 
domain was not included (annotated as pylSn below and in 
Fig. 3). This and other structures reported subsequently describe 
the unique organization of the binding pocket for the large Pyl side 
chain, thus elucidating the principles governing Pyl recognition by 
PylRS [47,48]. The core catalytic domain contains the typical fea-
tures of the class II aaRS family, and structural phylogeny sug-
gested the divergence of PylRS from an ancestral version of 
PheRS early in evolution, i.e., during the time of the last common 
ancestor of all life on earth [47]. 
The structure also revealed that hydrophobic interactions ac-
count for most of the contact surface between PylRS and the Pyl 
or Cyc substrates, but specific recognition is derived from hydrogen 
bonds formed between PylRS and the amino acid substrate 
(Fig. 3A). The interactions of two residues (Asn346 and Arg330 in 
Methanosarcina mazei numbering) with the primary and secondary 
carbonyl of the substrate were noticed in complexes with Pyl or 
Cyc. Although the cyclic components of both substrates were 
bound in a roughly equivalent position in the hydrophobic pocket 
of PylRS, subtle differences in the interactions are likely responsi-
ble for a significantly greater charging efficiency of tRNAPyl with 
Pyl as opposed to Cyc [45,49]. The residue Tyr384 in PylRS is be-
lieved to play an important role in orienting Pyl into the binding 
pocket through its hydrogen bond to the pyrrole ring nitrogen. 
Tyr384 is located on a mobile loop that only appears ordered in 
the presence of the cognate substrate Pyl [47,48]. A report of the 
first bacterial PylRS crystal structure revealed a somewhat more 
sterically constrained active site that can nevertheless accommo-
date Pyl [50]. The large active site of PylRS has been shown to 
accommodate several Pyl analogs [51-53], including some that 
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can be chemically altered post-translationally using "click chemis-
try" to specifically attach fluorescent probes [54,55]. 
7. Molecular basis for the PylRS:tRNAPyl orthogonality 
As is typical for class II aaRSs, PylRS is a dimer of two identical 
subunits, each of which bind one tRNA molecule from the major 
groove side. Each tRNA1 '̂ interacts with one subunit and makes 
few specific contacts with the second protomer. Since PylRS and 
tRNAPyl display no significant cross reactivity with other aaRS/ 
tRNA pairs in native or heterologous contexts [38,56,57], they are 
said to be orthogonal to other aminoacylation systems. Several un-
ique structural features in both the protein and its substrate RNA 
have emerged in the course of evolution that explain the specificity 
of PylRS for its tRNA (Fig. 3B). 
In both archaea and bacteria, the amber suppressor tRNAPyl has 
several unique structural features when compared to canonical 
tRNAs. These include an anticodon stem of six base pairs instead 
of five, a short variable loop of only three bases, a single base sep-
arating the acceptor and D-stems, a small D-loop with only five 
bases, the absence of the almost universally conserved G18G19 se-
quence in the D-loop and the T 54VP55C56 sequence in the T-Loop, 
and a small number of post-transcriptional base modifications. M. 
barkeri tRNA1 '̂ was found to have only a 4-thiouridine at position 8 
and a 1-methyl-pseudouridine at position 50 [45]. 
Crystallization of the Desulfitobacterium hafniense PylRS 
(DhPylRS) in complex with its cognate tRNA provided the first view 
of a naturally evolved orthogonal aaRS/tRNA pair. The structure 
supports what was predicted from sequence, that PylRS/tRNAPyl, 
unlike engineered orthogonal pairs, is highly distinct from even 
the most closely related aaRS/tRNA pair [57]. The structure showed 
that while the unusual features of tRNAPyl do not prevent the for-
mation of the expected L-shape tertiary structure fold, they result 
in a unique core more compact than those seen in canonical tRNAs. 
To match the structural peculiarity of its tRNA substrate, PylRS has 
evolved unique protein domains from which residues emerge and 
engage in specific interactions with tRNAPyl core nucleotides. The 
tRNA core comes in contact with one side of the protein hence 
termed core binding surface. This surface groups the tRNA binding 
domain 1 (N-terminus of pylSc domain), the C-terminal tail and 
helix a6 on the second protomer (Fig. 3B, upper). 
Structural data identified the tRNA core nucleotides involved in 
specific interactions with the protein. Nucleotide G9 and D-stem 
nucleotide pairs G10:C25 and A11:U24 are engaged in a series of 
hydrogen bonding interaction with PylRS amino acid side chains. 
Earlier biochemical evidence had indicated the importance of these 
particular nucleotides for tRNAPyl aminoacylation [49,58]. Their 
mutation resulted in dramatic decrease in aminoacylation effi-
ciency both in vitro and in vivo. It was, however, unclear whether 
the deficient aminoacylation resulted from destabilization of the 
tRNA structure or the direct disruption of specific contacts with 
PylRS. Structural data now unambiguously identify these nucleo-
tides as key elements contributing to the orthogonality of PylRS/ 
tRNA1^1. 
The tRNA binding domain 1, C-terminal tail and bulge domain 
of the opposite subunit form a U shaped concave structure comple-
mentary to the acceptor helix of the tRNA that directs its 3'-termi-
nus toward the PylRS catalytic site (Fig. 3B, lower). The structural 
data also show how PylRS selectively recognizes, through a net-
work of specific hydrogen bonding interactions, the discriminator 
base and the Gl :C72 base pair at the top of the acceptor stem. 
Compelling biochemical evidence demonstrating the critical 
importance of the same nucleotides for the aminoacylation of 
tRNAPyl with pyrrolysine in vitro and in vivo were also obtained 
[49,58]. The discriminator base G73 and the Gl :C72 base pair along 
with those of the core domain define the complete tRNA^1 identity 
set. Transfer of these nucleotides is able to convert a catalytically 
non-competent tRNA substrate into a pyrrolysine accepting tRNA 
[49]. Although biochemical studies have shown that tRNAPyl anti-
codon nucleotides are dispensable for the formation of PylRS/ 
tRNAPyl complex and tRNA aminoacylation, the two bases adjacent 
to the anticodon (U33 and A37) were shown to be identity ele-
ments for the M. mazei PylRS [49]. These two bases are possibly 
recognized in a sequence-specific manner by residues from the 
N-terminal domain, a domain lacking in the DhPylRS and all other 
PylRS crystal structures. 
The strict orthogonality of the PylRS/tRNA^1 system, which 
has been demonstrated [57], and available crystal structures 
have already been exploited for the genetic encoding, and thus 
site-specific incorporation of typically post-translationally modi-
fied amino acids directly into proteins. PylRS variants were se-
lected to generate a mutant that specifically charges tRNA^1 
with N-acetyl-lysine [59]. Wild type PylRS was employed to ami-
noacylate tRNA1'5'1 with a reactive Pyl analog which was chemi-
cally converted to the common histone modification N-methyl-
lysine [60]. 
8. Expanding the Pyl-decoding biosphere 
Data from newly sequenced genomes and metagenomic pro-
jects has doubled the potential number of Pyl-decoding organisms. 
The Pyl-decoding trait is associated with the presence of the Pyl 
operon, which includes genes for the tRNAPyl {pylT) and the PylRS 
{pylS) followed by genes that encode the putative Pyl biosynthetic 
machinery (pylBCD). The Pyl operon is sufficient to encode the 
Pyl-decoding trait as shown by transformation of the operon into 
a heterlogous E. coli context that then supported translational 
read-through of amber codons [38,56]. Earlier reports [37] found 
the Pyl-decoding trait confined to five archaeal organisms from 
the Methanosarcinaceae family and one bacterial organism 
(D. hafniense), while later studies [47,58,61 ] identified components 
of the Pyl operon in a (5-proteobacterial endosymbiont of the 
marine worm Olavius algarvensis, based on sequence data from a 
metagenomic survey [62]. 
There are now four additional examples of the bacterial version 
of the Pyl-trait, and one additional Methanosarcinaceae {Methano-
halophilus mahii) is shown to have the complete Pyl operon 
(Fig. 3C). For reasons unknown, only M. barkeri among the archaea 
appears to deviate from the otherwise strict operonal organization 
and includes a small (100 codon) ORF that is a mutated duplication 
of the 3'-end of pylC. The bacterial examples show greater diversity 
in Pyl operon structure. In keeping with this observation, an up-
dated phylogeny of the PylRS sequences continues to show a clear 
divide between the bacterial and archaeal type PylRSs, with a sta-
tistically significant root placed between the bacterial and archaeal 
clades according to an alignment with other subclass IIC aaRSs. 
While the archaeal Pyl-decoding trait is confined to the Methano-
sarcinaceae, bacterial examples appear in only a few members of 
the phyla Clostridia and <5-proteobacteria. 
A key difference between the archaeal and bacterial PylRS is 
that the bacteria encode the N-terminal domain (about 100 amino 
acids) of PylRS as a separate gene, often at the 3'-end of the operon, 
leading to the organization (pylT, pylSc, pylBCD, pylSn). While the 
evolutionary scenario for the pylS gene split and operonal re-
arrangement was previously unclear, the newly sequenced and 
deepest branching bacterial Pyl-decoding representative Acetohal-
obium arabaticum, appears to display a transitional form. In this 
organism, pylSn terminates 11 bases upstream of and is thus out-
of-frame with pylSc. The phylogeny indicates that the split pylS 
evolved after the divergence of the archaeal and bacterial pylS 
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genes and that the re-arrangement (placement of pylSn at the 3'-
end of the operon) occurred later in bacterial evolution. 
Only two organisms interrupt the Pyl operon with other genes. 
A. arabaticum encodes the Pyl-containing trimethylamine methyl-
transferase (MttB) and cognate corrinoid protein (MttC) in the op-
eron as well as a gene related to N-methylhydantoinase (hyuA) and 
5-oxoprolinase between pylB and pylC. The gene has close homo-
logs in most Pyl-decoding organisms and various bacteria. Proteins 
from this superfamily (hyuA) are typically involved in the break-
down of cyclic amines (similar to the pyrroline ring of Pyl), and this 
gene could be the first example of a catabolic Pyl enzyme. Desfulo-
tomaculum acetoxidans encodes an unknown iron-sulfur protein 
between pylT and pylSc and an exact copy of the 3' 30 bases of 
tRNA^1 downstream of the operon, which is an indication that 
the Pyl operon is on a mobile genetic element [63]. Finally, the 
complete genome of Desulfobacterium autotrophicum contains the 
first example of a degraded Pyl operon, only pylSc and pylB are 
present. Gene loss has been assumed to explain in part the sparsity 
of the Pyl-operon, and this example provides the first evidence of a 
transitional form towards loss of the Pyl-decoding trait. 
9. The 21st and 22nd amino acids promise exciting new 
directions 
The enzymes involved in the archaeal and eukaryotic Sec bio-
synthesis pathways achieve specificity for tRNASec by recognizing 
distinct structural features of the tRNA substrate. While a similar 
theme is observed in the Pyl-decoding system, Sec and Pyl fol-
lowed different evolutionary and metabolic routes to enter the ge-
netic code. Sec relied on a specialized tRNA that is recognized by a 
canonical aaRS and on the evolution of enzymes that specifically 
modify the aminoacyl-tRNA to ultimately form Sec-tRNASec. In con-
trast, Pyl entered the code as a result of the establishment of a 
tRNA-independent biosynthetic pathway and co-evolution of a 
aaRS/tRNA pair that is quite different from its closest known rela-
tives. Despite their differences, both systems will be important for 
future biotechnological applications. Just as detailed biochemical 
and structural investigation of the PylRS:tRNAPyl system facilitated 
the engineering of this orthogonal pair to incorporate other non-
canonical amino acids, the archaeal/eukaryotic Sec-tRNA^0 
synthesis machinery, specifically the intermediate Sep-tRNASec, 
provides another possible means to incorporate phosphoserine or 
possibly other phosphorylated amino acids directly into a growing 
polypeptide chain. 
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